Crohn's disease: A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.
Crohn disease (strict definition, require KELA, min 2 HDR)
K11_CD_STRICT2
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
2982 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2787 |
4. Check minimum number of eventsNone |
2787 |
5. Include endpointsNone |
2787 |
6. Filter based on genotype QC (FinnGen only) |
2684 |
Control definitions (FinnGen only)
- Control conditions
- not K11_KELACROHN
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- K50-K52
- Name in latin
- Morbus Crohn
Similar endpoints
↥List of similar endpoints to
Crohn disease (strict definition, require KELA, min 2 HDR)
based on the number of shared cases.
Similar with more cases:
- Crohn disease (strict definition, require KELA)
- Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)
- Crohn disease
- IBD patients in KELA-register
- Inflammatory bowel disease, strict (require KELA)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12555 | 6354 | 6153 |
| Only index persons | 12138 | 6175 | 5963 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.18 | 0.17 |
| Only index persons | 0.23 | 0.23 | 0.23 |
| Median age at first event (years) | |||
| Whole population | 35.44 | 35.86 | 34.99 |
| Only index persons | 35.17 | 35.59 | 34.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2684 | 1552 | 1132 |
| Unadjusted period prevalence (%) | 0.54 | 0.55 | 0.52 |
| Median age at first event (years) | 39.76 | 38.58 | 41.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2787
- Matched controls
- 27870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K50.9
ICD-10 Finland
Crohn disease, unspecified
379.8
307.7
1522
88
L04AC05
ATC
ustekinumab; parenteral
79.3
307.7
298
42
L04AX03
ATC
methotrexate; systemic
6.8
307.7
761
1451
UJF30
NOMESCO Finland
Ileoscopy through colon
23.8
307.7
1588
1469
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
7.7
307.7
1660
4460
UJF32
NOMESCO Finland
Coloscopy
19.3
307.7
2078
3674
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
14.1
307.7
473
398
256, ,
Kela drug reimbursment
202.8
307.7
241
13
L04AB04
ATC
adalimumab; parenteral
29.2
307.7
667
297
ZX120
NOMESCO Finland
Intravenous
6.7
307.7
639
1190
UJF92
NOMESCO Finland
Capsular endoscopy
53.9
307.7
809
210
K50.8
ICD-10 Finland
Other Crohn disease
585.7
307.7
1839
92
K50
ICD-10 Finland
Crohn disease [regional enteritis]
332.6
307.7
447
16
L01BB02
ATC
mercaptopurine; oral
70.0
307.7
652
121
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
135.8
307.7
366
31
L04AX01
ATC
azathioprine; systemic
73.2
307.7
1585
493
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
229.4
307.7
212
10
D94
ICPC
Chronic enteritis/ulcerative colitis
43.4
307.7
264
67
C10AC01
ATC
colestyramine; oral
15.3
307.7
367
273
A07EA06
ATC
budesonide; oral, local oral
128.1
307.7
1819
403
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
12.2
307.7
483
469
3042, ,
Kela drug reimbursment
88.4
307.7
182
22
JF1AD
NOMESCO Finland
Small bowel CT
59.3
307.7
249
46
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
121.8
307.7
580
60
K50.0
ICD-10 Finland
Crohn disease of small intestine
741.7
307.7
1913
82
H02AB06
ATC
prednisolone; systemic
5.3
307.7
2000
9063
K50.1
ICD-10 Finland
Crohn disease of large intestine
325.4
307.7
1225
67
JF1BD
NOMESCO Finland
Very extensive small bowel CT
75.8
307.7
204
29
A07EC02
ATC
mesalazine; oral, rectal
63.4
307.7
1710
681
L04AB02
ATC
infliximab; parenteral
41.0
307.7
237
63
253, ,
Kela drug reimbursment
88.4
307.7
182
22
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.7
307.7
1329
4548
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
307.7
2787
535
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
122.6
307.7
939
115
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
26.1
293.9
206
85
JFB20
NOMESCO Finland
Ileocaecal resection
41.1
280.0
170
44
P01AB01
ATC
metronidazole; oral, rectal
3.8
260.7
1661
7777
A07EC01
ATC
sulfasalazine; oral, rectal
5.9
258.9
536
1087
4AA12, ,
NOMESCO Finland
48.4
252.0
147
32
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.7
251.6
254
219
L04AG05
ATC
vedolizumab; parenteral
65.9
251.2
138
22
L04AA33
ATC
[U] vedolizumab
105.4
234.8
121
12
4AB02, ,
NOMESCO Finland
42.1
232.3
140
35
K51.5
ICD-10 Finland
Left sided colitis
8.8
230.7
306
385
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.4
228.2
314
413
A07EA02
ATC
hydrocortisone; rectal
11.7
225.9
239
221
JFB00
NOMESCO Finland
Partial resection of small intestine
19.0
210.4
168
94
J01MA02
ATC
ciprofloxacin; systemic
3.3
202.1
1389
6522
K51.8
ICD-10 Finland
Other ulcerative colitis
12.9
200.6
198
164
H02AB07
ATC
prednisone; oral
4.3
197.2
623
1768
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
27.3
194.1
133
51
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.8
192.3
500
1219
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.1
190.7
1523
7724
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
16.8
187.9
159
100
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
20.6
183.8
141
72
B03BA03
ATC
hydroxocobalamin; parenteral
7.3
183.2
285
429
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
171.9
1536
8146
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
18.7
152.7
122
68
WX002
NOMESCO Finland
Sedation and analgesia
3.3
149.8
722
2674
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
147.9
852
3498
K60.3
ICD-10 Finland
Anal fistula
9.2
147.8
184
212
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
8.7
136.6
178
217
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.5
135.6
366
908
UJF02
NOMESCO Finland
Peroral enteroscopy
28.0
128.4
87
32
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.6
125.0
323
773
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
46.8
124.3
73
16
K56.7
ICD-10 Finland
Ileus, unspecified
11.5
121.0
127
115
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
10.5
118.1
132
131
WVA20
NOMESCO Finland
Medicine administration
6.5
115.9
197
323
B81
ICPC
Anaemia vit B12/folate deficiency
6.9
115.1
183
280
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
108.1
516
1868
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.0
106.7
568
2188
A02BC02
ATC
pantoprazole; systemic
2.6
106.0
2026
14189
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
10.2
103.7
118
120
JHA00
NOMESCO Finland
Anal or perianal incision
8.0
102.9
142
185
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
98.9
410
1359
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.7
95.0
326
955
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
93.6
808
3945
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
92.5
792
3850
K61.0
ICD-10 Finland
Anal abscess
6.8
91.4
146
224
M45
ICD-10 Finland
Ankylosing spondylitis
6.4
90.7
155
255
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
90.6
522
2085
K83.0
ICD-10 Finland
Cholangitis
9.9
89.3
104
109
L04AF03
ATC
upadacitinib; oral
18.0
88.9
72
41
N02AX02
ATC
tramadol; systemic, rectal
2.2
87.6
1274
7713
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
33.6
87.5
56
17
107
Kela drug reimbursment
Pernicious anaemia
9.5
83.4
100
109
3AC01, ,
NOMESCO Finland
11.4
79.0
83
75
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
43.4
78.5
47
11
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
21.1
77.0
58
28
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
76.7
222
574
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
105.6
75.3
82
8
L04AC18
ATC
risankizumab; parenteral
25.2
74.0
52
21
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
92.7
73.3
81
9
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.7
73.2
94
112
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
726.8
72.5
71
*
L01BA01
ATC
methotrexate; systemic
4.7
72.5
172
381
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
361.3
71.0
71
*
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
23.1
68.8
50
22
A02BC01
ATC
omeprazole; systemic
2.2
68.8
783
4218
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.8
68.4
219
608
JFB30
NOMESCO Finland
Right hemicolectomy
11.0
65.4
70
65
Z93.2
ICD-10 Finland
Ileostomy status
20.3
65.3
50
25
WW200
NOMESCO Finland
Immunization
4.8
63.9
150
329
A02BC03
ATC
lansoprazole; oral
2.1
63.7
778
4288
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
62.3
456
2024
298, ,
Kela drug reimbursment
13.4
61.4
58
44
JAH00
NOMESCO Finland
Laparotomy
5.4
57.7
117
226
3029
Kela drug reimbursment
Upadacitinib
12.1
57.5
58
49
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.0
57.4
126
261
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
56.5
770
4391
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
53.6
712
4012
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
5.1
52.7
114
233
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
52.0
272
1017
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
51.9
365
1582
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
6.4
51.8
86
137
R50.9
ICD-10 Finland
Fever, unspecified
2.2
51.1
524
2671
H02AB09
ATC
hydrocortisone; systemic
4.4
49.6
126
294
4AA33, ,
NOMESCO Finland
80.2
49.1
55
7
A05AA02
ATC
ursodeoxycholic acid; oral
5.0
48.7
106
218
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
90.1
48.0
53
6
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.9
47.4
234
846
WZC30
NOMESCO Finland
Teaching
2.2
47.0
493
2530
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.6
46.7
303
1262
UJD02
NOMESCO Finland
Gastroscopy
3.6
46.5
162
475
JHD20
NOMESCO Finland
Incision of fistula-in-ano
7.1
46.2
70
101
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
16.5
46.1
39
24
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.4
45.1
169
519
A02BC05
ATC
esomeprazole; systemic
1.8
44.7
1096
7445
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
44.6
195
658
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
17.0
44.5
37
22
D01
ICPC
Abdominal pain/cramps general
2.1
43.9
463
2375
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.3
43.8
114
271
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
223.4
43.0
44
*
N02BE01
ATC
paracetamol; systemic, rectal
2.3
42.2
2469
21552
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.8
42.2
226
853
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.7
42.0
242
949
K29.8
ICD-10 Finland
Duodenitis
9.2
41.3
50
55
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
40.5
259
1069
5550A
ICD-9 Finland
Regional enteritis, Small intestine
109.2
39.8
43
*
A07AA09
ATC
vancomycin; oral
6.5
39.7
65
102
K59.1
ICD-10 Finland
Functional diarrhoea
2.8
39.7
212
799
J01MA12
ATC
levofloxacin; systemic
2.0
39.4
467
2496
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.7
39.3
73
130
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
39.2
555
3156
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.3
39.2
103
247
K92.1
ICD-10 Finland
Melaena
3.3
39.0
153
483
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.6
38.9
94
211
A06AC51
ATC
ispaghula, combinations; oral
3.2
38.2
158
515
C05AA08
ATC
fluocortolone; rectal, topical
2.2
37.5
359
1767
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
37.1
1258
9198
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
70.9
37.0
42
6
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.7
37.0
87
191
5551A
ICD-9 Finland
Regional enteritis, Large intestine
192.6
36.9
38
*
1370
FHL
Colonoscopy, whole colon
12.1
36.8
37
31
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
36.7
277
1233
WX402
NOMESCO Finland
General anaesthesia
1.8
35.7
683
4257
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
35.5
777
5036
J01DB01
ATC
cefalexin; oral
1.9
35.4
2343
20381
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
8.0
35.4
48
61
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
351.6
35.0
35
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
34.7
653
4046
K61.1
ICD-10 Finland
Rectal abscess
11.4
34.5
36
32
ZX112
NOMESCO Finland
Subcutaneous
4.4
33.8
86
201
A02BA02
ATC
ranitidine; systemic
2.0
32.6
434
2404
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
32.6
1240
9237
K56.0
ICD-10 Finland
Paralytic ileus
7.7
32.3
45
59
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
6.2
32.3
55
90
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
62.5
32.1
37
6
UJH02
NOMESCO Finland
Anoscopy
3.1
32.0
136
451
ZXE00
NOMESCO Finland
One hour or less
1.6
32.0
1038
7427
UJF30, ,
SPAT
6.1
31.9
55
91
K29.7
ICD-10 Finland
Gastritis, unspecified
3.3
31.4
120
373
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
31.1
414
2292
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.8
31.0
97
264
A07DA03
ATC
loperamide; oral
3.8
30.9
97
265
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
29.6
1161
8650
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
29.1
921
6513
E0000UV, ,
ATC
1.6
29.1
1172
8775
B80
ICPC
Iron deficiency anaemia
3.4
29.1
105
315
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
9.8
28.6
33
34
JAH01
NOMESCO Finland
Laparoscopy
2.7
28.2
157
603
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
28.1
130
452
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
28.0
862
6044
D07AC01
ATC
betamethasone; topical
1.6
28.0
953
6845
ZXD05
NOMESCO Finland
Urgent procedure
1.6
27.8
810
5600
J05AB11
ATC
valaciclovir; oral
1.9
27.7
414
2374
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
27.7
93
266
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
27.6
1003
7307
B02.9
ICD-10 Finland
Zoster without complication
2.5
27.4
183
768
D99
ICPC
Disease digestive system other
5.7
27.4
51
91
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
4.3
27.3
71
169
JFA60
NOMESCO Finland
Stricturoplasty in small intestine
273.6
26.8
27
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
7.9
26.4
36
46
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
26.3
908
6521
K65.0
ICD-10 Finland
Acute peritonitis
6.3
26.2
44
71
D07XC01
ATC
betamethasone; topical
2.0
25.9
318
1707
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
25.8
79
212
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
25.7
533
3362
4AC05, ,
NOMESCO Finland
136.3
25.6
27
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.6
25.3
83
234
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.2
25.0
100
320
TJF80
NOMESCO Finland
Ostomy education
6.5
24.7
40
62
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
10.1
24.7
28
28
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.6
24.6
81
229
WX004
NOMESCO Finland
Patient-controlled sedation
9.4
24.4
29
31
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
24.1
181
801
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
24.0
1033
7752
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
56.5
24.0
28
5
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.4
24.0
47
88
H02AB04
ATC
methylprednisolone; systemic
1.9
23.9
358
2048
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.4
23.7
59
136
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
23.2
574
3783
K60.2
ICD-10 Finland
Anal fissure, unspecified
3.6
23.1
77
219
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.8
22.8
113
409
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.9
22.8
109
387
L52
ICD-10 Finland
Erythema nodosum
5.8
22.4
41
72
UJF34
NOMESCO Finland
Left colonoscopy
8.0
22.2
30
38
J02AC01
ATC
fluconazole; systemic
1.5
22.1
1026
7789
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.4
22.0
81
246
M05BA04
ATC
alendronic acid; oral
2.4
22.0
155
667
UJG02
NOMESCO Finland
Proctoscopy
3.6
21.7
71
200
D11
ICPC
Diarrhoea
1.8
21.6
401
2442
R11
ICD-10 Finland
Nausea and vomiting
2.0
21.6
261
1389
K60.1
ICD-10 Finland
Chronic anal fissure
3.2
21.6
88
285
B01AB05
ATC
enoxaparin; parenteral
1.6
21.5
691
4841
A03CA02
ATC
clidinium and psycholeptics; oral
2.7
21.3
120
464
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
20.9
21.2
31
15
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
21.1
376
2262
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
20.7
781
5659
S01BA01
ATC
dexamethasone; ophthalmic
2.9
20.4
94
327
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.1
20.4
55
135
R10.0
ICD-10 Finland
Acute abdomen
2.7
20.3
109
411
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
20.3
158
710
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
6.0
20.0
35
59
M01AH01
ATC
celecoxib; oral
1.7
19.9
385
2370
Z2221
NOMESCO Finland
Medical doctor
1.5
19.8
698
4979
WW500
NOMESCO Finland
Blood transfusion
2.7
19.6
107
407
JFF13
NOMESCO Finland
Terminal enterostomy
16.5
19.6
31
19
Z3231
NOMESCO Finland
Registered nurse
1.5
19.6
663
4684
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
19.5
201
1011
D07AD01
ATC
clobetasol; topical
1.7
19.3
418
2650
WX610
NOMESCO Finland
Patient controlled analgesia
5.5
19.3
37
68
E86
ICD-10 Finland
Volume depletion
3.7
19.1
59
160
J05AB01
ATC
aciclovir; systemic
1.6
19.0
562
3847
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.7
18.9
59
161
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
18.7
276
1568
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
18.6
150
685
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
18.5
130
559
Z93.3
ICD-10 Finland
Colostomy status
6.3
18.5
31
50
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.1
18.4
38
75
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.6
18.3
103
398
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.3
18.3
68
208
R4190
NOMESCO Finland
Nutritional therapy
2.3
18.3
136
599
K60.4
ICD-10 Finland
Rectal fistula
17.7
18.2
28
16
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
4.1
18.2
49
120
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
18.1
269
1532
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
18.0
1624
13792
JFF10
NOMESCO Finland
Loop enterostomy
6.5
17.9
29
45
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
67.0
17.7
20
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
17.6
177
881
J01FF01
ATC
clindamycin; systemic
1.5
17.5
661
4763
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
17.5
204
1072
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.2
17.4
46
111
UJK02
NOMESCO Finland
ERCP
3.3
17.4
64
195
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
17.4
2027
17978
K30
ICD-10 Finland
Functional dyspepsia
1.7
17.1
313
1895
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
31.7
17.0
22
7
J01AA02
ATC
doxycycline; systemic
1.4
17.0
1921
16892
S18
ICPC
Laceration/cut
1.4
16.8
1123
9007
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
16.7
288
1713
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.7
16.7
52
142
SPAT1153
SPAT
Removal of sutures
1.5
16.6
667
4862
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.1
16.5
167
834
K60.0
ICD-10 Finland
Acute anal fissure
3.7
16.5
52
143
SPAT1263
SPAT
Sampling
1.4
16.4
1058
8419
JEA00
NOMESCO Finland
Appendectomy
2.0
16.4
188
982
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
16.4
91
350
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
16.2
134
618
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.5
16.2
55
159
SPAT1255
SPAT
Intravenous administration of medicine
2.1
16.1
154
753
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
16.0
306
1872
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
3.9
15.9
46
119
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
15.8
260
1526
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
15.7
113
491
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
5.0
15.7
33
66
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
15.7
241
1384
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
15.7
141
673
A03FA02
ATC
cisapride; oral, rectal
2.1
15.7
153
754
KH1AD
NOMESCO Finland
CT of urinary organs
2.5
15.6
97
394
6404
FHL
Hemicolectomy on the right
+∞
15.6
15
*
D07AC13
ATC
mometasone; topical
1.5
15.6
712
5311
JF1CD
NOMESCO Finland
Extensive small bowel CT
85.6
15.6
17
*
QBA10
NOMESCO Finland
Incision of skin of trunk
4.2
15.6
41
99
K63.2
ICD-10 Finland
Fistula of intestine
19.3
15.5
23
12
S01FA02
ATC
scopolamine; ophthalmic
5.8
15.4
28
49
R51.80
ICD-10 Finland
Headache
1.5
15.2
462
3170
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
15.1
87
341
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
23.5
15.1
21
9
JFB01
NOMESCO Finland
Laparoscopic partial resection of small intestine
20.1
15.1
22
11
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.6
14.9
48
134
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
14.8
452
3101
B07.9
ICD-10 Finland
Verruca simplex
2.2
14.8
125
582
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.8
14.8
72
259
K85
ICD-10 Finland
Acute pancreatitis
3.7
14.7
46
126
D06
ICPC
Abdominal pain localized other
1.8
14.7
245
1443
K51
ICD-10 Finland
Ulcerative colitis
3.6
14.6
48
136
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
14.6
506
3568
5559X
ICD-9 Finland
Regional enteritis, Unspecified site
80.5
14.6
16
*
JFA96
NOMESCO Finland
Other local operation on intestine
80.5
14.6
16
*
E000001, ,
ATC
1.5
14.4
517
3673
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
14.3
269
1637
D06BX01
ATC
metronidazole; topical
1.7
14.3
261
1576
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
14.3
229
1332
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
6.2
14.2
24
39
Z93
ICD-10 Finland
Artificial opening status
13.4
14.2
24
18
L73.8
ICD-10 Finland
Other specified follicular disorders
3.6
14.2
47
134
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.5
14.1
91
377
L04AB06
ATC
golimumab; parenteral
4.0
14.1
39
98
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
12.0
14.1
25
21
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.7
14.1
43
116
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
14.0
125
596
JFH10
NOMESCO Finland
Total colectomy and ileostomy
20.1
13.8
20
10
M50.8
ICD-10 Finland
Other cervical disc disorders
6.3
13.7
23
37
JKA20
NOMESCO Finland
Cholecystectomy
3.1
13.7
55
177
M25.5
ICD-10 Finland
Pain in joint
1.4
13.7
874
6893
J01DA01
ATC
[U] cefalexin
1.4
13.7
1545
13330
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.0
13.6
153
794
Z01.2
ICD-10 Finland
Dental examination
1.4
13.5
1319
11117
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
13.5
148
762
JFB96
NOMESCO Finland
Other partial excision of intestine
140.7
13.5
14
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
13.4
256
1566
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
13.2
194
1100
6403
FHL
Ileocal resection
40.3
13.1
16
*
A01AB09
ATC
miconazole; local oral
1.8
13.1
184
1028
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
13.1
93
403
L88
ICPC
Rheumatoid/seropositive arthritis
2.2
13.0
105
481
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
3.8
12.9
38
100
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
4.7
12.8
29
62
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
12.8
1419
12155
L04AD01
ATC
ciclosporin; systemic
2.9
12.8
60
212
A02BA03
ATC
famotidine; systemic
2.7
12.7
67
252
B01AB10
ATC
tinzaparin; parenteral
1.7
12.7
242
1479
R03AC02
ATC
salbutamol; inhalant
1.3
12.6
1440
12379
M81.4
ICD-10 Finland
Drug-induced osteoporosis
9.3
12.5
25
27
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.4
499
3614
L88
ICD-10 Finland
Pyoderma gangrenosum
13.2
12.4
21
16
A07AA02
ATC
nystatin; oral
2.1
12.4
120
590
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.0
12.4
34
85
L40.8
ICD-10 Finland
Other psoriasis
4.6
12.4
29
64
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
12.3
889
7129
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
5.8
12.3
22
38
B82
ICPC
Anaemia other/unspecified
2.7
12.2
66
251
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
4.3
12.2
31
73
K02.1
ICD-10 Finland
Caries of dentine
1.3
12.2
1696
14973
WVA30, ,
SPAT
1.9
12.1
157
856
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.7
12.1
245
1521
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
26.8
12.0
16
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
12.0
243
1507
JFA70
NOMESCO Finland
Suture of small intestine
8.7
12.0
25
29
6455
FHL
Perianal fistula surgery
8.7
12.0
25
29
JFB46
NOMESCO Finland
Resection of sigmoid colon
4.2
12.0
31
74
N06AX11
ATC
mirtazapine; oral
1.4
11.9
829
6599
N03AX16
ATC
[U] pregabalin
1.5
11.8
493
3592
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
11.8
126
642
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
5.1
11.7
24
47
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
3.5
11.7
40
117
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
30.1
11.6
15
5
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
11.6
257
1633
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.5
11.5
69
277
TPH04, ,
SPAT
3.8
11.5
34
90
K63.8
ICD-10 Finland
Other specified diseases of intestine
13.7
11.4
19
14
J01FA06
ATC
roxithromycin; oral
1.3
11.3
901
7310
JK3MN
NOMESCO Finland
Bile absorbtion isotope examination
35.2
11.3
14
*
J01DA09
ATC
[U] cefadroxil
1.4
11.2
649
5007
D05AX52
ATC
calcipotriol, combinations; topical
1.9
11.2
130
683
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
11.2
117
593
M54.5
ICD-10 Finland
Low back pain
1.3
11.1
953
7811
6402
FHL
Small bowel resection
20.1
11.1
16
8
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
11.1
2022
18430
K13.78
ICD-10 Finland
Other change in the oral mucosa
2.5
11.1
68
276
RD210, ,
NOMESCO Finland
2.7
11.1
60
229
N05CF02
ATC
zolpidem; oral
1.5
11.1
410
2919
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
13.9
11.0
18
13
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
4.5
10.9
26
58
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.7
10.9
59
225
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
10.8
2228
23642
K03.66
ICD-10 Finland
Tooth plaque
1.7
10.8
207
1266
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.5
10.8
64
256
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.9
10.8
50
176
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
10.6
188
1125
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.5
10.6
35
100
Z94.4
ICD-10 Finland
Liver transplant status
5.3
10.6
21
40
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.7
10.6
54
200
A06AD11
ATC
lactulose; oral
1.6
10.5
244
1566
S10
ICPC
Boil/carbuncle
1.8
10.5
159
909
R52.9
ICD-10 Finland
Pain, unspecified
1.6
10.5
253
1639
S01BA04
ATC
prednisolone; ophthalmic
2.8
10.4
50
179
R06AE07
ATC
cetirizine; oral
1.3
10.4
1160
9841
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
10.3
102
506
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
10.3
135
738
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
10.3
239
1536
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.9
10.3
22
45
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
4.6
10.2
24
53
J01FA10
ATC
azithromycin; systemic
1.3
10.2
1584
14030
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
10.1
304
2070
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
10.1
258
1694
ZX114
NOMESCO Finland
Intramuscular
2.9
10.1
46
160
JN4AD
NOMESCO Finland
Body CT examination
1.6
10.1
218
1375
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
10.1
85
397
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
10.0
87
411
A04AA01
ATC
ondansetron; systemic, rectal
1.7
10.0
176
1052
D95
ICPC
Anal fissure/perianal abscess
3.2
10.0
38
119
K63.0
ICD-10 Finland
Abscess of intestine
14.6
10.0
16
11
4AA17, ,
NOMESCO Finland
40.2
10.0
12
*
L71.9
ICD-10 Finland
Rosacea, unspecified
2.3
9.9
72
316
H15.1
ICD-10 Finland
Episcleritis
2.8
9.9
48
173
S21
ICPC
Skin texture symptom/complaint
1.5
9.9
346
2432
A02BX02
ATC
sucralfate; oral
2.3
9.9
71
310
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.2
9.9
81
374
B02
ICD-10 Finland
Zoster [herpes zoster]
2.0
9.9
108
557
A03
ICPC
Fever
1.4
9.8
522
3961
M79.7
ICD-10 Finland
Fibromyalgia
2.1
9.8
93
455
SFA20
NOMESCO Finland
Two-surface restoration
1.3
9.8
1603
14255
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
4.7
9.8
22
47
K61.2
ICD-10 Finland
Anorectal abscess
9.6
9.8
19
20
M03BX02
ATC
tizanidine; oral
1.3
9.7
1590
14129
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
9.7
1926
17557
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
2.8
9.7
48
175
SFA10
NOMESCO Finland
One-surface restoration
1.3
9.7
1515
13386
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
9.6
705
5623
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.6
9.6
54
211
M79.6
ICD-10 Finland
Pain in limb
1.3
9.5
1083
9183
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
9.5
296
2034
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
9.4
197
1233
A02BC04
ATC
rabeprazole; oral
1.6
9.4
213
1360
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
9.4
600
4687
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.2
9.4
24
57
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
3.1
9.4
38
124
WX290
NOMESCO Finland
Other blockage of nerve
1.3
9.3
1414
12421
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
8.7
9.3
19
22
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
9.3
235
3477
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.0
9.3
39
130
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
9.3
252
1680
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
9.2
74
339
R01AD12
ATC
fluticasone furoate; nasal
1.3
9.2
878
7260
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
9.2
367
2645
L57.0
ICD-10 Finland
Actinic keratosis
1.7
9.2
150
879
N07BA03
ATC
varenicline; oral
1.8
9.2
135
767
A07EC03
ATC
olsalazine; oral
13.7
9.2
15
11
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.8
9.2
126
701
UKC02
NOMESCO Finland
Cystoscopy
1.5
9.2
258
1733
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
9.1
189
1180
JHD10
NOMESCO Finland
Myotomy of anal sphincter
5.0
9.1
19
38
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
5.0
9.1
19
38
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
9.1
286
1968
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
11.5
9.1
16
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
9.0
452
3392
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
15.6
9.0
14
9
D82
ICPC
Teeth/gum disease
1.3
9.0
1056
8966
SPAT1325
SPAT
Vaccination
1.3
8.9
666
5318
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
8.9
133
760
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
8.8
235
1559
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
8.8
486
3705
ZY010
NOMESCO Finland
Hospital outpatient
1.7
8.8
161
973
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.9
8.8
117
644
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
8.8
322
2283
K13.00
ICD-10 Finland
Cheilitis NOS
4.0
8.8
24
60
UJK12
NOMESCO Finland
Peroral cholangioscopy
9.5
8.8
17
18
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.8
8.8
42
151
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.7
549
4272
R2110
NOMESCO Finland
Giving the first information
1.7
8.7
156
937
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.0
8.7
98
511
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.1
8.7
82
401
M79.1
ICD-10 Finland
Myalgia
1.4
8.6
394
2909
JN2AD
NOMESCO Finland
CT examination of lower part of abdomen
7.6
8.6
19
25
K63.9
ICD-10 Finland
Disease of intestine, unspecified
4.4
8.6
21
48
K85.8
ICD-10 Finland
Other acute pancreatitis
4.0
8.6
24
61
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.9
8.6
39
136
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
8.6
128
731
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
4.1
8.5
23
57
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.1
8.5
23
57
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
6.4
8.5
21
33
K85.3
ICD-10 Finland
Drug-induced acute pancreatitis
20.1
8.5
12
6
S29
ICPC
Skin symptom/complaint other
1.4
8.5
462
3516
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.1
8.4
82
406
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
8.4
1437
12738
T91
ICPC
Vitamin/nutritional deficiency
3.9
8.4
24
62
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
7.9
8.4
18
23
J01CA04
ATC
amoxicillin; systemic
1.3
8.3
2246
21070
E000002, ,
ATC
1.5
8.3
274
1902
56510
ICD-8 Finland
Anal fissure and fistula, Anal fistula
10.8
8.3
15
14
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
8.3
570
4494
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.8
8.3
39
139
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
8.2
552
4336
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
8.2
131
763
N06AX21
ATC
duloxetine; oral
1.5
8.2
287
2018
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
4.4
8.1
20
46
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
8.1
84
426
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
3.2
8.1
31
98
D07AB08
ATC
desonide; topical
1.5
8.0
254
1748
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
8.0
148
897
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
8.0
71
339
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
8.9
8.0
16
18
JHC60
NOMESCO Finland
Transanal submucous or intersphincteric injection
8.9
8.0
16
18
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
10.0
8.0
15
15
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
10.0
8.0
15
15
D28
ICPC
Limited function/disability (D)
10.0
8.0
15
15
JFB43
NOMESCO Finland
Left hemicolectomy
6.3
8.0
20
32
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.0
263
3700
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.4
8.0
51
212
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
8.0
129
755
A02BA04
ATC
nizatidine; systemic
1.8
7.9
120
688
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
7.9
298
2122
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
7.9
89
464
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.3
7.9
20
47
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.9
930
7870
L04AA01
ATC
[U] ciclosporin
3.1
7.9
32
105
N05BA04
ATC
oxazepam; oral
1.3
7.8
586
4672
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
7.8
121
699
SCA02
NOMESCO Finland
Preventive oral health care
1.4
7.8
301
2156
E87.6
ICD-10 Finland
Hypokalaemia
2.1
7.7
72
351
M01AX17
ATC
nimesulide; oral
1.4
7.7
417
3164
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
45.1
7.7
9
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.7
1482
13262
M01AH02
ATC
rofecoxib; oral
1.5
7.7
208
1385
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
7.7
220
1483
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
7.7
1206
10548
M04AA01
ATC
allopurinol; systemic
1.6
7.7
187
1217
SPAT1312
SPAT
General health counselling
1.3
7.6
769
6378
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
7.6
576
4599
K90.4
ICD-10 Finland
Malabsorption due to intolerance, not elsewhere classified
18.4
7.6
11
6
R07.0
ICD-10 Finland
Pain in throat
1.5
7.6
212
1422
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
7.6
146
896
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
2.5
7.6
47
193
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
6.7
7.6
18
27
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.6
7.6
24
67
JFC20
NOMESCO Finland
Other enterocolostomy
25.1
7.6
10
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.9
7.6
89
472
OAB93, ,
SPAT
1.5
7.6
215
1448
R01AD58
ATC
fluticasone, combinations; nasal
1.3
7.6
697
5714
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.1
7.5
20
49
ULA02
NOMESCO Finland
Kolposcopy
1.5
7.5
232
1589
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.7
7.5
141
860
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.7
7.5
39
147
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
7.4
119
695
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.5
7.4
45
183
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
7.4
254
1779
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
7.4
523
4135
K80.8
ICD-10 Finland
Other cholelithiasis
2.6
7.3
42
166
K76.9
ICD-10 Finland
Liver disease, unspecified
2.8
7.3
35
126
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
7.3
190
1255
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.2
7.3
60
279
JHD96
NOMESCO Finland
Other incision of anal sphincter
9.4
7.3
14
15
6451
FHL
Dilatation
4.2
7.3
19
46
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
7.3
617
5001
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.3
7.2
54
241
L20.0
ICD-10 Finland
Besnier prurigo
1.5
7.2
229
1577
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
6.2
7.2
18
29
A07EA01
ATC
prednisolone; oral, rectal
6.2
7.2
18
29
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.8
7.2
35
127
UDC00
NOMESCO Finland
Ear microscopy
1.6
7.2
162
1034
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.9
7.2
33
116
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
4.3
7.2
18
42
K92.0
ICD-10 Finland
Haematemesis
2.4
7.2
47
198
JJC00
NOMESCO Finland
Allogenic transplantation of liver
7.3
7.2
16
22
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
7.2
66
321
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
30.1
7.1
9
*
1380
FHL
Colonoscopy, left side
20.1
7.1
10
5
Q43.0
ICD-10 Finland
Meckel diverticulum
20.1
7.1
10
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.8
7.1
94
518
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
7.1
54
243
K29.6
ICD-10 Finland
Other gastritis
3.0
7.0
29
96
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
7.0
224
1545
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
7.0
384
2920
JAD10
NOMESCO Finland
Repair of incisional hernia
3.9
7.0
20
52
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
3.9
7.0
20
52
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.0
1064
9244
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.4
7.0
47
201
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.2
7.0
53
239
M02AA10
ATC
ketoprofen; topical
1.4
7.0
301
2200
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.3
7.0
50
220
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.5
6.9
221
1524
J01CF05
ATC
flucloxacillin; systemic
1.6
6.9
176
1156
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.9
6.9
89
487
SPAT1254
SPAT
Administration of medicine
1.4
6.9
298
2177
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.3
6.9
51
227
A02BB01
ATC
misoprostol; oral
5.5
6.9
19
35
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
6.9
75
388
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
4.0
6.9
19
48
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.9
6.8
30
103
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
2.7
6.8
35
131
SFA30
NOMESCO Finland
Three-surface restoration
1.2
6.8
1010
8740
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
6.8
137
851
EB1VA, ,
NOMESCO Finland
1.3
6.8
447
3492
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.0
6.8
69
348
F45.0
ICD-10 Finland
Somatization disorder
4.1
6.8
18
44
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
9.3
6.8
13
14
SPAT1260
SPAT
Consultation of another employee
1.4
6.8
359
2715
N06AX16
ATC
venlafaxine; oral
1.4
6.8
366
2777
4AB04, ,
NOMESCO Finland
40.1
6.8
8
*
K11.2
ICD-10 Finland
Sialoadenitis
1.9
6.7
78
412
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
4.3
6.7
17
40
TEA00
NOMESCO Finland
Biopsy of lip
3.2
6.7
25
78
H57.1
ICD-10 Finland
Ocular pain
1.7
6.7
106
618
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.5
6.7
40
162
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
6.7
908
7780
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
6.6
548
4421
LEB00
NOMESCO Finland
Biopsy of vagina
2.6
6.6
37
145
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
7.8
6.6
14
18
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.6
623
5111
S97
ICPC
Chronic ulcer skin
1.8
6.6
103
598
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
6.6
358
2719
WVA20, ,
SPAT
1.9
6.6
83
452
A04
ICPC
Weakness/tiredness general
1.4
6.6
372
2843
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.5
6.5
224
1568
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.5
861
7348
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.9
6.5
30
106
N02BF02
ATC
pregabalin; oral
1.6
6.5
152
981
ZX100
NOMESCO Finland
Oral
2.8
6.5
31
112
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.7
6.5
20
55
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
5.3
6.5
18
34
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.7
6.4
32
118
A55
ICPC
General and Unspecified, Local injection/infiltration
2.5
6.4
37
147
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.8
6.4
93
528
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.5
6.4
185
1250
JGB40
NOMESCO Finland
Excision of rectum and end ileostomy
70.0
6.4
7
*
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
6.4
636
5247
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.9
6.4
76
405
N32.1
ICD-10 Finland
Vesicointestinal fistula
7.4
6.4
14
19
N03AX12
ATC
[U] gabapentin; oral
1.4
6.4
320
2397
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
6.4
680
5659
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.5
6.4
170
1130
127
Kela drug reimbursment
Transplant complication
2.4
6.4
41
172
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.3
6.4
45
197
E000007, ,
ATC
1.6
6.3
126
781
R06AX27
ATC
desloratadine; oral
1.3
6.3
779
6595
A07AA11
ATC
rifaximin; oral
6.0
6.3
16
27
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
5.5
6.3
17
31
R60.0
ICD-10 Finland
Localized oedema
1.5
6.3
223
1572
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.5
6.3
21
61
5608A
ICD-9 Finland
Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]
9.3
6.3
12
13
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.3
250
1802
JFB34
NOMESCO Finland
Other laparoscopic resection comprising small intestine and colon
+∞
6.3
6
*
392
Kela drug reimbursment
Ferric maltol
+∞
6.3
6
*
R01AD08
ATC
fluticasone; nasal
1.3
6.2
696
5823
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
6.2
228
1617
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
6.2
218
1534
K83.1
ICD-10 Finland
Obstruction of bile duct
2.9
6.2
28
98
ECA20
NOMESCO Finland
Biopsy of gingiva
3.1
6.2
25
82
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.7
6.2
31
115
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.8
6.2
85
476
K56.2
ICD-10 Finland
Volvulus
4.0
6.2
17
43
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.6
6.1
142
914
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
5.7
6.1
16
28
F01
ICPC
Eye pain
1.9
6.1
78
426
WW200, ,
SPAT
1.3
6.1
634
5255
S85
ICPC
Pilonidal cyst/fistula
7.7
6.1
13
17
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
696
5837
N05CF01
ATC
zopiclone; oral
1.3
6.1
614
5075
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
6.1
236
1693
N20.1
ICD-10 Finland
Calculus of ureter
1.9
6.1
75
406
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
8.6
6.0
12
14
WX419
NOMESCO Finland
Other general anesthesy
3.2
6.0
23
73
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
6.0
108
653
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Gastroenterology
10 [38004455]
10 [38004455]
1.1e+00
3.0e+00
4.0e+00
8.6e+00
5.2e+00
4.9e+00
4.3e+00
cases:9.36%
controls:3.25%
cases:22.61%
controls:1.44%
cases:13.58%
controls:0.30%
cases:50.75%
controls:0.02%
cases:32.99%
controls:0.26%
cases:63.77%
controls:1.32%
cases:76.29%
controls:4.09%
255
883
2469
26312
616
391
2109
26810
370
81
2355
27120
1383
6
1342
27195
899
72
1826
27122
1734
356
985
26702
1931
1021
600
23949
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
2.1e+00
3.8e+00
4.8e+00
1.0e+50
5.9e+00
5.7e+00
4.8e+00
cases:2.13%
controls:0.26%
cases:5.80%
controls:0.14%
cases:3.01%
controls:0.03%
cases:6.24%
controls:0.00%
cases:11.38%
controls:0.03%
cases:31.00%
controls:0.15%
cases:31.33%
controls:0.36%
58
70
2666
27125
158
38
2567
27163
82
7
2643
27194
170
0
2555
27201
310
9
2415
27185
843
40
1876
27018
793
90
1738
24880
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
2.5e+00
3.6e+00
4.1e+00
—
5.3e+00
5.0e+00
4.7e+00
cases:8.19%
controls:0.71%
cases:16.70%
controls:0.56%
cases:9.91%
controls:0.19%
—
—
cases:27.23%
controls:0.19%
cases:48.51%
controls:0.63%
cases:48.08%
controls:0.83%
223
192
2501
27003
455
151
2270
27050
270
52
2455
27149
—
742
53
1983
27141
1319
171
1400
26887
1217
207
1314
24763
Other Crohn disease
K50.8 [45533599]
K50.8 [45533599]
2.2e+00
3.3e+00
3.5e+00
1.0e+50
—
6.8e+00
7.2e+00
cases:0.48%
controls:0.06%
cases:1.14%
controls:0.04%
cases:0.59%
controls:0.02%
cases:23.05%
controls:0.00%
—
—
cases:33.58%
controls:0.06%
cases:48.24%
controls:0.07%
13
15
2711
27180
31
11
2694
27190
16
5
2709
27196
628
0
2097
27201
—
913
16
1806
27042
1221
17
1310
24953
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
1.2e+00
3.4e+00
5.3e+00
—
4.2e+00
4.0e+00
3.4e+00
cases:5.95%
controls:1.80%
cases:20.88%
controls:0.83%
cases:14.94%
controls:0.08%
—
—
cases:7.16%
controls:0.11%
cases:32.84%
controls:0.90%
cases:47.29%
controls:2.77%
162
489
2562
26706
569
227
2156
26974
407
23
2318
27178
—
195
30
2530
27164
893
244
1826
26814
1197
692
1334
24278
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.3e+00
2.2e+00
2.5e+00
—
5.0e+00
5.0e+00
4.8e+00
cases:1.54%
controls:0.43%
cases:2.90%
controls:0.33%
cases:1.50%
controls:0.12%
—
—
cases:10.02%
controls:0.08%
cases:31.67%
controls:0.32%
cases:35.99%
controls:0.44%
42
117
2682
27078
79
91
2646
27110
41
33
2684
27168
—
273
21
2452
27173
861
86
1858
26972
911
110
1620
24860
Ulcerative colitis and Crohn's disease
208 [2001600206]
208 [2001600206]
3.2e+00
5.3e+00
—
1.0e+50
1.0e+50
7.2e+00
4.3e+00
cases:5.40%
controls:0.23%
cases:7.45%
controls:0.04%
—
—
cases:1.32%
controls:0.00%
cases:29.28%
controls:0.00%
cases:37.77%
controls:0.04%
cases:8.73%
controls:0.13%
147
63
2577
27132
203
11
2522
27190
—
36
0
2689
27201
798
0
1927
27194
1027
12
1692
27046
221
33
2310
24937
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
1.2e+00
3.1e+00
4.4e+00
1.0e+50
4.1e+00
3.5e+00
3.2e+00
cases:6.61%
controls:2.17%
cases:12.40%
controls:0.67%
cases:4.99%
controls:0.06%
cases:20.62%
controls:0.00%
cases:3.93%
controls:0.07%
cases:16.40%
controls:0.59%
cases:37.77%
controls:2.42%
180
590
2544
26605
338
181
2387
27020
136
17
2589
27184
562
0
2163
27201
107
18
2618
27176
446
159
2273
26899
956
605
1575
24365
Ulcerative colitis, unspecified
K51.9 [45605941]
K51.9 [45605941]
1.7e+00
3.5e+00
4.0e+00
—
3.2e+00
3.4e+00
3.0e+00
cases:1.58%
controls:0.28%
cases:4.70%
controls:0.15%
cases:2.86%
controls:0.05%
—
—
cases:1.36%
controls:0.06%
cases:4.74%
controls:0.17%
cases:6.64%
controls:0.34%
43
76
2681
27119
128
42
2597
27159
78
14
2647
27187
—
37
16
2688
27178
129
47
2590
27011
168
84
2363
24886
Capsular endoscopy
UJF92 [2001305032]
UJF92 [2001305032]
2.3e+00
5.2e+00
1.0e+50
1.0e+50
1.0e+50
5.2e+00
4.5e+00
cases:1.40%
controls:0.14%
cases:4.37%
controls:0.03%
cases:3.52%
controls:0.00%
cases:2.90%
controls:0.00%
cases:1.94%
controls:0.00%
cases:7.94%
controls:0.05%
cases:9.48%
controls:0.12%
38
37
2686
27158
119
7
2606
27194
96
0
2629
27201
79
0
2646
27201
53
0
2672
27194
216
13
2503
27045
240
29
2291
24941
Internal Medicine
11 [38004456]
11 [38004456]
3.9e-01
1.2e+00
2.1e+00
6.7e+00
2.8e+00
2.2e+00
1.8e+00
cases:22.61%
controls:16.48%
cases:20.95%
controls:7.35%
cases:9.36%
controls:1.25%
cases:31.30%
controls:0.06%
cases:15.41%
controls:1.15%
cases:40.46%
controls:6.90%
cases:53.81%
controls:16.57%
616
4483
2108
22712
571
1999
2154
25202
255
340
2470
26861
853
16
1872
27185
420
313
2305
26881
1100
1866
1619
25192
1362
4138
1169
20832
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
1.0e+00
2.3e+00
3.0e+00
1.0e+50
4.7e+00
3.3e+00
2.3e+00
cases:3.01%
controls:1.08%
cases:3.27%
controls:0.33%
cases:1.32%
controls:0.07%
cases:1.06%
controls:0.00%
cases:4.40%
controls:0.04%
cases:6.77%
controls:0.26%
cases:8.02%
controls:0.89%
82
293
2642
26902
89
89
2636
27112
36
18
2689
27183
29
0
2696
27201
120
11
2605
27183
184
71
2535
26987
203
222
2328
24748
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
1.0e+00
2.3e+00
3.0e+00
1.0e+50
4.7e+00
3.3e+00
2.3e+00
cases:3.01%
controls:1.08%
cases:3.27%
controls:0.33%
cases:1.32%
controls:0.07%
cases:1.06%
controls:0.00%
cases:4.40%
controls:0.04%
cases:6.77%
controls:0.26%
cases:8.02%
controls:0.89%
82
293
2642
26902
89
89
2636
27112
36
18
2689
27183
29
0
2696
27201
120
11
2605
27183
184
71
2535
26987
203
222
2328
24748
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.2e-01
1.7e+00
3.6e+00
3.4e+00
2.9e+00
2.6e+00
2.2e+00
cases:6.42%
controls:4.77%
cases:12.48%
controls:2.64%
cases:14.31%
controls:0.47%
cases:0.84%
controls:0.03%
cases:7.93%
controls:0.47%
cases:29.31%
controls:2.93%
cases:44.17%
controls:7.76%
175
1296
2549
25899
340
719
2385
26482
390
129
2335
27072
23
8
2702
27193
216
129
2509
27065
797
793
1922
26265
1118
1938
1413
23032
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
7.4e-01
1.7e+00
3.2e+00
3.6e+00
3.8e+00
2.0e+00
1.5e+00
cases:8.48%
controls:4.23%
cases:6.39%
controls:1.25%
cases:2.64%
controls:0.11%
cases:0.66%
controls:0.02%
cases:5.21%
controls:0.12%
cases:8.20%
controls:1.15%
cases:16.59%
controls:4.17%
231
1149
2493
26046
174
340
2551
26861
72
30
2653
27171
18
5
2707
27196
142
33
2583
27161
223
310
2496
26748
420
1042
2111
23928
Pediatric Gastroenterology
OMOP4822029 [45756810]
OMOP4822029 [45756810]
4.1e-01
2.1e+00
3.4e+00
1.0e+50
4.3e+00
3.2e+00
3.3e+00
cases:0.40%
controls:0.27%
cases:0.99%
controls:0.12%
cases:0.77%
controls:0.03%
cases:1.32%
controls:0.00%
cases:1.87%
controls:0.03%
cases:2.94%
controls:0.12%
cases:3.87%
controls:0.15%
11
73
2713
27122
27
32
2698
27169
21
7
2704
27194
36
0
2689
27201
51
7
2674
27187
80
33
2639
27025
98
37
2433
24933
mercaptopurine
L01BB02 [21601428]
L01BB02 [21601428]
—
1.5e+00
—
1.0e+50
4.8e+00
5.4e+00
4.6e+00
—
—
cases:0.33%
controls:0.07%
—
—
cases:0.99%
controls:0.00%
cases:2.64%
controls:0.02%
cases:12.32%
controls:0.06%
cases:10.90%
controls:0.12%
—
9
20
2716
27181
—
27
0
2698
27201
72
6
2653
27188
335
17
2384
27041
276
31
2255
24939
Crohn disease of large intestine
K50.1 [45601173]
K50.1 [45601173]
2.3e+00
—
1.0e+50
1.0e+50
—
6.8e+00
7.1e+00
cases:0.33%
controls:0.03%
—
—
cases:0.62%
controls:0.00%
cases:16.22%
controls:0.00%
—
—
cases:20.78%
controls:0.03%
cases:27.78%
controls:0.03%
9
9
2715
27186
—
17
0
2708
27201
442
0
2283
27201
—
565
8
2154
27050
703
8
1828
24962
Crohn disease, unspecified
K50.9 [45562490]
K50.9 [45562490]
2.4e+00
—
—
1.0e+50
1.0e+50
7.1e+00
6.7e+00
cases:0.40%
controls:0.04%
—
—
—
—
cases:16.33%
controls:0.00%
cases:10.02%
controls:0.00%
cases:20.56%
controls:0.02%
cases:29.20%
controls:0.05%
11
10
2713
27185
—
—
445
0
2280
27201
273
0
2452
27194
559
6
2160
27052
739
13
1792
24957
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
1.7e+00
3.0e+00
3.6e+00
—
3.6e+00
2.4e+00
1.5e+00
cases:2.53%
controls:0.48%
cases:3.93%
controls:0.21%
cases:1.21%
controls:0.03%
—
—
cases:1.10%
controls:0.03%
cases:1.84%
controls:0.17%
cases:2.92%
controls:0.69%
69
131
2655
27064
107
56
2618
27145
33
9
2692
27192
—
30
8
2695
27186
50
45
2669
27013
74
173
2457
24797
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
1.1e+00
3.3e+00
3.9e+00
1.0e+50
—
3.8e+00
3.5e+00
cases:1.95%
controls:0.65%
cases:6.42%
controls:0.26%
cases:1.54%
controls:0.03%
cases:8.62%
controls:0.00%
—
—
cases:8.39%
controls:0.20%
cases:20.27%
controls:0.80%
53
176
2671
27019
175
70
2550
27131
42
9
2683
27192
235
0
2490
27201
—
228
54
2491
27004
513
199
2018
24771
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
9.5e-01
2.8e+00
3.3e+00
—
3.5e+00
2.8e+00
2.0e+00
cases:6.90%
controls:2.80%
cases:11.63%
controls:0.78%
cases:2.97%
controls:0.12%
—
—
cases:2.83%
controls:0.09%
cases:11.62%
controls:0.78%
cases:17.54%
controls:2.72%
188
761
2536
26434
317
212
2408
26989
81
32
2644
27169
—
77
25
2648
27169
316
211
2403
26847
444
680
2087
24290
Ankylosing spondylitis
M45 [45591841]
M45 [45591841]
2.0e+00
2.2e+00
3.3e+00
—
3.0e+00
2.5e+00
2.2e+00
cases:2.20%
controls:0.31%
cases:1.72%
controls:0.19%
cases:0.62%
controls:0.02%
—
—
cases:0.92%
controls:0.05%
cases:2.39%
controls:0.21%
cases:3.08%
controls:0.36%
60
85
2664
27110
47
52
2678
27149
17
6
2708
27195
—
25
13
2700
27181
65
56
2654
27002
78
89
2453
24881
infliximab; parenteral
L04AB02 [21603909]
L04AB02 [21603909]
—
1.4e+00
2.2e+00
—
3.5e+00
4.3e+00
5.0e+00
—
—
cases:0.29%
controls:0.07%
cases:0.26%
controls:0.03%
—
—
cases:1.14%
controls:0.03%
cases:5.88%
controls:0.08%
cases:12.60%
controls:0.10%
—
8
20
2717
27181
7
8
2718
27193
—
31
9
2694
27185
160
22
2559
27036
319
25
2212
24945
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
7.2e-01
2.4e+00
—
—
5.2e+00
4.3e+00
3.0e+00
cases:0.62%
controls:0.31%
cases:1.28%
controls:0.12%
—
—
—
—
cases:3.38%
controls:0.02%
cases:9.45%
controls:0.14%
cases:9.44%
controls:0.51%
17
83
2707
27112
35
32
2690
27169
—
—
92
5
2633
27189
257
37
2462
27021
239
127
2292
24843
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
4.5e-01
1.1e+00
2.6e+00
3.5e+00
2.7e+00
2.3e+00
1.8e+00
cases:10.54%
controls:6.98%
cases:12.70%
controls:4.58%
cases:11.23%
controls:0.89%
cases:0.88%
controls:0.03%
cases:11.82%
controls:0.85%
cases:32.48%
controls:4.71%
cases:44.88%
controls:11.41%
287
1899
2437
25296
346
1246
2379
25955
306
243
2419
26958
24
7
2701
27194
322
231
2403
26963
883
1275
1836
25783
1136
2849
1395
22121
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
4.3e-01
1.1e+00
2.6e+00
3.5e+00
2.8e+00
2.3e+00
1.8e+00
cases:10.32%
controls:6.96%
cases:12.62%
controls:4.59%
cases:11.23%
controls:0.89%
cases:0.88%
controls:0.03%
cases:11.82%
controls:0.85%
cases:32.40%
controls:4.71%
cases:44.84%
controls:11.39%
281
1894
2443
25301
344
1248
2381
25953
306
242
2419
26959
24
7
2701
27194
322
230
2403
26964
881
1275
1838
25783
1135
2844
1396
22126
adalimumab; parenteral
L04AB04 [21603911]
L04AB04 [21603911]
1.0e+00
1.5e+00
2.0e+00
—
2.5e+00
3.5e+00
3.9e+00
cases:0.55%
controls:0.20%
cases:0.62%
controls:0.14%
cases:0.51%
controls:0.07%
—
—
cases:0.77%
controls:0.06%
cases:5.74%
controls:0.19%
cases:13.31%
controls:0.30%
15
54
2709
27141
17
37
2708
27164
14
19
2711
27182
—
21
17
2704
27177
156
52
2563
27006
337
74
2194
24896
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
4.0e-01
1.1e+00
2.6e+00
3.6e+00
2.7e+00
2.2e+00
1.8e+00
cases:10.76%
controls:7.45%
cases:13.03%
controls:4.80%
cases:11.27%
controls:0.94%
cases:0.92%
controls:0.03%
cases:11.78%
controls:0.90%
cases:32.59%
controls:4.87%
cases:45.12%
controls:11.86%
293
2026
2431
25169
355
1307
2370
25894
307
255
2418
26946
25
7
2700
27194
321
245
2404
26949
886
1317
1833
25741
1142
2961
1389
22009
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
K52.9 [45572215]
2.4e+00
4.9e+00
—
1.0e+50
—
4.6e+00
2.5e+00
cases:2.09%
controls:0.19%
cases:8.62%
controls:0.07%
—
—
cases:1.94%
controls:0.00%
—
—
cases:3.24%
controls:0.03%
cases:2.84%
controls:0.23%
57
53
2667
27142
235
20
2490
27181
—
53
0
2672
27201
—
88
9
2631
27049
72
58
2459
24912
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
4.5e-01
1.1e+00
2.6e+00
3.4e+00
2.7e+00
2.2e+00
1.8e+00
cases:11.09%
controls:7.38%
cases:13.10%
controls:4.75%
cases:11.41%
controls:0.97%
cases:0.84%
controls:0.03%
cases:11.96%
controls:0.92%
cases:32.81%
controls:4.90%
cases:45.36%
controls:11.88%
302
2008
2422
25187
357
1291
2368
25910
311
263
2414
26938
23
8
2702
27193
326
249
2399
26945
892
1327
1827
25731
1148
2967
1383
22003
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
5.3e-01
1.2e+00
2.7e+00
3.0e+00
2.6e+00
2.3e+00
1.9e+00
cases:6.98%
controls:4.23%
cases:9.06%
controls:2.90%
cases:8.22%
controls:0.60%
cases:0.44%
controls:0.02%
cases:7.34%
controls:0.58%
cases:22.91%
controls:3.03%
cases:32.20%
controls:6.73%
190
1150
2534
26045
247
788
2478
26413
224
164
2501
27037
12
6
2713
27195
200
158
2525
27036
623
819
2096
26239
815
1680
1716
23290
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.9e-01
1.4e+00
2.8e+00
3.5e+00
2.5e+00
2.0e+00
1.5e+00
cases:16.01%
controls:11.42%
cases:23.63%
controls:7.18%
cases:19.52%
controls:1.39%
cases:2.06%
controls:0.06%
cases:13.58%
controls:1.31%
cases:37.22%
controls:7.55%
cases:50.65%
controls:17.94%
436
3106
2288
24089
644
1953
2081
25248
532
377
2193
26824
56
17
2669
27184
370
356
2355
26838
1012
2044
1707
25014
1282
4480
1249
20490
Crohn disease of small intestine
K50.0 [45596324]
K50.0 [45596324]
2.1e+00
4.3e+00
1.0e+50
1.0e+50
—
—
7.6e+00
cases:0.37%
controls:0.04%
cases:1.65%
controls:0.02%
cases:0.73%
controls:0.00%
cases:40.66%
controls:0.00%
—
—
—
—
cases:52.35%
controls:0.06%
10
12
2714
27183
45
6
2680
27195
20
0
2705
27201
1108
0
1617
27201
—
—
1325
14
1206
24956
Outpatient Visit
OP [9202]
OP [9202]
2.3e-01
7.1e-01
1.1e+00
5.7e+00
2.0e+00
2.1e+00
2.2e+00
cases:66.74%
controls:61.43%
cases:58.79%
controls:41.32%
cases:24.15%
controls:9.51%
cases:56.81%
controls:0.46%
cases:42.50%
controls:9.45%
cases:85.07%
controls:41.66%
cases:95.69%
controls:71.65%
1818
16707
906
10488
1602
11240
1123
15961
658
2586
2067
24615
1548
124
1177
27077
1158
2570
1567
24624
2313
11273
406
15785
2422
17890
109
7080
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
7.5e-01
1.6e+00
4.0e+00
1.0e+50
3.7e+00
2.4e+00
1.5e+00
cases:2.57%
controls:1.23%
cases:2.28%
controls:0.47%
cases:1.17%
controls:0.02%
cases:0.66%
controls:0.00%
cases:1.21%
controls:0.03%
cases:3.49%
controls:0.34%
cases:6.01%
controls:1.44%
70
334
2654
26861
62
128
2663
27073
32
6
2693
27195
18
0
2707
27201
33
8
2692
27186
95
93
2624
26965
152
359
2379
24611
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.7e-01
1.0e+00
2.6e+00
3.2e+00
2.7e+00
2.2e+00
1.8e+00
cases:9.47%
controls:6.74%
cases:11.30%
controls:4.33%
cases:10.17%
controls:0.84%
cases:0.73%
controls:0.03%
cases:10.39%
controls:0.80%
cases:28.58%
controls:4.35%
cases:40.14%
controls:10.40%
258
1833
2466
25362
308
1177
2417
26024
277
229
2448
26972
20
8
2705
27193
283
217
2442
26977
777
1176
1942
25882
1016
2596
1515
22374
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.6e-01
1.0e+00
2.6e+00
3.2e+00
2.7e+00
2.2e+00
1.8e+00
cases:9.36%
controls:6.73%
cases:11.23%
controls:4.30%
cases:10.17%
controls:0.83%
cases:0.73%
controls:0.03%
cases:10.39%
controls:0.80%
cases:28.58%
controls:4.36%
cases:40.06%
controls:10.36%
255
1831
2469
25364
306
1171
2419
26030
277
227
2448
26974
20
8
2705
27193
283
217
2442
26977
777
1181
1942
25877
1014
2586
1517
22384
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.6e-01
1.0e+00
2.6e+00
3.2e+00
2.7e+00
2.2e+00
1.7e+00
cases:9.36%
controls:6.70%
cases:11.23%
controls:4.30%
cases:10.09%
controls:0.83%
cases:0.73%
controls:0.03%
cases:10.28%
controls:0.79%
cases:28.47%
controls:4.34%
cases:39.83%
controls:10.38%
255
1823
2469
25372
306
1169
2419
26032
275
227
2450
26974
20
8
2705
27193
280
216
2445
26978
774
1174
1945
25884
1008
2591
1523
22379
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
5.6e-01
2.0e+00
4.2e+00
1.0e+50
2.8e+00
2.4e+00
1.7e+00
cases:1.62%
controls:0.93%
cases:2.09%
controls:0.28%
cases:1.47%
controls:0.02%
cases:1.17%
controls:0.00%
cases:0.59%
controls:0.04%
cases:2.02%
controls:0.18%
cases:3.40%
controls:0.64%
44
253
2680
26942
57
77
2668
27124
40
6
2685
27195
32
0
2693
27201
16
10
2709
27184
55
49
2664
27009
86
159
2445
24811
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
3.2e-01
1.5e+00
3.4e+00
—
3.8e+00
2.7e+00
2.2e+00
cases:0.51%
controls:0.38%
cases:0.55%
controls:0.13%
cases:0.77%
controls:0.03%
—
—
cases:0.81%
controls:0.02%
cases:2.02%
controls:0.13%
cases:3.24%
controls:0.35%
14
102
2710
27093
15
35
2710
27166
21
7
2704
27194
—
22
5
2703
27189
55
36
2664
27022
82
88
2449
24882
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.3e-01
1.0e+00
2.5e+00
3.4e+00
2.5e+00
2.1e+00
1.7e+00
cases:9.29%
controls:6.88%
cases:11.05%
controls:4.37%
cases:9.36%
controls:0.86%
cases:0.77%
controls:0.03%
cases:9.39%
controls:0.81%
cases:27.33%
controls:4.37%
cases:39.35%
controls:10.55%
253
1870
2471
25325
301
1189
2424
26012
255
235
2470
26966
21
7
2704
27194
256
219
2469
26975
743
1182
1976
25876
996
2634
1535
22336
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
1.2e+00
3.3e+00
3.7e+00
1.0e+50
—
2.6e+00
2.7e+00
cases:3.23%
controls:1.01%
cases:10.94%
controls:0.45%
cases:2.17%
controls:0.06%
cases:7.41%
controls:0.00%
—
—
cases:5.85%
controls:0.45%
cases:19.87%
controls:1.57%
88
275
2636
26920
298
123
2427
27078
59
15
2666
27186
202
0
2523
27201
—
159
121
2560
26937
503
391
2028
24579
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.4e-01
1.0e+00
2.5e+00
3.2e+00
2.6e+00
2.1e+00
1.7e+00
cases:9.62%
controls:7.05%
cases:11.41%
controls:4.49%
cases:10.02%
controls:0.88%
cases:0.77%
controls:0.03%
cases:10.31%
controls:0.82%
cases:28.39%
controls:4.51%
cases:40.10%
controls:10.88%
262
1917
2462
25278
311
1222
2414
25979
273
239
2452
26962
21
9
2704
27192
281
224
2444
26970
772
1220
1947
25838
1015
2717
1516
22253
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
7.6e-01
1.8e+00
3.2e+00
1.0e+50
3.9e+00
2.3e+00
1.5e+00
cases:12.26%
controls:6.11%
cases:10.68%
controls:1.91%
cases:4.15%
controls:0.17%
cases:1.25%
controls:0.00%
cases:8.62%
controls:0.19%
cases:13.87%
controls:1.66%
cases:22.80%
controls:6.41%
334
1661
2390
25534
291
519
2434
26682
113
47
2612
27154
34
0
2691
27201
235
52
2490
27142
377
450
2342
26608
577
1601
1954
23369
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
9.0e-01
2.8e+00
3.3e+00
—
2.8e+00
2.1e+00
1.2e+00
cases:1.47%
controls:0.60%
cases:2.35%
controls:0.15%
cases:1.17%
controls:0.04%
—
—
cases:0.55%
controls:0.03%
cases:1.36%
controls:0.16%
cases:2.29%
controls:0.68%
40
164
2684
27031
64
41
2661
27160
32
12
2693
27189
—
15
9
2710
27185
37
44
2682
27014
58
169
2473
24801
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
9.9e-01
2.4e+00
4.0e+00
—
2.9e+00
1.7e+00
1.1e+00
cases:11.97%
controls:4.79%
cases:14.86%
controls:1.49%
cases:7.78%
controls:0.16%
—
—
cases:2.83%
controls:0.16%
cases:7.72%
controls:1.48%
cases:14.54%
controls:5.53%
326
1303
2398
25892
405
406
2320
26795
212
44
2513
27157
—
77
43
2648
27151
210
400
2509
26658
368
1380
2163
23590
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.4e+00
2.7e+00
—
1.0e+50
3.8e+00
2.9e+00
2.3e+00
cases:1.73%
controls:0.45%
cases:3.82%
controls:0.26%
—
—
cases:0.40%
controls:0.00%
cases:1.43%
controls:0.03%
cases:4.12%
controls:0.24%
cases:8.73%
controls:0.95%
47
122
2677
27073
104
70
2621
27131
—
11
0
2714
27201
39
9
2686
27185
112
64
2607
26994
221
236
2310
24734
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
326 [2001600287]
326 [2001600287]
-1.0e+50
2.5e+00
—
—
1.0e+50
5.2e+00
5.4e+00
cases:0.00%
controls:0.02%
cases:0.26%
controls:0.02%
—
—
—
—
cases:0.70%
controls:0.00%
cases:6.29%
controls:0.04%
cases:12.41%
controls:0.06%
0
5
2724
27190
7
6
2718
27195
—
—
19
0
2706
27194
171
10
2548
27048
314
16
2217
24954
Inpatient Hospital
21 [8717]
21 [8717]
2.0e-01
8.5e-01
1.8e+00
6.0e+00
2.0e+00
1.2e+00
9.5e-01
cases:32.89%
controls:28.59%
cases:19.01%
controls:9.16%
cases:7.01%
controls:1.21%
cases:17.65%
controls:0.06%
cases:7.74%
controls:1.11%
cases:23.28%
controls:8.16%
cases:42.91%
controls:22.55%
896
7776
1828
19419
518
2491
2207
24710
191
330
2534
26871
481
15
2244
27186
211
301
2514
26893
633
2208
2086
24850
1086
5631
1445
19339
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
8.4e-01
1.9e+00
3.2e+00
—
2.8e+00
2.4e+00
1.9e+00
cases:5.51%
controls:2.45%
cases:7.93%
controls:1.33%
cases:4.99%
controls:0.21%
—
—
cases:3.08%
controls:0.19%
cases:14.12%
controls:1.43%
cases:24.38%
controls:4.75%
150
665
2574
26530
216
363
2509
26838
136
57
2589
27144
—
84
53
2641
27141
384
388
2335
26670
617
1187
1914
23783
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
4.2e-01
1.4e+00
2.6e+00
3.7e+00
2.1e+00
1.5e+00
1.1e+00
cases:16.85%
controls:11.74%
cases:20.22%
controls:6.00%
cases:10.75%
controls:0.85%
cases:0.92%
controls:0.02%
cases:6.35%
controls:0.86%
cases:24.31%
controls:6.47%
cases:40.34%
controls:17.65%
459
3194
2265
24001
551
1633
2174
25568
293
230
2432
26971
25
6
2700
27195
173
233
2552
26961
661
1751
2058
25307
1021
4408
1510
20562
Outpatient Hospital
22 [8756]
22 [8756]
2.4e-01
7.1e-01
1.6e+00
6.3e+00
1.9e+00
1.2e+00
9.4e-01
cases:25.73%
controls:21.38%
cases:12.18%
controls:6.36%
cases:3.67%
controls:0.74%
cases:9.21%
controls:0.02%
cases:4.44%
controls:0.67%
cases:15.12%
controls:5.28%
cases:31.61%
controls:15.34%
701
5814
2023
21381
332
1731
2393
25470
100
201
2625
27000
251
5
2474
27196
121
182
2604
27012
411
1429
2308
25629
800
3831
1731
21139
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
8.9e-01
2.5e+00
2.7e+00
1.0e+50
3.1e+00
2.3e+00
1.4e+00
cases:3.23%
controls:1.36%
cases:5.80%
controls:0.49%
cases:0.95%
controls:0.06%
cases:1.17%
controls:0.00%
cases:1.10%
controls:0.05%
cases:4.19%
controls:0.44%
cases:6.56%
controls:1.72%
88
369
2636
26826
158
134
2567
27067
26
17
2699
27184
32
0
2693
27201
30
14
2695
27180
114
118
2605
26940
166
429
2365
24541
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
92695-6 [37019628]
1.3e+00
2.7e+00
4.1e+00
—
—
2.8e+00
2.0e+00
cases:0.66%
controls:0.18%
cases:1.25%
controls:0.08%
cases:1.06%
controls:0.02%
—
—
—
—
cases:1.07%
controls:0.06%
cases:2.92%
controls:0.42%
18
49
2706
27146
34
23
2691
27178
29
5
2696
27196
—
—
29
17
2690
27041
74
106
2457
24864
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.7e-01
1.0e+00
2.2e+00
3.2e+00
2.2e+00
2.0e+00
1.7e+00
cases:11.75%
controls:8.42%
cases:14.06%
controls:5.64%
cases:11.56%
controls:1.39%
cases:1.36%
controls:0.06%
cases:11.52%
controls:1.38%
cases:31.81%
controls:5.70%
cases:45.32%
controls:12.75%
320
2290
2404
24905
383
1533
2342
25668
315
377
2410
26824
37
15
2688
27186
314
374
2411
26820
865
1542
1854
25516
1147
3184
1384
21786
General Surgery
2 [38004447]
2 [38004447]
5.4e-01
1.2e+00
2.2e+00
5.6e+00
1.7e+00
9.7e-01
6.2e-01
cases:22.47%
controls:14.48%
cases:12.59%
controls:4.24%
cases:5.50%
controls:0.66%
cases:6.31%
controls:0.03%
cases:3.05%
controls:0.56%
cases:9.97%
controls:4.04%
cases:20.35%
controls:12.10%
612
3938
2112
23257
343
1153
2382
26048
150
179
2575
27022
172
7
2553
27194
83
153
2642
27041
271
1093
2448
25965
515
3021
2016
21949
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
6.9e-01
1.5e+00
2.5e+00
—
3.7e+00
2.4e+00
1.8e+00
cases:13.55%
controls:7.32%
cases:12.11%
controls:3.06%
cases:5.87%
controls:0.49%
—
—
cases:17.36%
controls:0.50%
cases:26.85%
controls:3.08%
cases:34.14%
controls:8.24%
369
1990
2355
25205
330
832
2395
26369
160
134
2565
27067
—
473
135
2252
27059
730
834
1989
26224
864
2057
1667
22913
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
6.6e-01
1.5e+00
2.5e+00
—
3.7e+00
2.4e+00
1.8e+00
cases:13.25%
controls:7.30%
cases:12.07%
controls:3.03%
cases:5.87%
controls:0.49%
—
—
cases:17.28%
controls:0.50%
cases:26.74%
controls:3.07%
cases:34.02%
controls:8.18%
361
1984
2363
25211
329
824
2396
26377
160
133
2565
27068
—
471
135
2254
27059
727
832
1992
26226
861
2042
1670
22928
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
K58.0 [45596336]
1.2e+00
2.8e+00
2.5e+00
1.0e+50
2.8e+00
2.0e+00
1.1e+00
cases:1.58%
controls:0.48%
cases:2.86%
controls:0.18%
cases:0.40%
controls:0.03%
cases:0.44%
controls:0.00%
cases:0.44%
controls:0.03%
cases:1.10%
controls:0.14%
cases:1.86%
controls:0.62%
43
130
2681
27065
78
48
2647
27153
11
9
2714
27192
12
0
2713
27201
12
7
2713
27187
30
39
2689
27019
47
154
2484
24816
Emergency Room Visit
ER [9203]
ER [9203]
3.9e-01
1.0e+00
2.1e+00
5.4e+00
1.6e+00
1.1e+00
8.0e-01
cases:39.43%
controls:30.64%
cases:25.54%
controls:10.76%
cases:10.39%
controls:1.35%
cases:9.32%
controls:0.05%
cases:6.13%
controls:1.26%
cases:24.38%
controls:9.84%
cases:45.91%
controls:27.63%
1074
8333
1650
18862
696
2928
2029
24273
283
367
2442
26834
254
13
2471
27188
167
342
2558
26852
663
2662
2056
24396
1162
6900
1369
18070
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
3.8e-01
5.9e-01
1.1e+00
4.3e+00
2.2e+00
1.7e+00
1.8e+00
cases:5.98%
controls:4.18%
cases:5.58%
controls:3.16%
cases:2.35%
controls:0.76%
cases:1.91%
controls:0.03%
cases:5.72%
controls:0.67%
cases:15.74%
controls:3.28%
cases:25.25%
controls:5.06%
163
1137
2561
26058
152
860
2573
26341
64
206
2661
26995
52
7
2673
27194
156
182
2569
27012
428
888
2291
26170
639
1264
1892
23706
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
7.9e-01
2.3e+00
3.2e+00
—
2.8e+00
1.9e+00
1.2e+00
cases:2.20%
controls:1.01%
cases:3.63%
controls:0.36%
cases:1.21%
controls:0.05%
—
—
cases:0.66%
controls:0.04%
cases:2.50%
controls:0.40%
cases:4.58%
controls:1.41%
60
275
2664
26920
99
99
2626
27102
33
14
2692
27187
—
18
11
2707
27183
68
107
2651
26951
116
352
2415
24618
clidinium and psycholeptics
A03CA02 [21600204]
A03CA02 [21600204]
1.5e+00
2.3e+00
2.3e+00
—
2.3e+00
1.9e+00
1.7e+00
cases:2.42%
controls:0.54%
cases:2.24%
controls:0.22%
cases:0.40%
controls:0.04%
—
—
cases:0.33%
controls:0.03%
cases:1.36%
controls:0.21%
cases:2.88%
controls:0.55%
66
148
2658
27047
61
61
2664
27140
11
11
2714
27190
—
9
9
2716
27185
37
57
2682
27001
73
137
2458
24833
Functional diarrhoea
K59.1 [45543327]
K59.1 [45543327]
1.7e+00
3.6e+00
3.4e+00
1.0e+50
—
2.4e+00
9.0e-01
cases:1.40%
controls:0.26%
cases:3.12%
controls:0.09%
cases:0.73%
controls:0.03%
cases:0.18%
controls:0.00%
—
—
cases:0.66%
controls:0.06%
cases:1.03%
controls:0.42%
38
71
2686
27124
85
24
2640
27177
20
7
2705
27194
5
0
2720
27201
—
18
17
2701
27041
26
105
2505
24865
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.3e-01
9.5e-01
9.8e-01
2.9e+00
1.7e+00
2.6e+00
2.4e+00
cases:92.33%
controls:89.67%
cases:89.14%
controls:76.10%
cases:58.13%
controls:34.23%
cases:24.18%
controls:1.68%
cases:75.41%
controls:34.77%
cases:97.72%
controls:76.98%
cases:99.33%
controls:93.32%
2515
24386
209
2809
2429
20701
296
6500
1584
9310
1141
17891
659
457
2066
26744
2055
9455
670
17739
2657
20830
62
6228
2514
23303
17
1667
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
7.9e-01
2.2e+00
2.8e+00
1.0e+50
2.6e+00
2.0e+00
1.5e+00
cases:1.47%
controls:0.67%
cases:1.47%
controls:0.17%
cases:0.40%
controls:0.03%
cases:0.37%
controls:0.00%
cases:0.48%
controls:0.04%
cases:1.58%
controls:0.21%
cases:2.88%
controls:0.66%
40
183
2684
27012
40
47
2685
27154
11
7
2714
27194
10
0
2715
27201
13
10
2712
27184
43
56
2676
27002
73
165
2458
24805
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
6.5e-01
1.8e+00
2.8e+00
—
2.9e+00
2.0e+00
1.6e+00
cases:10.61%
controls:5.85%
cases:12.73%
controls:2.36%
cases:5.76%
controls:0.39%
—
—
cases:5.43%
controls:0.31%
cases:14.56%
controls:2.19%
cases:25.92%
controls:6.58%
289
1590
2435
25605
347
642
2378
26559
157
105
2568
27096
—
148
83
2577
27111
396
592
2323
26466
656
1643
1875
23327
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
9.8e-01
2.0e+00
2.2e+00
1.0e+50
2.6e+00
2.2e+00
1.7e+00
cases:1.10%
controls:0.42%
cases:1.17%
controls:0.16%
cases:0.29%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.40%
controls:0.03%
cases:1.14%
controls:0.13%
cases:2.37%
controls:0.46%
30
113
2694
27082
32
43
2693
27158
8
9
2717
27192
7
0
2718
27201
11
8
2714
27186
31
34
2688
27024
60
114
2471
24856
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
4.1e-01
1.3e+00
2.1e+00
3.7e+00
1.6e+00
1.5e+00
1.1e+00
cases:8.81%
controls:6.03%
cases:11.63%
controls:3.44%
cases:5.03%
controls:0.66%
cases:1.17%
controls:0.03%
cases:3.12%
controls:0.65%
cases:13.94%
controls:3.53%
cases:24.38%
controls:10.04%
240
1639
2484
25556
317
935
2408
26266
137
180
2588
27021
32
8
2693
27193
85
177
2640
27017
379
954
2340
26104
617
2508
1914
22462
sulfasalazine; oral, rectal
A07EC01 [21600663]
A07EC01 [21600663]
1.6e+00
1.6e+00
1.4e+00
—
2.5e+00
2.3e+00
2.2e+00
cases:4.59%
controls:0.98%
cases:3.27%
controls:0.67%
cases:0.92%
controls:0.22%
—
—
cases:2.24%
controls:0.19%
cases:6.29%
controls:0.69%
cases:8.85%
controls:1.01%
125
266
2599
26929
89
183
2636
27018
25
61
2700
27140
—
61
52
2664
27142
171
187
2548
26871
224
253
2307
24717
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.4e-01
8.0e-01
1.6e+00
4.2e+00
2.7e+00
1.3e+00
1.0e+00
cases:9.58%
controls:8.44%
cases:5.91%
controls:2.75%
cases:1.91%
controls:0.41%
cases:2.39%
controls:0.04%
cases:5.06%
controls:0.36%
cases:8.31%
controls:2.41%
cases:16.44%
controls:6.70%
261
2296
2463
24899
161
748
2564
26453
52
111
2673
27090
65
10
2660
27191
138
97
2587
27097
226
652
2493
26406
416
1674
2115
23296
colestyramine; oral
C10AC01 [21601876]
C10AC01 [21601876]
1.7e+00
2.9e+00
—
—
—
3.7e+00
3.2e+00
cases:0.77%
controls:0.15%
cases:0.81%
controls:0.04%
—
—
—
—
—
—
cases:1.99%
controls:0.05%
cases:5.37%
controls:0.22%
21
40
2703
27155
22
12
2703
27189
—
—
—
54
13
2665
27045
136
56
2395
24914
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-2.1e-02
7.1e-01
2.3e+00
3.5e+00
2.1e+00
1.5e+00
1.2e+00
cases:5.54%
controls:5.66%
cases:8.95%
controls:4.62%
cases:8.73%
controls:0.93%
cases:1.17%
controls:0.04%
cases:7.49%
controls:0.96%
cases:18.68%
controls:4.87%
cases:28.41%
controls:10.26%
151
1538
2573
25657
244
1256
2481
25945
238
253
2487
26948
32
10
2693
27191
204
260
2521
26934
508
1317
2211
25741
719
2563
1812
22407
Anal fistula
K60.3 [45576995]
K60.3 [45576995]
1.3e+00
3.2e+00
—
1.0e+50
—
3.9e+00
3.0e+00
cases:0.55%
controls:0.15%
cases:1.03%
controls:0.04%
—
—
cases:0.40%
controls:0.00%
—
—
cases:1.40%
controls:0.03%
cases:2.05%
controls:0.10%
15
40
2709
27155
28
12
2697
27189
—
11
0
2714
27201
—
38
8
2681
27050
52
26
2479
24944
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.7e-01
1.1e+00
2.4e+00
3.3e+00
2.0e+00
1.4e+00
8.5e-01
cases:24.52%
controls:19.80%
cases:29.43%
controls:12.71%
cases:21.83%
controls:2.46%
cases:3.49%
controls:0.13%
cases:15.01%
controls:2.35%
cases:38.76%
controls:13.53%
cases:51.80%
controls:31.53%
668
5385
2056
21810
802
3458
1923
23743
595
670
2130
26531
95
35
2630
27166
409
640
2316
26554
1054
3662
1665
23396
1311
7872
1220
17098
Bacteria identified in Stool by Culture
625-4 [3025941]
625-4 [3025941]
1.1e+00
2.8e+00
4.3e+00
—
—
2.0e+00
1.1e+00
cases:2.20%
controls:0.77%
cases:3.78%
controls:0.23%
cases:1.54%
controls:0.02%
—
—
—
—
cases:1.47%
controls:0.20%
cases:2.73%
controls:0.91%
60
209
2664
26986
103
63
2622
27138
42
6
2683
27195
—
—
40
55
2679
27003
69
226
2462
24744
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
5.0e-01
1.1e+00
2.8e+00
—
2.7e+00
2.4e+00
2.1e+00
cases:0.73%
controls:0.44%
cases:1.21%
controls:0.40%
cases:1.14%
controls:0.07%
—
—
cases:1.28%
controls:0.08%
cases:4.60%
controls:0.44%
cases:10.04%
controls:1.34%
20
121
2704
27074
33
108
2692
27093
31
19
2694
27182
—
35
23
2690
27171
125
119
2594
26939
254
335
2277
24635
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
5.8e-01
1.3e+00
2.7e+00
—
2.8e+00
2.2e+00
1.6e+00
cases:4.77%
controls:2.72%
cases:5.80%
controls:1.62%
cases:4.22%
controls:0.28%
—
—
cases:4.62%
controls:0.31%
cases:14.49%
controls:1.92%
cases:21.57%
controls:5.30%
130
741
2594
26454
158
442
2567
26759
115
77
2610
27124
—
126
84
2599
27110
394
520
2325
26538
546
1323
1985
23647
Other and unspecified intestinal obstruction
K56.6 [45562499]
K56.6 [45562499]
1.6e+00
3.2e+00
—
1.0e+50
—
3.4e+00
2.9e+00
cases:0.59%
controls:0.11%
cases:1.32%
controls:0.06%
—
—
cases:0.59%
controls:0.00%
—
—
cases:1.10%
controls:0.04%
cases:2.45%
controls:0.14%
16
31
2708
27164
36
15
2689
27186
—
16
0
2709
27201
—
30
10
2689
27048
62
36
2469
24934
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
5.6e-01
2.1e+00
2.9e+00
—
2.9e+00
1.9e+00
1.2e+00
cases:0.77%
controls:0.44%
cases:1.76%
controls:0.21%
cases:0.51%
controls:0.03%
—
—
cases:0.33%
controls:0.02%
cases:1.62%
controls:0.24%
cases:3.52%
controls:1.07%
21
120
2703
27075
48
58
2677
27143
14
8
2711
27193
—
9
5
2716
27189
44
65
2675
26993
89
267
2442
24703
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
2.5e-01
1.1e+00
2.8e+00
—
2.7e+00
2.3e+00
2.0e+00
cases:0.55%
controls:0.43%
cases:1.21%
controls:0.39%
cases:1.17%
controls:0.07%
—
—
cases:1.32%
controls:0.09%
cases:4.71%
controls:0.49%
cases:9.88%
controls:1.41%
15
117
2709
27078
33
106
2692
27095
32
19
2693
27182
—
36
25
2689
27169
128
132
2591
26926
250
352
2281
24618
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
4.2e-01
1.1e+00
2.8e+00
—
2.6e+00
2.3e+00
2.1e+00
cases:0.73%
controls:0.48%
cases:1.25%
controls:0.40%
cases:1.17%
controls:0.07%
—
—
cases:1.25%
controls:0.09%
cases:4.89%
controls:0.49%
cases:10.31%
controls:1.38%
20
131
2704
27064
34
110
2691
27091
32
20
2693
27181
—
34
25
2691
27169
133
133
2586
26925
261
345
2270
24625
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
3.8e-01
1.1e+00
2.8e+00
—
2.6e+00
2.3e+00
2.1e+00
cases:0.73%
controls:0.50%
cases:1.32%
controls:0.44%
cases:1.17%
controls:0.07%
—
—
cases:1.25%
controls:0.09%
cases:5.11%
controls:0.51%
cases:10.67%
controls:1.45%
20
137
2704
27058
36
120
2689
27081
32
20
2693
27181
—
34
25
2691
27169
139
139
2580
26919
270
361
2261
24609
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
K52.88 [2000502923]
2.1e+00
3.8e+00
—
1.0e+50
—
3.2e+00
1.8e+00
cases:0.88%
controls:0.11%
cases:2.86%
controls:0.07%
—
—
cases:0.99%
controls:0.00%
—
—
cases:1.29%
controls:0.05%
cases:1.15%
controls:0.20%
24
31
2700
27164
78
18
2647
27183
—
27
0
2698
27201
—
35
14
2684
27044
29
49
2502
24921
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
6.6e-01
1.2e+00
1.4e+00
3.3e+00
1.9e+00
1.3e+00
9.8e-01
cases:19.09%
controls:10.87%
cases:16.37%
controls:5.66%
cases:4.11%
controls:1.09%
cases:1.58%
controls:0.06%
cases:6.97%
controls:1.13%
cases:18.39%
controls:5.79%
cases:30.46%
controls:14.13%
520
2957
2204
24238
446
1540
2279
25661
112
296
2613
26905
43
16
2682
27185
190
308
2535
26886
500
1568
2219
25490
771
3529
1760
21441
loperamide oxide; oral
A07DA05 [21600648]
A07DA05 [21600648]
1.2e+00
1.9e+00
2.1e+00
—
2.2e+00
1.7e+00
1.7e+00
cases:1.95%
controls:0.62%
cases:1.83%
controls:0.29%
cases:0.70%
controls:0.08%
—
—
cases:0.48%
controls:0.06%
cases:1.58%
controls:0.30%
cases:4.31%
controls:0.85%
53
169
2671
27026
50
78
2675
27123
19
23
2706
27178
—
13
15
2712
27179
43
82
2676
26976
109
211
2422
24759
loperamide; oral
A07DA03 [21600646]
A07DA03 [21600646]
1.2e+00
1.9e+00
2.1e+00
—
2.2e+00
1.7e+00
1.7e+00
cases:1.95%
controls:0.62%
cases:1.83%
controls:0.29%
cases:0.70%
controls:0.08%
—
—
cases:0.48%
controls:0.06%
cases:1.58%
controls:0.30%
cases:4.31%
controls:0.85%
53
169
2671
27026
50
78
2675
27123
19
23
2706
27178
—
13
15
2712
27179
43
82
2676
26976
109
211
2422
24759
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
6.1e-01
1.8e+00
2.6e+00
—
2.3e+00
2.0e+00
1.2e+00
cases:6.24%
controls:3.49%
cases:8.88%
controls:1.62%
cases:3.41%
controls:0.26%
—
—
cases:2.31%
controls:0.23%
cases:11.14%
controls:1.59%
cases:15.96%
controls:5.59%
170
948
2554
26247
242
440
2483
26761
93
70
2632
27131
—
63
62
2662
27132
303
431
2416
26627
404
1396
2127
23574
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
4.2e-01
1.5e+00
3.7e+00
—
—
3.0e+00
2.4e+00
cases:0.48%
controls:0.31%
cases:0.44%
controls:0.10%
cases:0.73%
controls:0.02%
—
—
—
—
cases:1.99%
controls:0.10%
cases:3.20%
controls:0.30%
13
85
2711
27110
12
28
2713
27173
20
5
2705
27196
—
—
54
27
2665
27031
81
75
2450
24895
Other ulcerative colitis
K51.8 [45586720]
K51.8 [45586720]
1.4e+00
2.8e+00
—
1.0e+50
—
3.4e+00
3.0e+00
cases:0.51%
controls:0.13%
cases:0.95%
controls:0.06%
—
—
cases:0.29%
controls:0.00%
—
—
cases:1.91%
controls:0.07%
cases:2.69%
controls:0.14%
14
34
2710
27161
26
16
2699
27185
—
8
0
2717
27201
—
52
18
2667
27040
68
36
2463
24934
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.5e-01
1.8e+00
3.3e+00
1.0e+50
2.3e+00
1.8e+00
1.3e+00
cases:1.58%
controls:1.36%
cases:2.02%
controls:0.36%
cases:1.06%
controls:0.04%
cases:0.73%
controls:0.00%
cases:0.33%
controls:0.03%
cases:1.84%
controls:0.31%
cases:4.54%
controls:1.27%
43
371
2681
26824
55
97
2670
27104
29
11
2696
27190
20
0
2705
27201
9
9
2716
27185
50
83
2669
26975
115
316
2416
24654
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
6.8e-01
1.3e+00
2.7e+00
—
2.3e+00
1.9e+00
1.5e+00
cases:2.09%
controls:1.07%
cases:2.64%
controls:0.73%
cases:1.36%
controls:0.10%
—
—
cases:1.10%
controls:0.11%
cases:4.60%
controls:0.71%
cases:10.43%
controls:2.43%
57
292
2667
26903
72
198
2653
27003
37
26
2688
27175
—
30
29
2695
27165
125
191
2594
26867
264
608
2267
24362
Cholangitis
K83.0 [45552955]
K83.0 [45552955]
1.2e+00
2.0e+00
—
—
3.0e+00
2.6e+00
2.8e+00
cases:0.33%
controls:0.10%
cases:0.44%
controls:0.06%
—
—
—
—
cases:0.44%
controls:0.02%
cases:1.07%
controls:0.08%
cases:2.13%
controls:0.13%
9
27
2715
27168
12
16
2713
27185
—
—
12
6
2713
27188
29
22
2690
27036
54
32
2477
24938
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
1.0e-01
4.7e-01
3.0e+00
1.0e+50
3.5e+00
2.5e+00
1.5e+00
cases:2.35%
controls:2.13%
cases:1.47%
controls:0.93%
cases:1.87%
controls:0.09%
cases:0.18%
controls:0.00%
cases:2.94%
controls:0.10%
cases:8.42%
controls:0.78%
cases:10.79%
controls:2.73%
64
579
2660
26616
40
252
2685
26949
51
25
2674
27176
5
0
2720
27201
80
26
2645
27168
229
211
2490
26847
273
681
2258
24289
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
6.4e-01
1.1e+00
1.4e+00
3.2e+00
2.1e+00
1.2e+00
8.3e-01
cases:5.73%
controls:3.10%
cases:4.00%
controls:1.35%
cases:1.03%
controls:0.26%
cases:0.44%
controls:0.02%
cases:1.76%
controls:0.22%
cases:3.97%
controls:1.28%
cases:6.64%
controls:3.02%
156
843
2568
26352
109
368
2616
26833
28
72
2697
27129
12
5
2713
27196
48
60
2677
27134
108
346
2611
26712
168
754
2363
24216
Left sided colitis
K51.5 [45533604]
K51.5 [45533604]
8.8e-01
1.4e+00
1.7e+00
—
1.9e+00
2.0e+00
2.4e+00
cases:0.73%
controls:0.31%
cases:1.10%
controls:0.26%
cases:0.59%
controls:0.11%
—
—
cases:0.51%
controls:0.07%
cases:2.13%
controls:0.29%
cases:4.66%
controls:0.44%
20
83
2704
27112
30
72
2695
27129
16
30
2709
27171
—
14
20
2711
27174
58
78
2661
26980
118
111
2413
24859
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
64084-7 [40766800]
6.6e-01
1.9e+00
—
—
—
5.1e+00
3.4e+00
cases:0.22%
controls:0.11%
cases:0.26%
controls:0.04%
—
—
—
—
—
—
cases:4.56%
controls:0.03%
cases:3.95%
controls:0.14%
6
31
2718
27164
7
11
2718
27190
—
—
—
124
8
2595
27050
100
34
2431
24936
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
10704-5 [3003327]
1.1e+00
3.2e+00
—
—
3.3e+00
1.8e+00
9.0e-01
cases:1.28%
controls:0.43%
cases:3.41%
controls:0.15%
—
—
—
—
cases:0.62%
controls:0.02%
cases:0.92%
controls:0.16%
cases:1.90%
controls:0.78%
35
118
2689
27077
93
40
2632
27161
—
—
17
6
2708
27188
25
42
2694
27016
48
195
2483
24775
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
2.8e-01
9.0e-01
2.8e+00
—
2.6e+00
2.1e+00
1.8e+00
cases:5.62%
controls:4.30%
cases:6.28%
controls:2.64%
cases:5.47%
controls:0.36%
—
—
cases:3.96%
controls:0.29%
cases:20.52%
controls:3.03%
cases:39.15%
controls:9.71%
153
1169
2571
26026
171
718
2554
26483
149
97
2576
27104
—
108
80
2617
27114
558
821
2161
26237
991
2425
1540
22545
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
7.3e-01
1.3e+00
2.6e+00
—
2.3e+00
1.8e+00
1.4e+00
cases:2.61%
controls:1.27%
cases:3.08%
controls:0.83%
cases:1.47%
controls:0.11%
—
—
cases:1.17%
controls:0.11%
cases:4.71%
controls:0.85%
cases:10.94%
controls:2.93%
71
346
2653
26849
84
225
2641
26976
40
30
2685
27171
—
32
31
2693
27163
128
230
2591
26828
277
732
2254
24238
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
7.3e-01
1.3e+00
2.6e+00
—
2.3e+00
1.8e+00
1.5e+00
cases:2.31%
controls:1.13%
cases:2.79%
controls:0.76%
cases:1.36%
controls:0.10%
—
—
cases:1.10%
controls:0.11%
cases:4.52%
controls:0.78%
cases:10.35%
controls:2.63%
63
306
2661
26889
76
207
2649
26994
37
28
2688
27173
—
30
31
2695
27163
123
212
2596
26846
262
656
2269
24314
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
8.2e-01
2.1e+00
3.9e+00
1.0e+50
1.5e+00
1.2e+00
6.0e-01
cases:4.22%
controls:1.90%
cases:4.66%
controls:0.62%
cases:2.42%
controls:0.05%
cases:1.32%
controls:0.00%
cases:0.33%
controls:0.07%
cases:1.99%
controls:0.63%
cases:5.02%
controls:2.82%
115
516
2609
26679
127
170
2598
27031
66
13
2659
27188
36
0
2689
27201
9
20
2716
27174
54
170
2665
26888
127
705
2404
24265
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
88928-7 [36305771]
88928-7 [36305771]
2.2e+00
3.4e+00
1.0e+50
—
—
2.5e+00
1.9e+00
cases:0.37%
controls:0.04%
cases:1.03%
controls:0.03%
cases:0.44%
controls:0.00%
—
—
—
—
cases:0.37%
controls:0.03%
cases:0.95%
controls:0.14%
10
11
2714
27184
28
9
2697
27192
12
0
2713
27201
—
—
10
8
2709
27050
24
36
2507
24934
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
92687-3 [37020937]
92687-3 [37020937]
2.2e+00
3.4e+00
1.0e+50
—
—
2.5e+00
1.9e+00
cases:0.37%
controls:0.04%
cases:1.03%
controls:0.03%
cases:0.44%
controls:0.00%
—
—
—
—
cases:0.37%
controls:0.03%
cases:0.91%
controls:0.14%
10
11
2714
27184
28
9
2697
27192
12
0
2713
27201
—
—
10
8
2709
27050
23
35
2508
24935
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
-2.9e-01
1.2e+00
1.5e+00
—
2.8e+00
3.1e+00
2.9e+00
cases:0.55%
controls:0.73%
cases:1.03%
controls:0.32%
cases:0.33%
controls:0.08%
—
—
cases:1.28%
controls:0.08%
cases:5.66%
controls:0.27%
cases:10.87%
controls:0.64%
15
199
2709
26996
28
87
2697
27114
9
21
2716
27180
—
35
21
2690
27173
154
72
2565
26986
275
160
2256
24810
Ulcerative (chronic) ileocolitis
K51.1 [45755436]
K51.1 [45755436]
1.4e+00
2.9e+00
—
—
—
3.2e+00
3.9e+00
cases:0.22%
controls:0.06%
cases:0.33%
controls:0.02%
—
—
—
—
—
—
cases:0.74%
controls:0.03%
cases:2.02%
controls:0.04%
6
15
2718
27180
9
5
2716
27196
—
—
—
20
8
2699
27050
51
10
2480
24960
Anal or perianal incision
JHA00 [2001305134]
JHA00 [2001305134]
1.4e+00
3.7e+00
1.0e+50
—
1.0e+50
3.3e+00
3.0e+00
cases:0.33%
controls:0.08%
cases:0.84%
controls:0.02%
cases:0.22%
controls:0.00%
—
—
cases:0.22%
controls:0.00%
cases:0.70%
controls:0.03%
cases:1.30%
controls:0.07%
9
23
2715
27172
23
6
2702
27195
6
0
2719
27201
—
6
0
2719
27194
19
7
2700
27051
33
17
2498
24953
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.5e-01
8.1e-01
2.2e+00
3.0e+00
1.9e+00
1.2e+00
6.3e-01
cases:23.35%
controls:20.74%
cases:28.92%
controls:15.30%
cases:21.17%
controls:2.82%
cases:2.35%
controls:0.11%
cases:15.85%
controls:2.68%
cases:39.32%
controls:17.01%
cases:52.07%
controls:36.58%
636
5641
2088
21554
788
4162
1937
23039
577
767
2148
26434
64
31
2661
27170
432
728
2293
26466
1069
4603
1650
22455
1318
9134
1213
15836
Acute and subacute iridocyclitis
H20.0 [45542994]
H20.0 [45542994]
1.8e+00
2.0e+00
2.6e+00
—
—
1.7e+00
1.7e+00
cases:1.80%
controls:0.32%
cases:1.03%
controls:0.14%
cases:0.44%
controls:0.03%
—
—
—
—
cases:0.92%
controls:0.16%
cases:2.05%
controls:0.40%
49
86
2675
27109
28
37
2697
27164
12
9
2713
27192
—
—
25
44
2694
27014
52
99
2479
24871
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
5.4e-01
1.6e+00
2.8e+00
—
2.3e+00
1.7e+00
9.1e-01
cases:1.98%
controls:1.17%
cases:1.80%
controls:0.38%
cases:0.92%
controls:0.06%
—
—
cases:0.66%
controls:0.07%
cases:1.95%
controls:0.37%
cases:3.99%
controls:1.65%
54
317
2670
26878
49
103
2676
27098
25
16
2700
27185
—
18
18
2707
27176
53
101
2666
26957
101
411
2430
24559
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
UJF45 [2001305031]
1.0e+00
1.8e+00
2.3e+00
1.0e+50
—
2.5e+00
2.0e+00
cases:1.14%
controls:0.41%
cases:1.03%
controls:0.18%
cases:0.22%
controls:0.02%
cases:0.73%
controls:0.00%
—
—
cases:1.62%
controls:0.13%
cases:3.75%
controls:0.50%
31
112
2693
27083
28
48
2697
27153
6
6
2719
27195
20
0
2705
27201
—
44
36
2675
27022
95
125
2436
24845
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
14685-2 [3009035]
5.2e-01
1.1e+00
2.6e+00
—
2.6e+00
1.7e+00
1.2e+00
cases:3.71%
controls:2.23%
cases:2.79%
controls:0.99%
cases:1.58%
controls:0.12%
—
—
cases:1.03%
controls:0.08%
cases:4.93%
controls:0.94%
cases:10.47%
controls:3.42%
101
606
2623
26589
76
268
2649
26933
43
34
2682
27167
—
28
21
2697
27173
134
253
2585
26805
265
853
2266
24117
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
5.9e-01
2.2e+00
2.9e+00
—
2.3e+00
1.1e+00
5.6e-01
cases:4.99%
controls:2.82%
cases:8.81%
controls:1.06%
cases:2.20%
controls:0.12%
—
—
cases:1.03%
controls:0.11%
cases:3.20%
controls:1.10%
cases:7.74%
controls:4.57%
136
767
2588
26428
240
287
2485
26914
60
34
2665
27167
—
28
29
2697
27165
87
298
2632
26760
196
1140
2335
23830
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
90780-8 [1175556]
90780-8 [1175556]
—
-1.0e+50
—
—
—
4.6e+00
4.9e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:1.84%
controls:0.02%
cases:6.80%
controls:0.05%
—
0
7
2725
27194
—
—
—
50
5
2669
27053
172
13
2359
24957
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
25907-7 [3000570]
1.3e+00
2.8e+00
3.6e+00
—
—
1.7e+00
7.7e-01
cases:0.70%
controls:0.18%
cases:1.65%
controls:0.10%
cases:0.70%
controls:0.02%
—
—
—
—
cases:0.63%
controls:0.11%
cases:0.87%
controls:0.40%
19
50
2705
27145
45
27
2680
27174
19
5
2706
27196
—
—
17
30
2702
27028
22
101
2509
24869
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
-1.6e-01
4.0e-01
1.8e+00
3.0e+00
1.9e+00
1.3e+00
1.1e+00
cases:3.41%
controls:4.00%
cases:3.23%
controls:2.19%
cases:2.97%
controls:0.49%
cases:0.51%
controls:0.03%
cases:2.79%
controls:0.45%
cases:7.02%
controls:2.05%
cases:13.39%
controls:4.82%
93
1087
2631
26108
88
597
2637
26604
81
133
2644
27068
14
7
2711
27194
76
122
2649
27072
191
554
2528
26504
339
1204
2192
23766
Intestinal adhesions [bands] with obstruction
K56.5 [45601181]
K56.5 [45601181]
1.8e+00
2.8e+00
—
—
—
2.6e+00
2.2e+00
cases:0.37%
controls:0.06%
cases:0.59%
controls:0.04%
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.67%
controls:0.08%
10
16
2714
27179
16
10
2709
27191
—
—
—
11
8
2708
27050
17
19
2514
24951
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
6.5e-03
1.0e-01
2.9e+00
—
3.2e+00
2.2e+00
1.1e+00
cases:3.23%
controls:3.21%
cases:1.58%
controls:1.43%
cases:2.20%
controls:0.12%
—
—
cases:3.52%
controls:0.14%
cases:9.86%
controls:1.22%
cases:13.24%
controls:5.07%
88
873
2636
26322
43
389
2682
26812
60
34
2665
27167
—
96
39
2629
27155
268
331
2451
26727
335
1265
2196
23705
Pediatric Medicine
37 [38004477]
37 [38004477]
-4.0e-01
3.5e-01
1.3e+00
4.9e+00
1.8e+00
9.2e-01
9.2e-01
cases:3.49%
controls:5.10%
cases:3.05%
controls:2.16%
cases:1.76%
controls:0.50%
cases:2.75%
controls:0.02%
cases:2.79%
controls:0.49%
cases:4.27%
controls:1.75%
cases:5.18%
controls:2.13%
95
1387
2629
25808
83
587
2642
26614
48
135
2677
27066
75
6
2650
27195
76
133
2649
27061
116
473
2603
26585
131
532
2400
24438
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
4.3e-01
1.5e+00
2.5e+00
1.0e+50
2.1e+00
2.0e+00
8.3e-01
cases:3.27%
controls:2.15%
cases:3.12%
controls:0.69%
cases:0.88%
controls:0.07%
cases:0.55%
controls:0.00%
cases:0.62%
controls:0.08%
cases:3.90%
controls:0.57%
cases:6.08%
controls:2.76%
89
586
2635
26609
85
189
2640
27012
24
20
2701
27181
15
0
2710
27201
17
21
2708
27173
106
155
2613
26903
154
689
2377
24281
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
4.8e-01
1.0e+00
3.0e+00
—
2.2e+00
1.8e+00
1.2e+00
cases:1.98%
controls:1.24%
cases:1.80%
controls:0.65%
cases:1.50%
controls:0.08%
—
—
cases:0.73%
controls:0.08%
cases:3.35%
controls:0.56%
cases:4.94%
controls:1.55%
54
336
2670
26859
49
176
2676
27025
41
21
2684
27180
—
20
22
2705
27172
91
151
2628
26907
125
387
2406
24583
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
1.0e-01
1.4e+00
3.8e+00
—
—
2.7e+00
1.3e+00
cases:0.77%
controls:0.69%
cases:0.99%
controls:0.24%
cases:0.84%
controls:0.02%
—
—
—
—
cases:3.02%
controls:0.21%
cases:3.28%
controls:0.92%
21
189
2703
27006
27
66
2698
27135
23
5
2702
27196
—
—
82
57
2637
27001
83
229
2448
24741
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
3.5e-01
1.0e+00
2.4e+00
—
2.6e+00
1.6e+00
1.7e+00
cases:1.28%
controls:0.91%
cases:1.39%
controls:0.50%
cases:0.77%
controls:0.07%
—
—
cases:1.03%
controls:0.08%
cases:2.43%
controls:0.49%
cases:6.64%
controls:1.33%
35
248
2689
26947
38
136
2687
27065
21
20
2704
27181
—
28
22
2697
27172
66
133
2653
26925
168
332
2363
24638
inFLIXimab [Mass/volume] in Serum or Plasma
39803-2 [3042299]
39803-2 [3042299]
—
—
—
—
—
4.4e+00
4.8e+00
—
—
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.03%
cases:8.06%
controls:0.07%
—
—
—
—
—
65
8
2654
27050
204
18
2327
24952
methotrexate
L01BA01 [21601423]
L01BA01 [21601423]
9.0e-01
8.3e-01
8.5e-01
—
1.7e+00
2.4e+00
2.5e+00
cases:3.34%
controls:1.38%
cases:2.35%
controls:1.04%
cases:0.84%
controls:0.36%
—
—
cases:1.72%
controls:0.32%
cases:10.74%
controls:1.05%
cases:15.53%
controls:1.54%
91
376
2633
26819
64
282
2661
26919
23
99
2702
27102
—
47
88
2678
27106
292
283
2427
26775
393
384
2138
24586
methotrexate; oral, parenteral
L04AX03 [21603929]
L04AX03 [21603929]
9.0e-01
8.3e-01
8.5e-01
—
1.7e+00
2.4e+00
2.5e+00
cases:3.34%
controls:1.38%
cases:2.35%
controls:1.04%
cases:0.84%
controls:0.36%
—
—
cases:1.72%
controls:0.32%
cases:10.74%
controls:1.05%
cases:15.53%
controls:1.54%
91
376
2633
26819
64
282
2661
26919
23
99
2702
27102
—
47
88
2678
27106
292
283
2427
26775
393
384
2138
24586
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
4.5e-01
1.3e+00
2.3e+00
—
2.1e+00
2.0e+00
1.6e+00
cases:0.99%
controls:0.63%
cases:1.14%
controls:0.33%
cases:0.51%
controls:0.05%
—
—
cases:0.40%
controls:0.05%
cases:2.21%
controls:0.31%
cases:4.78%
controls:1.05%
27
172
2697
27023
31
89
2694
27112
14
14
2711
27187
—
11
14
2714
27180
60
84
2659
26974
121
261
2410
24709
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
5.0e-01
1.1e+00
2.4e+00
—
2.4e+00
1.4e+00
1.3e+00
cases:3.45%
controls:2.12%
cases:2.24%
controls:0.73%
cases:0.84%
controls:0.07%
—
—
cases:0.48%
controls:0.04%
cases:2.28%
controls:0.59%
cases:6.72%
controls:1.93%
94
576
2630
26619
61
198
2664
27003
23
20
2702
27181
—
13
12
2712
27182
62
160
2657
26898
170
483
2361
24487
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
Z03.89 [2000503757]
3.0e-01
1.7e+00
3.2e+00
1.0e+50
1.9e+00
1.5e+00
8.0e-01
cases:1.69%
controls:1.25%
cases:2.06%
controls:0.39%
cases:0.62%
controls:0.03%
cases:0.51%
controls:0.00%
cases:0.37%
controls:0.06%
cases:1.73%
controls:0.41%
cases:3.32%
controls:1.52%
46
341
2678
26854
56
106
2669
27095
17
7
2708
27194
14
0
2711
27201
10
15
2715
27179
47
110
2672
26948
84
380
2447
24590
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.4e-01
7.0e-01
2.1e+00
3.0e+00
1.7e+00
1.0e+00
5.8e-01
cases:24.41%
controls:21.85%
cases:29.50%
controls:17.23%
cases:21.61%
controls:3.42%
cases:3.27%
controls:0.17%
cases:15.60%
controls:3.27%
cases:38.98%
controls:18.66%
cases:52.03%
controls:37.90%
665
5942
2059
21253
804
4686
1921
22515
589
931
2136
26270
89
47
2636
27154
425
889
2300
26305
1060
5048
1659
22010
1317
9464
1214
15506
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
4.6e-01
1.4e+00
1.7e+00
—
1.7e+00
2.2e+00
2.0e+00
cases:0.44%
controls:0.28%
cases:0.66%
controls:0.16%
cases:0.29%
controls:0.05%
—
—
cases:0.33%
controls:0.06%
cases:1.29%
controls:0.15%
cases:2.88%
controls:0.40%
12
76
2712
27119
18
44
2707
27157
8
14
2717
27187
—
9
17
2716
27177
35
40
2684
27018
73
101
2458
24869
Anal abscess
K61.0 [45601183]
K61.0 [45601183]
1.2e+00
3.3e+00
—
—
—
3.2e+00
2.4e+00
cases:0.40%
controls:0.12%
cases:1.03%
controls:0.04%
—
—
—
—
—
—
cases:0.88%
controls:0.04%
cases:1.46%
controls:0.13%
11
33
2713
27162
28
10
2697
27191
—
—
—
24
10
2695
27048
37
32
2494
24938
Rheumatology
66 [38004491]
66 [38004491]
9.2e-01
1.2e+00
1.7e+00
—
2.0e+00
1.6e+00
1.6e+00
cases:5.76%
controls:2.38%
cases:5.17%
controls:1.60%
cases:1.54%
controls:0.30%
—
—
cases:1.76%
controls:0.25%
cases:6.88%
controls:1.51%
cases:12.37%
controls:2.75%
157
647
2567
26548
141
435
2584
26766
42
81
2683
27120
—
48
68
2677
27126
187
408
2532
26650
313
686
2218
24284
Gastroscopy
UJD02 [2001304787]
UJD02 [2001304787]
1.5e+00
2.8e+00
—
1.0e+50
—
3.0e+00
1.6e+00
cases:0.73%
controls:0.17%
cases:0.81%
controls:0.05%
—
—
cases:0.51%
controls:0.00%
—
—
cases:0.44%
controls:0.02%
cases:0.95%
controls:0.20%
20
46
2704
27149
22
13
2703
27188
—
14
0
2711
27201
—
12
6
2707
27052
24
50
2507
24920
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
4.9e-01
1.1e+00
2.1e+00
—
1.9e+00
2.0e+00
1.2e+00
cases:2.61%
controls:1.62%
cases:2.13%
controls:0.69%
cases:0.51%
controls:0.06%
—
—
cases:0.59%
controls:0.09%
cases:4.16%
controls:0.60%
cases:8.30%
controls:2.55%
71
440
2653
26755
58
189
2667
27012
14
17
2711
27184
—
16
25
2709
27169
113
161
2606
26897
210
637
2321
24333
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
4.8e-01
1.0e+00
2.1e+00
—
2.7e+00
1.4e+00
1.1e+00
cases:2.17%
controls:1.35%
cases:1.43%
controls:0.51%
cases:0.59%
controls:0.07%
—
—
cases:0.84%
controls:0.06%
cases:1.95%
controls:0.48%
cases:3.79%
controls:1.30%
59
367
2665
26828
39
139
2686
27062
16
20
2709
27181
—
23
16
2702
27178
53
129
2666
26929
96
325
2435
24645
Emergency Medicine
93 [38004510]
93 [38004510]
2.6e-01
8.0e-01
1.6e+00
3.8e+00
1.1e+00
7.8e-01
4.0e-01
cases:11.05%
controls:8.77%
cases:10.02%
controls:4.76%
cases:3.27%
controls:0.69%
cases:1.28%
controls:0.03%
cases:2.13%
controls:0.71%
cases:11.07%
controls:5.38%
cases:23.35%
controls:16.91%
301
2385
2423
24810
273
1296
2452
25905
89
187
2636
27014
35
8
2690
27193
58
192
2667
27002
301
1455
2418
25603
591
4222
1940
20748
Adalimumab [Mass/volume] in Serum or Plasma
74117-3 [44786774]
74117-3 [44786774]
—
—
—
—
—
4.2e+00
4.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.03%
cases:7.47%
controls:0.10%
—
—
—
—
—
48
7
2671
27051
189
24
2342
24946
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
3.0e-01
1.5e+00
2.0e+00
1.0e+50
1.8e+00
1.8e+00
1.7e+00
cases:2.13%
controls:1.58%
cases:2.17%
controls:0.48%
cases:0.44%
controls:0.06%
cases:1.61%
controls:0.00%
cases:0.40%
controls:0.07%
cases:2.39%
controls:0.42%
cases:7.27%
controls:1.47%
58
431
2666
26764
59
130
2666
27071
12
17
2713
27184
44
0
2681
27201
11
19
2714
27175
65
114
2654
26944
184
366
2347
24604
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
7.5e-01
2.7e+00
—
1.0e+50
—
3.2e+00
2.8e+00
cases:0.55%
controls:0.26%
cases:0.88%
controls:0.06%
—
—
cases:0.55%
controls:0.00%
—
—
cases:1.29%
controls:0.06%
cases:2.73%
controls:0.16%
15
71
2709
27124
24
17
2701
27184
—
15
0
2710
27201
—
35
15
2684
27043
69
41
2462
24929
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
-4.8e-02
1.2e+00
2.5e+00
—
2.4e+00
1.6e+00
9.5e-01
cases:1.03%
controls:1.08%
cases:1.72%
controls:0.50%
cases:0.44%
controls:0.04%
—
—
cases:0.55%
controls:0.05%
cases:2.17%
controls:0.45%
cases:3.99%
controls:1.58%
28
293
2696
26902
47
137
2678
27064
12
10
2713
27191
—
15
14
2710
27180
59
122
2660
26936
101
395
2430
24575
Adalimumab Ab [Units/volume] in Serum or Plasma
87742-3 [36304052]
87742-3 [36304052]
—
—
—
—
—
4.0e+00
4.6e+00
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.02%
cases:5.61%
controls:0.06%
—
—
—
—
—
28
5
2691
27053
142
15
2389
24955
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
3.4e-01
1.2e+00
2.3e+00
—
2.0e+00
1.7e+00
1.4e+00
cases:1.32%
controls:0.94%
cases:1.69%
controls:0.53%
cases:0.73%
controls:0.08%
—
—
cases:0.48%
controls:0.07%
cases:2.87%
controls:0.51%
cases:5.69%
controls:1.44%
36
256
2688
26939
46
143
2679
27058
20
21
2705
27180
—
13
18
2712
27176
78
139
2641
26919
144
360
2387
24610
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.1e-01
6.0e-01
1.9e+00
2.9e+00
1.6e+00
9.4e-01
6.4e-01
cases:15.42%
controls:14.08%
cases:19.12%
controls:11.48%
cases:12.99%
controls:2.22%
cases:2.13%
controls:0.12%
cases:9.87%
controls:2.17%
cases:26.85%
controls:12.56%
cases:41.37%
controls:27.06%
420
3829
2304
23366
521
3122
2204
24079
354
604
2371
26597
58
33
2667
27168
269
590
2456
26604
730
3398
1989
23660
1047
6757
1484
18213
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
4.0e-01
1.7e+00
—
—
3.1e+00
2.3e+00
1.4e+00
cases:0.51%
controls:0.35%
cases:0.92%
controls:0.17%
—
—
—
—
cases:0.40%
controls:0.02%
cases:1.40%
controls:0.14%
cases:1.94%
controls:0.50%
14
94
2710
27101
25
46
2700
27155
—
—
11
5
2714
27189
38
37
2681
27021
49
125
2482
24845
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.9e-01
7.9e-01
1.4e+00
3.5e+00
1.4e+00
8.1e-01
5.6e-01
cases:5.03%
controls:4.21%
cases:4.55%
controls:2.12%
cases:1.54%
controls:0.37%
cases:0.59%
controls:0.02%
cases:1.14%
controls:0.28%
cases:4.78%
controls:2.18%
cases:10.94%
controls:6.59%
137
1146
2587
26049
124
576
2601
26625
42
100
2683
27101
16
5
2709
27196
31
76
2694
27118
130
589
2589
26469
277
1645
2254
23325
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
-9.7e-02
9.0e-01
2.0e+00
—
2.2e+00
1.8e+00
1.4e+00
cases:3.93%
controls:4.31%
cases:2.94%
controls:1.21%
cases:1.17%
controls:0.15%
—
—
cases:1.39%
controls:0.15%
cases:5.63%
controls:1.00%
cases:9.32%
controls:2.38%
107
1172
2617
26023
80
329
2645
26872
32
42
2693
27159
—
38
41
2687
27153
153
270
2566
26788
236
595
2295
24375
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
5.5e-01
1.2e+00
2.3e+00
—
1.9e+00
1.5e+00
9.3e-01
cases:8.48%
controls:5.07%
cases:10.57%
controls:3.35%
cases:4.26%
controls:0.46%
—
—
cases:3.34%
controls:0.51%
cases:14.42%
controls:3.68%
cases:26.39%
controls:12.36%
231
1380
2493
25815
288
910
2437
26291
116
126
2609
27075
—
91
139
2634
27055
392
995
2327
26063
668
3087
1863
21883
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
4.4e-01
1.7e+00
—
—
2.8e+00
2.4e+00
1.4e+00
cases:0.55%
controls:0.36%
cases:0.99%
controls:0.18%
—
—
—
—
cases:0.29%
controls:0.02%
cases:1.51%
controls:0.14%
cases:2.17%
controls:0.57%
15
97
2709
27098
27
48
2698
27153
—
—
8
5
2717
27189
41
37
2678
27021
55
142
2476
24828
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.1e-01
6.4e-01
1.9e+00
2.8e+00
1.6e+00
8.4e-01
3.7e-01
cases:27.90%
controls:25.82%
cases:33.61%
controls:21.13%
cases:24.77%
controls:4.59%
cases:3.67%
controls:0.23%
cases:18.24%
controls:4.36%
cases:40.57%
controls:22.77%
cases:52.86%
controls:43.61%
760
7021
1964
20174
916
5747
1809
21454
675
1248
2050
25953
100
63
2625
27138
497
1187
2228
26007
1103
6160
1616
20898
1338
10890
1193
14080
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.1e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.4e-01
3.7e-01
cases:28.05%
controls:25.93%
cases:33.61%
controls:21.19%
cases:24.81%
controls:4.62%
cases:3.71%
controls:0.23%
cases:18.24%
controls:4.37%
cases:40.57%
controls:22.84%
cases:52.86%
controls:43.72%
764
7051
1960
20144
916
5764
1809
21437
676
1256
2049
25945
101
63
2624
27138
497
1189
2228
26005
1103
6181
1616
20877
1338
10916
1193
14054
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.1e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.4e-01
3.7e-01
cases:28.05%
controls:25.92%
cases:33.58%
controls:21.18%
cases:24.81%
controls:4.60%
cases:3.67%
controls:0.23%
cases:18.28%
controls:4.37%
cases:40.57%
controls:22.83%
cases:52.86%
controls:43.68%
764
7049
1960
20146
915
5762
1810
21439
676
1252
2049
25949
100
63
2625
27138
498
1188
2227
26006
1103
6176
1616
20882
1338
10908
1193
14062
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.1e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.3e-01
3.7e-01
cases:28.01%
controls:25.89%
cases:33.61%
controls:21.17%
cases:24.77%
controls:4.60%
cases:3.67%
controls:0.23%
cases:18.20%
controls:4.37%
cases:40.53%
controls:22.83%
cases:52.86%
controls:43.69%
763
7040
1961
20155
916
5758
1809
21443
675
1251
2050
25950
100
63
2625
27138
496
1188
2229
26006
1102
6177
1617
20881
1338
10910
1193
14060
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.1e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.4e-01
3.7e-01
cases:28.05%
controls:25.91%
cases:33.61%
controls:21.19%
cases:24.77%
controls:4.61%
cases:3.67%
controls:0.23%
cases:18.24%
controls:4.37%
cases:40.57%
controls:22.84%
cases:52.86%
controls:43.71%
764
7047
1960
20148
916
5764
1809
21437
675
1253
2050
25948
100
63
2625
27138
497
1189
2228
26005
1103
6181
1616
20877
1338
10914
1193
14056
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.0e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.3e-01
3.6e-01
cases:28.05%
controls:26.00%
cases:33.65%
controls:21.26%
cases:24.81%
controls:4.61%
cases:3.67%
controls:0.23%
cases:18.31%
controls:4.39%
cases:40.60%
controls:22.94%
cases:52.86%
controls:43.78%
764
7071
1960
20124
917
5784
1808
21417
676
1254
2049
25947
100
63
2625
27138
499
1193
2226
26001
1104
6206
1615
20852
1338
10931
1193
14039
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.1e-01
6.3e-01
1.9e+00
2.8e+00
1.6e+00
8.3e-01
3.7e-01
cases:28.16%
controls:25.97%
cases:33.65%
controls:21.22%
cases:24.77%
controls:4.62%
cases:3.67%
controls:0.23%
cases:18.24%
controls:4.39%
cases:40.60%
controls:22.88%
cases:52.86%
controls:43.76%
767
7062
1957
20133
917
5771
1808
21430
675
1256
2050
25945
100
63
2625
27138
497
1193
2228
26001
1104
6192
1615
20866
1338
10928
1193
14042
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
2.3e-02
6.7e-01
1.6e+00
3.4e+00
1.3e+00
7.4e-01
3.6e-01
cases:4.00%
controls:3.91%
cases:4.11%
controls:2.14%
cases:1.61%
controls:0.33%
cases:0.55%
controls:0.02%
cases:1.17%
controls:0.31%
cases:4.89%
controls:2.39%
cases:10.47%
controls:7.51%
109
1064
2615
26131
112
581
2613
26620
44
90
2681
27111
15
5
2710
27196
32
84
2693
27110
133
648
2586
26410
265
1875
2266
23095
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
2.1e-01
7.3e-01
1.2e+00
3.2e+00
1.1e+00
9.7e-01
8.5e-01
cases:5.91%
controls:4.85%
cases:5.80%
controls:2.87%
cases:2.39%
controls:0.72%
cases:0.73%
controls:0.03%
cases:2.20%
controls:0.72%
cases:7.28%
controls:2.90%
cases:15.57%
controls:7.28%
161
1318
2563
25877
158
781
2567
26420
65
197
2660
27004
20
8
2705
27193
60
196
2665
26998
198
786
2521
26272
394
1819
2137
23151
ursodeoxycholic acid; oral
A05AA02 [21600513]
A05AA02 [21600513]
8.4e-01
1.3e+00
2.4e+00
—
1.6e+00
2.0e+00
2.3e+00
cases:0.33%
controls:0.14%
cases:0.44%
controls:0.12%
cases:0.29%
controls:0.03%
—
—
cases:0.22%
controls:0.04%
cases:1.03%
controls:0.14%
cases:2.17%
controls:0.21%
9
39
2715
27156
12
34
2713
27167
8
7
2717
27194
—
6
12
2719
27182
28
38
2691
27020
55
53
2476
24917
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
4.4e-01
1.1e+00
2.6e+00
—
2.3e+00
1.3e+00
7.8e-01
cases:2.13%
controls:1.39%
cases:1.14%
controls:0.39%
cases:0.40%
controls:0.03%
—
—
cases:0.48%
controls:0.05%
cases:1.58%
controls:0.45%
cases:3.32%
controls:1.55%
58
377
2666
26818
31
107
2694
27094
11
8
2714
27193
—
13
13
2712
27181
43
122
2676
26936
84
387
2447
24583
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
70242-3 [42868716]
70242-3 [42868716]
1.3e+00
2.6e+00
—
—
—
2.9e+00
2.5e+00
cases:0.40%
controls:0.11%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.66%
controls:0.14%
11
31
2713
27164
22
16
2703
27185
—
—
—
18
10
2701
27048
42
34
2489
24936
Sacro-iliac joint MRI examination with high intensity magnet
NA6BG [2001307059]
NA6BG [2001307059]
1.2e+00
2.1e+00
—
—
—
3.2e+00
2.7e+00
cases:0.40%
controls:0.12%
cases:0.33%
controls:0.04%
—
—
—
—
—
—
cases:0.63%
controls:0.03%
cases:1.38%
controls:0.09%
11
32
2713
27163
9
11
2716
27190
—
—
—
17
7
2702
27051
35
23
2496
24947
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
2.8e-01
2.2e-01
2.1e+00
—
3.0e+00
1.9e+00
1.0e+00
cases:1.62%
controls:1.23%
cases:0.81%
controls:0.65%
cases:0.55%
controls:0.07%
—
—
cases:0.84%
controls:0.04%
cases:2.87%
controls:0.45%
cases:4.46%
controls:1.64%
44
334
2680
26861
22
176
2703
27025
15
18
2710
27183
—
23
12
2702
27182
78
121
2641
26937
113
410
2418
24560
Salmonella sp identified in Specimen by Organism specific culture
17563-8 [3024522]
17563-8 [3024522]
1.3e+00
2.6e+00
—
—
—
2.9e+00
2.5e+00
cases:0.40%
controls:0.11%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.62%
controls:0.13%
11
31
2713
27164
22
17
2703
27184
—
—
—
18
10
2701
27048
41
33
2490
24937
Chronic anal fissure
K60.1 [45557665]
K60.1 [45557665]
1.6e+00
2.3e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:0.51%
controls:0.11%
cases:0.51%
controls:0.05%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.74%
controls:0.06%
cases:0.91%
controls:0.19%
14
29
2710
27166
14
14
2711
27187
—
6
0
2719
27201
—
20
16
2699
27042
23
48
2508
24922
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
2.2e-01
1.2e+00
2.3e+00
—
2.0e+00
1.4e+00
1.1e+00
cases:4.70%
controls:3.81%
cases:5.61%
controls:1.84%
cases:2.35%
controls:0.25%
—
—
cases:1.80%
controls:0.24%
cases:8.42%
controls:2.19%
cases:20.66%
controls:7.89%
128
1035
2596
26160
153
500
2572
26701
64
68
2661
27133
—
49
66
2676
27128
229
593
2490
26465
523
1971
2008
22999
Campylobacter sp identified in Specimen by Organism specific culture
6332-1 [3012568]
6332-1 [3012568]
1.2e+00
2.6e+00
—
—
—
2.9e+00
2.5e+00
cases:0.40%
controls:0.12%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.66%
controls:0.14%
11
32
2713
27163
22
17
2703
27184
—
—
—
18
10
2701
27048
42
35
2489
24935
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
3.9e-01
1.4e+00
2.1e+00
1.0e+50
2.7e+00
1.2e+00
6.9e-01
cases:2.90%
controls:1.98%
cases:2.28%
controls:0.60%
cases:0.66%
controls:0.08%
cases:0.44%
controls:0.00%
cases:0.84%
controls:0.06%
cases:2.10%
controls:0.67%
cases:4.27%
controls:2.18%
79
539
2645
26656
62
163
2663
27038
18
23
2707
27178
12
0
2713
27201
23
16
2702
27178
57
180
2662
26878
108
544
2423
24426
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.6e-01
7.0e-01
1.8e+00
2.8e+00
1.3e+00
6.9e-01
3.6e-01
cases:24.52%
controls:21.74%
cases:26.31%
controls:15.11%
cases:15.12%
controls:2.73%
cases:2.06%
controls:0.13%
cases:9.28%
controls:2.60%
cases:26.85%
controls:15.57%
cases:43.18%
controls:34.75%
668
5911
2056
21284
717
4110
2008
23091
412
743
2313
26458
56
36
2669
27165
253
706
2472
26488
730
4213
1989
22845
1093
8677
1438
16293
Ileus, unspecified
K56.7 [45567314]
K56.7 [45567314]
2.9e+00
2.8e+00
—
—
—
—
2.2e+00
cases:0.51%
controls:0.03%
cases:0.29%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.08%
14
8
2710
27187
8
5
2717
27196
—
—
—
—
19
21
2512
24949
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
3.6e-01
8.5e-01
1.6e+00
—
1.9e+00
1.9e+00
1.2e+00
cases:7.23%
controls:5.15%
cases:4.44%
controls:1.94%
cases:1.32%
controls:0.27%
—
—
cases:1.32%
controls:0.21%
cases:9.89%
controls:1.59%
cases:16.75%
controls:5.46%
197
1400
2527
25795
121
528
2604
26673
36
74
2689
27127
—
36
57
2689
27137
269
430
2450
26628
424
1364
2107
23606
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
701-3 [3025468]
1.2e+00
2.6e+00
—
—
—
2.8e+00
2.4e+00
cases:0.40%
controls:0.12%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.38%
controls:0.13%
11
33
2713
27162
22
16
2703
27185
—
—
—
18
11
2701
27047
35
32
2496
24938
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
82198-3 [21493466]
1.2e+00
2.6e+00
—
—
—
2.8e+00
2.4e+00
cases:0.40%
controls:0.12%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.38%
controls:0.13%
11
33
2713
27162
22
16
2703
27185
—
—
—
18
11
2701
27047
35
32
2496
24938
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
6581-3 [3005988]
1.2e+00
2.6e+00
—
—
—
2.8e+00
2.4e+00
cases:0.40%
controls:0.12%
cases:0.81%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.04%
cases:1.38%
controls:0.13%
11
33
2713
27162
22
16
2703
27185
—
—
—
18
11
2701
27047
35
32
2496
24938
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
M46.1 [45577263]
1.4e+00
2.0e+00
—
—
—
2.2e+00
2.2e+00
cases:0.40%
controls:0.10%
cases:0.48%
controls:0.07%
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:1.19%
controls:0.13%
11
27
2713
27168
13
18
2712
27183
—
—
—
15
17
2704
27041
30
32
2501
24938
ustekinumab; parenteral
L04AC05 [21603919]
L04AC05 [21603919]
-1.0e+50
-1.0e+50
—
—
—
3.2e+00
4.6e+00
cases:0.00%
controls:0.03%
cases:0.00%
controls:0.02%
—
—
—
—
—
—
cases:0.74%
controls:0.03%
cases:4.11%
controls:0.04%
0
7
2724
27188
0
6
2725
27195
—
—
—
20
8
2699
27050
104
11
2427
24959
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
1.6e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.7e+00
cases:0.70%
controls:0.15%
cases:0.84%
controls:0.09%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.85%
controls:0.09%
cases:1.66%
controls:0.31%
19
40
2705
27155
23
25
2702
27176
—
7
0
2718
27201
—
23
23
2696
27035
42
77
2489
24893
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.5e-02
8.7e-01
1.6e+00
1.0e+50
1.9e+00
1.9e+00
1.5e+00
cases:1.95%
controls:1.79%
cases:1.80%
controls:0.76%
cases:0.62%
controls:0.12%
cases:1.14%
controls:0.00%
cases:0.66%
controls:0.10%
cases:3.94%
controls:0.62%
cases:9.44%
controls:2.29%
53
487
2671
26708
49
207
2676
26994
17
33
2708
27168
31
0
2694
27201
18
27
2707
27167
107
169
2612
26889
239
571
2292
24399
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
6.2e-02
5.0e-01
1.3e+00
3.3e+00
1.3e+00
7.6e-01
6.1e-01
cases:6.02%
controls:5.68%
cases:4.59%
controls:2.82%
cases:1.25%
controls:0.34%
cases:0.48%
controls:0.02%
cases:1.21%
controls:0.32%
cases:5.00%
controls:2.41%
cases:14.42%
controls:8.35%
164
1544
2560
25651
125
768
2600
26433
34
93
2691
27108
13
5
2712
27196
33
87
2692
27107
136
653
2583
26405
365
2085
2166
22885
Pauciarticular juvenile arthritis
M08.4 [45582020]
M08.4 [45582020]
1.1e+00
1.6e+00
2.9e+00
—
1.8e+00
1.7e+00
1.6e+00
cases:0.37%
controls:0.12%
cases:0.33%
controls:0.07%
cases:0.33%
controls:0.02%
—
—
cases:0.18%
controls:0.03%
cases:0.37%
controls:0.07%
cases:0.40%
controls:0.08%
10
32
2714
27163
9
19
2716
27182
9
5
2716
27196
—
5
8
2720
27186
10
18
2709
27040
10
20
2521
24950
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.3e-02
7.9e-01
1.4e+00
2.5e+00
1.4e+00
8.6e-01
8.5e-01
cases:5.43%
controls:5.21%
cases:6.79%
controls:3.21%
cases:2.39%
controls:0.61%
cases:0.26%
controls:0.02%
cases:1.94%
controls:0.49%
cases:7.58%
controls:3.36%
cases:18.61%
controls:8.91%
148
1418
2576
25777
185
872
2540
26329
65
165
2660
27036
7
6
2718
27195
53
132
2672
27062
206
910
2513
26148
471
2224
2060
22746
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
5.8e-01
2.3e+00
2.9e+00
—
2.0e+00
4.4e-01
6.9e-02
cases:6.13%
controls:3.52%
cases:11.19%
controls:1.30%
cases:2.39%
controls:0.13%
—
—
cases:0.77%
controls:0.11%
cases:2.06%
controls:1.33%
cases:6.08%
controls:5.70%
167
956
2557
26239
305
353
2420
26848
65
36
2660
27165
—
21
30
2704
27164
56
360
2663
26698
154
1424
2377
23546
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-1.5e-01
4.1e-01
1.7e+00
2.6e+00
1.5e+00
8.7e-01
5.1e-01
cases:14.50%
controls:16.41%
cases:18.39%
controls:13.06%
cases:14.61%
controls:2.90%
cases:2.06%
controls:0.15%
cases:11.41%
controls:2.71%
cases:27.77%
controls:13.82%
cases:40.26%
controls:28.75%
395
4464
2329
22731
501
3553
2224
23648
398
788
2327
26413
56
41
2669
27160
311
736
2414
26458
755
3740
1964
23318
1019
7179
1512
17791
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
2.3e-01
7.9e-01
1.7e+00
—
2.4e+00
1.5e+00
1.3e+00
cases:5.73%
controls:4.60%
cases:2.83%
controls:1.31%
cases:0.77%
controls:0.14%
—
—
cases:1.28%
controls:0.12%
cases:4.16%
controls:0.97%
cases:10.59%
controls:3.02%
156
1250
2568
25945
77
355
2648
26846
21
39
2704
27162
—
35
32
2690
27162
113
262
2606
26796
268
755
2263
24215
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
5.5e-01
2.0e+00
2.7e+00
—
1.0e+00
1.6e+00
7.7e-01
cases:2.39%
controls:1.39%
cases:3.27%
controls:0.47%
cases:0.73%
controls:0.05%
—
—
cases:0.18%
controls:0.07%
cases:2.10%
controls:0.43%
cases:4.35%
controls:2.07%
65
378
2659
26817
89
127
2636
27074
20
13
2705
27188
—
5
18
2720
27176
57
116
2662
26942
110
517
2421
24453
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
8.4e-01
1.2e+00
1.6e+00
—
2.0e+00
1.1e+00
9.1e-01
cases:7.01%
controls:3.16%
cases:4.66%
controls:1.49%
cases:1.39%
controls:0.29%
—
—
cases:1.91%
controls:0.28%
cases:4.49%
controls:1.48%
cases:7.74%
controls:3.28%
191
859
2533
26336
127
405
2598
26796
38
80
2687
27121
—
52
75
2673
27119
122
401
2597
26657
196
820
2335
24150
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.2e+00
-1.0e+00
-3.6e-01
—
3.3e+00
3.1e+00
3.4e+00
cases:9.69%
controls:26.55%
cases:3.93%
controls:10.41%
cases:0.70%
controls:1.00%
—
—
cases:0.92%
controls:0.03%
cases:6.80%
controls:0.33%
cases:16.44%
controls:0.68%
264
7220
2460
19975
107
2832
2618
24369
19
272
2706
26929
—
25
9
2700
27185
185
88
2534
26970
416
170
2115
24800
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
1.4e-01
7.6e-01
1.3e+00
2.3e+00
1.4e+00
8.0e-01
8.4e-01
cases:5.47%
controls:4.79%
cases:5.98%
controls:2.90%
cases:2.06%
controls:0.56%
cases:0.22%
controls:0.02%
cases:1.65%
controls:0.40%
cases:6.25%
controls:2.92%
cases:16.00%
controls:7.60%
149
1304
2575
25891
163
789
2562
26412
56
151
2669
27050
6
6
2719
27195
45
108
2680
27086
170
791
2549
26267
405
1897
2126
23073
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
4.7e-01
1.2e+00
2.0e+00
—
1.8e+00
1.4e+00
1.0e+00
cases:1.69%
controls:1.06%
cases:1.91%
controls:0.56%
cases:0.70%
controls:0.09%
—
—
cases:0.51%
controls:0.09%
cases:2.02%
controls:0.51%
cases:4.82%
controls:1.80%
46
288
2678
26907
52
152
2673
27049
19
25
2706
27176
—
14
24
2711
27170
55
139
2664
26919
122
450
2409
24520
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.1e-02
7.2e-01
1.7e+00
—
2.2e+00
1.6e+00
1.2e+00
cases:2.68%
controls:2.63%
cases:1.47%
controls:0.72%
cases:0.33%
controls:0.06%
—
—
cases:0.48%
controls:0.06%
cases:1.95%
controls:0.40%
cases:4.39%
controls:1.33%
73
714
2651
26481
40
196
2685
27005
9
16
2716
27185
—
13
15
2712
27179
53
108
2666
26950
111
332
2420
24638
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.0e-01
6.7e-01
1.5e+00
2.6e+00
1.0e+00
8.0e-01
5.7e-01
cases:12.89%
controls:10.79%
cases:10.61%
controls:5.74%
cases:3.78%
controls:0.85%
cases:0.51%
controls:0.04%
cases:2.24%
controls:0.82%
cases:12.14%
controls:5.82%
cases:25.48%
controls:16.27%
351
2934
2373
24261
289
1560
2436
25641
103
232
2622
26969
14
10
2711
27191
61
222
2664
26972
330
1574
2389
25484
645
4063
1886
20907
tropicamide
S01FA06 [21605065]
S01FA06 [21605065]
1.8e+00
2.3e+00
—
—
—
1.9e+00
1.4e+00
cases:0.70%
controls:0.12%
cases:0.40%
controls:0.04%
—
—
—
—
—
—
cases:0.51%
controls:0.08%
cases:0.95%
controls:0.23%
19
32
2705
27163
11
11
2714
27190
—
—
—
14
21
2705
27037
24
58
2507
24912
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.1e-01
3.9e-01
7.4e-01
3.4e+00
1.4e+00
9.0e-01
3.8e-01
cases:57.16%
controls:51.97%
cases:55.23%
controls:45.58%
cases:31.16%
controls:17.82%
cases:23.12%
controls:1.03%
cases:46.46%
controls:17.38%
cases:69.62%
controls:48.20%
cases:74.28%
controls:66.39%
1557
14133
1167
13062
1505
12398
1220
14803
849
4846
1876
22355
630
281
2095
26920
1266
4727
1459
22467
1893
13042
826
14016
1880
16577
651
8393
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
20955-1 [3004716]
3.8e-01
1.8e+00
2.8e+00
—
2.7e+00
7.2e-01
2.2e-01
cases:1.76%
controls:1.21%
cases:1.91%
controls:0.31%
cases:0.62%
controls:0.04%
—
—
cases:0.33%
controls:0.02%
cases:0.55%
controls:0.27%
cases:1.26%
controls:1.02%
48
328
2676
26867
52
84
2673
27117
17
10
2708
27191
—
9
6
2716
27188
15
73
2704
26985
32
254
2499
24716
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
7.0e-02
3.8e-01
1.5e+00
3.6e+00
1.3e+00
4.8e-01
1.6e-01
cases:31.98%
controls:30.48%
cases:37.17%
controls:28.91%
cases:29.36%
controls:8.54%
cases:14.42%
controls:0.47%
cases:24.26%
controls:8.17%
cases:42.63%
controls:31.53%
cases:53.81%
controls:49.70%
871
8289
1853
18906
1013
7863
1712
19338
800
2323
1925
24878
393
127
2332
27074
661
2223
2064
24971
1159
8532
1560
18526
1362
12409
1169
12561
Partial resection of small intestine
JFB00 [2001304885]
JFB00 [2001304885]
1.1e+00
3.2e+00
—
1.0e+50
—
—
4.1e+00
cases:0.18%
controls:0.06%
cases:0.55%
controls:0.02%
—
—
cases:0.77%
controls:0.00%
—
—
—
—
cases:1.50%
controls:0.02%
5
16
2719
27179
15
6
2710
27195
—
21
0
2704
27201
—
—
38
6
2493
24964
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
D50.0 [45566697]
1.0e+00
3.2e+00
—
1.0e+50
—
2.7e+00
1.5e+00
cases:0.37%
controls:0.13%
cases:1.14%
controls:0.05%
—
—
cases:0.37%
controls:0.00%
—
—
cases:0.70%
controls:0.05%
cases:0.87%
controls:0.20%
10
36
2714
27159
31
13
2694
27188
—
10
0
2715
27201
—
19
13
2700
27045
22
49
2509
24921
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
1.6e-01
9.5e-01
2.4e+00
—
1.8e+00
1.1e+00
1.1e+00
cases:1.43%
controls:1.22%
cases:0.95%
controls:0.37%
cases:0.37%
controls:0.03%
—
—
cases:0.26%
controls:0.04%
cases:0.85%
controls:0.28%
cases:1.74%
controls:0.59%
39
333
2685
26862
26
101
2699
27100
10
9
2715
27192
—
7
12
2718
27182
23
76
2696
26982
44
147
2487
24823
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
-5.8e-02
2.2e-01
2.3e+00
—
2.7e+00
1.7e+00
6.8e-01
cases:4.33%
controls:4.58%
cases:2.64%
controls:2.12%
cases:1.87%
controls:0.20%
—
—
cases:2.97%
controls:0.21%
cases:9.56%
controls:1.87%
cases:12.88%
controls:6.94%
118
1245
2606
25950
72
577
2653
26624
51
54
2674
27147
—
81
58
2644
27136
260
505
2459
26553
326
1734
2205
23236
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
4.7e-01
1.5e+00
—
—
2.3e+00
2.0e+00
1.6e+00
cases:1.03%
controls:0.64%
cases:0.92%
controls:0.21%
—
—
—
—
cases:0.22%
controls:0.02%
cases:1.54%
controls:0.22%
cases:3.32%
controls:0.70%
28
175
2696
27020
25
58
2700
27143
—
—
6
6
2719
27188
42
59
2677
26999
84
176
2447
24794
Diarrhoea
D11 [2002000310]
D11 [2002000310]
6.9e-01
2.0e+00
3.3e+00
—
-1.0e+50
8.1e-01
5.4e-01
cases:2.90%
controls:1.48%
cases:2.90%
controls:0.41%
cases:0.59%
controls:0.02%
—
—
cases:0.00%
controls:0.04%
cases:0.85%
controls:0.38%
cases:2.61%
controls:1.53%
79
403
2645
26792
79
111
2646
27090
16
6
2709
27195
—
0
10
2725
27184
23
102
2696
26956
66
383
2465
24587
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
4.6e-01
1.1e+00
2.0e+00
1.0e+50
1.8e+00
1.4e+00
6.8e-01
cases:3.67%
controls:2.34%
cases:3.27%
controls:1.15%
cases:1.03%
controls:0.15%
cases:0.66%
controls:0.00%
cases:0.95%
controls:0.16%
cases:4.16%
controls:1.10%
cases:7.59%
controls:4.00%
100
636
2624
26559
89
313
2636
26888
28
40
2697
27161
18
0
2707
27201
26
44
2699
27150
113
297
2606
26761
192
1000
2339
23970
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
9.9e-01
1.1e+00
2.3e+00
—
—
2.0e+00
9.0e-01
cases:1.84%
controls:0.69%
cases:0.62%
controls:0.21%
cases:0.22%
controls:0.02%
—
—
—
—
cases:1.14%
controls:0.16%
cases:1.38%
controls:0.56%
50
187
2674
27008
17
57
2708
27144
6
6
2719
27195
—
—
31
43
2688
27015
35
141
2496
24829
Ulcerative colitis
K51 [45557655]
K51 [45557655]
1.8e+00
2.3e+00
—
—
—
1.8e+00
1.4e+00
cases:0.62%
controls:0.11%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.51%
controls:0.12%
17
29
2707
27166
10
10
2715
27191
—
—
—
7
12
2712
27046
13
31
2518
24939
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.0e-01
9.3e-01
1.8e+00
—
2.1e+00
1.1e+00
1.1e+00
cases:6.86%
controls:5.18%
cases:3.82%
controls:1.54%
cases:0.88%
controls:0.15%
—
—
cases:1.06%
controls:0.13%
cases:3.68%
controls:1.29%
cases:10.94%
controls:4.07%
187
1410
2537
25785
104
420
2621
26781
24
41
2701
27160
—
29
35
2696
27159
100
348
2619
26710
277
1016
2254
23954
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
7.2e-02
9.1e-01
1.5e+00
2.9e+00
8.5e-01
6.2e-01
4.3e-01
cases:11.16%
controls:10.46%
cases:11.89%
controls:5.17%
cases:2.97%
controls:0.68%
cases:0.62%
controls:0.03%
cases:1.61%
controls:0.70%
cases:9.75%
controls:5.48%
cases:24.61%
controls:17.54%
304
2845
2420
24350
324
1405
2401
25796
81
184
2644
27017
17
9
2708
27192
44
189
2681
27005
265
1482
2454
25576
623
4380
1908
20590
Chronic superficial gastritis
K29.3 [45596316]
K29.3 [45596316]
8.5e-01
3.2e+00
—
—
—
2.6e+00
1.4e+00
cases:0.26%
controls:0.11%
cases:0.44%
controls:0.02%
—
—
—
—
—
—
cases:0.55%
controls:0.04%
cases:0.55%
controls:0.14%
7
30
2717
27165
12
5
2713
27196
—
—
—
15
11
2704
27047
14
34
2517
24936
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.9e-01
6.6e-01
1.4e+00
3.0e+00
9.2e-01
7.4e-01
4.2e-01
cases:11.86%
controls:10.01%
cases:9.28%
controls:5.00%
cases:2.94%
controls:0.77%
cases:0.84%
controls:0.04%
cases:1.87%
controls:0.76%
cases:10.41%
controls:5.26%
cases:21.57%
controls:15.26%
323
2721
2401
24474
253
1361
2472
25840
80
210
2645
26991
23
11
2702
27190
51
206
2674
26988
283
1422
2436
25636
546
3810
1985
21160
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32787-4 [3043453]
32787-4 [3043453]
4.6e-01
2.3e+00
—
—
1.0e+50
2.4e+00
2.4e+00
cases:0.22%
controls:0.14%
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.18%
controls:0.00%
cases:0.59%
controls:0.05%
cases:1.19%
controls:0.11%
6
38
2718
27157
11
11
2714
27190
—
—
5
0
2720
27194
16
14
2703
27044
30
27
2501
24943
Neutrophil cytoplasmic Ab.classic [Titer] in Serum
32708-0 [3046294]
32708-0 [3046294]
4.6e-01
2.3e+00
—
—
1.0e+50
2.4e+00
2.4e+00
cases:0.22%
controls:0.14%
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.18%
controls:0.00%
cases:0.59%
controls:0.05%
cases:1.19%
controls:0.11%
6
38
2718
27157
11
11
2714
27190
—
—
5
0
2720
27194
16
14
2703
27044
30
27
2501
24943
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
-5.1e-02
6.3e-01
1.5e+00
1.0e+50
2.4e+00
1.4e+00
1.1e+00
cases:4.37%
controls:4.59%
cases:2.35%
controls:1.26%
cases:0.44%
controls:0.10%
cases:0.77%
controls:0.00%
cases:0.81%
controls:0.07%
cases:3.13%
controls:0.76%
cases:8.30%
controls:2.84%
119
1247
2605
25948
64
344
2661
26857
12
26
2713
27175
21
0
2704
27201
22
20
2703
27174
85
205
2634
26853
210
709
2321
24261
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
1.1e-01
8.2e-01
1.5e+00
1.0e+50
2.0e+00
1.3e+00
1.4e+00
cases:3.63%
controls:3.27%
cases:1.91%
controls:0.85%
cases:0.33%
controls:0.07%
cases:0.70%
controls:0.00%
cases:0.62%
controls:0.08%
cases:2.17%
controls:0.57%
cases:6.80%
controls:1.84%
99
888
2625
26307
52
232
2673
26969
9
20
2716
27181
19
0
2706
27201
17
22
2708
27172
59
155
2660
26903
172
460
2359
24510
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
1.8e-01
1.7e+00
—
—
—
3.5e+00
1.9e+00
cases:0.40%
controls:0.34%
cases:0.70%
controls:0.13%
—
—
—
—
—
—
cases:2.76%
controls:0.09%
cases:2.73%
controls:0.42%
11
92
2713
27103
19
35
2706
27166
—
—
—
75
24
2644
27034
69
105
2462
24865
folic acid; oral, parenteral
B03BB01 [21601129]
B03BB01 [21601129]
7.6e-01
7.5e-01
7.3e-01
—
1.8e+00
2.6e+00
1.9e+00
cases:1.06%
controls:0.50%
cases:0.81%
controls:0.38%
cases:0.22%
controls:0.11%
—
—
cases:0.59%
controls:0.10%
cases:6.62%
controls:0.54%
cases:9.05%
controls:1.53%
29
136
2695
27059
22
104
2703
27097
6
29
2719
27172
—
16
26
2709
27168
180
145
2539
26913
229
381
2302
24589
folic acid
V04CX02 [715877]
V04CX02 [715877]
7.6e-01
7.5e-01
7.3e-01
—
1.8e+00
2.6e+00
1.9e+00
cases:1.06%
controls:0.50%
cases:0.81%
controls:0.38%
cases:0.22%
controls:0.11%
—
—
cases:0.59%
controls:0.10%
cases:6.62%
controls:0.54%
cases:9.05%
controls:1.53%
29
136
2695
27059
22
104
2703
27097
6
29
2719
27172
—
16
26
2709
27168
180
145
2539
26913
229
381
2302
24589
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
2.3e-01
1.7e+00
—
—
—
3.4e+00
1.9e+00
cases:0.44%
controls:0.35%
cases:0.73%
controls:0.13%
—
—
—
—
—
—
cases:2.91%
controls:0.10%
cases:2.77%
controls:0.44%
12
95
2712
27100
20
36
2705
27165
—
—
—
79
27
2640
27031
70
109
2461
24861
Abdominal pain/cramps general
D01 [2002000300]
D01 [2002000300]
4.8e-01
2.0e+00
2.6e+00
—
1.7e+00
1.1e+00
8.3e-01
cases:2.17%
controls:1.36%
cases:2.64%
controls:0.38%
cases:0.55%
controls:0.04%
—
—
cases:0.18%
controls:0.03%
cases:1.18%
controls:0.40%
cases:3.52%
controls:1.56%
59
369
2665
26826
72
103
2653
27098
15
11
2710
27190
—
5
9
2720
27185
32
107
2687
26951
89
390
2442
24580
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
92689-9 [37020300]
92689-9 [37020300]
2.1e+00
2.9e+00
—
—
—
2.3e+00
1.9e+00
cases:0.22%
controls:0.03%
cases:0.33%
controls:0.02%
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.47%
controls:0.07%
6
7
2718
27188
9
5
2716
27196
—
—
—
5
5
2714
27053
12
17
2519
24953
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
4.8e-01
1.2e+00
1.7e+00
—
1.8e+00
1.3e+00
8.5e-01
cases:1.69%
controls:1.05%
cases:2.61%
controls:0.77%
cases:0.62%
controls:0.11%
—
—
cases:0.62%
controls:0.10%
cases:3.71%
controls:1.04%
cases:9.44%
controls:4.28%
46
286
2678
26909
71
210
2654
26991
17
30
2708
27171
—
17
27
2708
27167
101
281
2618
26777
239
1069
2292
23901
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
NK4XE [2001308469]
8.8e-01
9.1e-01
—
—
2.5e+00
1.3e+00
1.4e+00
cases:1.73%
controls:0.72%
cases:0.95%
controls:0.39%
—
—
—
—
cases:0.22%
controls:0.02%
cases:1.03%
controls:0.30%
cases:2.92%
controls:0.73%
47
197
2677
26998
26
105
2699
27096
—
—
6
5
2719
27189
28
80
2691
26978
74
183
2457
24787
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
3.1e-01
1.5e+00
—
—
2.6e+00
2.0e+00
8.7e-01
cases:0.84%
controls:0.62%
cases:1.03%
controls:0.24%
—
—
—
—
cases:0.29%
controls:0.02%
cases:1.36%
controls:0.19%
cases:1.62%
controls:0.68%
23
169
2701
27026
28
64
2697
27137
—
—
8
6
2717
27188
37
51
2682
27007
41
171
2490
24799
Varicella zoster virus Ab [Titer] in Serum
21594-7 [3014148]
21594-7 [3014148]
-9.7e-02
1.8e+00
1.0e+50
1.0e+50
1.0e+50
3.6e+00
1.6e+00
cases:0.18%
controls:0.20%
cases:0.40%
controls:0.07%
cases:0.51%
controls:0.00%
cases:0.18%
controls:0.00%
cases:0.70%
controls:0.00%
cases:2.32%
controls:0.07%
cases:1.70%
controls:0.36%
5
55
2719
27140
11
19
2714
27182
14
0
2711
27201
5
0
2720
27201
19
0
2706
27194
63
18
2656
27040
43
89
2488
24881
Infectious Disease
44 [38004484]
44 [38004484]
3.4e-01
1.1e+00
2.3e+00
—
1.7e+00
9.9e-01
8.1e-01
cases:1.76%
controls:1.26%
cases:1.65%
controls:0.54%
cases:0.51%
controls:0.05%
—
—
cases:0.44%
controls:0.08%
cases:1.43%
controls:0.54%
cases:3.60%
controls:1.64%
48
342
2676
26853
45
146
2680
27055
14
14
2711
27187
—
12
23
2713
27171
39
145
2680
26913
91
409
2440
24561
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
4.2e-01
9.0e-01
2.1e+00
—
1.5e+00
1.2e+00
7.8e-01
cases:5.47%
controls:3.66%
cases:4.95%
controls:2.08%
cases:2.35%
controls:0.29%
—
—
cases:1.32%
controls:0.31%
cases:6.66%
controls:2.15%
cases:13.28%
controls:6.57%
149
994
2575
26201
135
567
2590
26634
64
78
2661
27123
—
36
83
2689
27111
181
581
2538
26477
336
1641
2195
23329
Functional dyspepsia
K30 [45591584]
K30 [45591584]
4.6e-01
1.9e+00
3.1e+00
—
—
1.2e+00
5.4e-01
cases:1.32%
controls:0.84%
cases:1.80%
controls:0.26%
cases:0.66%
controls:0.03%
—
—
—
—
cases:0.85%
controls:0.25%
cases:1.82%
controls:1.07%
36
229
2688
26966
49
71
2676
27130
18
8
2707
27193
—
—
23
68
2696
26990
46
266
2485
24704
Enterocolitis due to Clostridium difficile
A04.7 [45552153]
A04.7 [45552153]
9.7e-01
2.5e+00
—
1.0e+50
—
2.5e+00
1.8e+00
cases:0.18%
controls:0.07%
cases:0.37%
controls:0.03%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.26%
controls:0.02%
cases:0.79%
controls:0.13%
5
19
2719
27176
10
8
2715
27193
—
5
0
2720
27201
—
7
6
2712
27052
20
32
2511
24938
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.2e-01
6.1e-01
1.4e+00
2.9e+00
1.0e+00
5.3e-01
3.1e-01
cases:21.11%
controls:19.24%
cases:23.56%
controls:14.29%
cases:9.69%
controls:2.70%
cases:2.72%
controls:0.15%
cases:6.46%
controls:2.44%
cases:23.61%
controls:15.45%
cases:40.34%
controls:33.13%
575
5232
2149
21963
642
3888
2083
23313
264
735
2461
26466
74
40
2651
27161
176
664
2549
26530
642
4181
2077
22877
1021
8273
1510
16697
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
7.7e-01
1.3e+00
1.6e+00
—
1.3e+00
1.1e+00
7.8e-01
cases:11.89%
controls:5.89%
cases:9.17%
controls:2.81%
cases:2.61%
controls:0.56%
—
—
cases:2.13%
controls:0.60%
cases:7.94%
controls:2.79%
cases:13.83%
controls:6.85%
324
1602
2400
25593
250
765
2475
26436
71
151
2654
27050
—
58
164
2667
27030
216
755
2503
26303
350
1710
2181
23260
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 [3012220]
29662-4 [3012220]
-1.8e-01
1.6e+00
1.0e+50
1.0e+50
—
3.5e+00
1.7e+00
cases:0.18%
controls:0.22%
cases:0.40%
controls:0.08%
cases:0.51%
controls:0.00%
cases:0.18%
controls:0.00%
—
—
cases:2.28%
controls:0.07%
cases:1.74%
controls:0.34%
5
60
2719
27135
11
22
2714
27179
14
0
2711
27201
5
0
2720
27201
—
62
20
2657
27038
44
84
2487
24886
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.1e-01
6.1e-01
1.4e+00
2.9e+00
9.9e-01
5.2e-01
3.0e-01
cases:21.22%
controls:19.37%
cases:23.71%
controls:14.48%
cases:9.80%
controls:2.71%
cases:2.72%
controls:0.15%
cases:6.46%
controls:2.50%
cases:23.83%
controls:15.63%
cases:40.42%
controls:33.38%
578
5269
2146
21926
646
3940
2079
23261
267
737
2458
26464
74
41
2651
27160
176
680
2549
26514
648
4228
2071
22830
1023
8335
1508
16635
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
1.0e+00
1.6e+00
1.8e+00
—
1.5e+00
1.4e+00
9.5e-01
cases:1.25%
controls:0.46%
cases:1.39%
controls:0.30%
cases:0.33%
controls:0.06%
—
—
cases:0.26%
controls:0.06%
cases:1.32%
controls:0.34%
cases:3.24%
controls:1.28%
34
125
2690
27070
38
81
2687
27120
9
15
2716
27186
—
7
15
2718
27179
36
91
2683
26967
82
320
2449
24650
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
7.7e-01
1.4e+00
1.2e+00
—
1.1e+00
1.1e+00
1.1e+00
cases:4.59%
controls:2.17%
cases:4.40%
controls:1.10%
cases:0.66%
controls:0.21%
—
—
cases:0.62%
controls:0.22%
cases:3.64%
controls:1.22%
cases:8.42%
controls:2.89%
125
590
2599
26605
120
298
2605
26903
18
56
2707
27145
—
17
59
2708
27135
99
329
2620
26729
213
721
2318
24249
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-2.0e-02
4.4e-01
1.6e+00
2.7e+00
1.3e+00
5.5e-01
1.1e-01
cases:19.49%
controls:19.80%
cases:21.61%
controls:15.10%
cases:13.87%
controls:3.19%
cases:2.24%
controls:0.15%
cases:10.42%
controls:2.96%
cases:24.71%
controls:15.98%
cases:35.60%
controls:33.04%
531
5385
2193
21810
589
4108
2136
23093
378
868
2347
26333
61
41
2664
27160
284
806
2441
26388
672
4323
2047
22735
901
8249
1630
16721
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
2.0e-01
9.0e-01
1.5e+00
—
2.1e+00
1.1e+00
9.9e-01
cases:6.35%
controls:5.28%
cases:5.06%
controls:2.11%
cases:1.03%
controls:0.22%
—
—
cases:1.39%
controls:0.17%
cases:5.77%
controls:2.01%
cases:15.88%
controls:6.56%
173
1435
2551
25760
138
575
2587
26626
28
61
2697
27140
—
38
47
2687
27147
157
544
2562
26514
402
1637
2129
23333
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
5.4e-01
9.3e-01
1.1e+00
—
1.6e+00
1.4e+00
1.1e+00
cases:8.81%
controls:5.32%
cases:5.14%
controls:2.09%
cases:1.25%
controls:0.44%
—
—
cases:2.09%
controls:0.45%
cases:6.80%
controls:1.81%
cases:14.82%
controls:5.45%
240
1447
2484
25748
140
569
2585
26632
34
119
2691
27082
—
57
122
2668
27072
185
491
2534
26567
375
1361
2156
23609
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
7.1e-01
1.7e+00
2.0e+00
—
2.1e+00
2.5e+00
2.3e+00
cases:0.59%
controls:0.29%
cases:0.59%
controls:0.10%
cases:0.18%
controls:0.03%
—
—
cases:0.18%
controls:0.02%
cases:1.47%
controls:0.13%
cases:3.75%
controls:0.40%
16
79
2708
27116
16
28
2709
27173
5
7
2720
27194
—
5
6
2720
27188
40
34
2679
27024
95
100
2436
24870
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
5.5e-01
1.6e+00
2.8e+00
—
1.2e+00
9.6e-01
5.5e-01
cases:4.99%
controls:2.94%
cases:4.59%
controls:0.94%
cases:1.87%
controls:0.12%
—
—
cases:0.44%
controls:0.14%
cases:2.76%
controls:1.08%
cases:6.44%
controls:3.82%
136
800
2588
26395
125
257
2600
26944
51
33
2674
27168
—
12
38
2713
27156
75
291
2644
26767
163
954
2368
24016
Anoscopy
UJH02 [2001305182]
UJH02 [2001305182]
9.8e-01
1.8e+00
—
—
—
1.8e+00
1.8e+00
cases:0.59%
controls:0.22%
cases:0.44%
controls:0.07%
—
—
—
—
—
—
cases:0.29%
controls:0.05%
cases:1.22%
controls:0.21%
16
60
2708
27135
12
19
2713
27182
—
—
—
8
13
2711
27045
31
52
2500
24918
Ulcerative (chronic) rectosigmoiditis
K51.3 [45533603]
K51.3 [45533603]
6.1e-01
1.3e+00
1.8e+00
—
2.5e+00
1.7e+00
2.1e+00
cases:0.26%
controls:0.14%
cases:0.29%
controls:0.08%
cases:0.18%
controls:0.03%
—
—
cases:0.22%
controls:0.02%
cases:0.51%
controls:0.09%
cases:1.42%
controls:0.17%
7
38
2717
27157
8
21
2717
27180
5
8
2720
27193
—
6
5
2719
27189
14
25
2705
27033
36
43
2495
24927
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.1e-01
6.7e-01
6.6e-01
2.1e+00
9.9e-01
8.1e-01
7.6e-01
cases:30.21%
controls:24.13%
cases:20.29%
controls:11.56%
cases:3.67%
controls:1.93%
cases:0.51%
controls:0.06%
cases:4.88%
controls:1.87%
cases:23.61%
controls:12.07%
cases:48.44%
controls:30.62%
823
6561
1901
20634
553
3145
2172
24056
100
526
2625
26675
14
17
2711
27184
133
509
2592
26685
642
3267
2077
23791
1226
7646
1305
17324
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
JN1CG [2001305527]
4.1e-01
2.3e+00
—
—
—
1.7e+00
2.3e+00
cases:0.18%
controls:0.12%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.91%
controls:0.09%
5
33
2719
27162
12
12
2713
27189
—
—
—
8
15
2711
27043
23
23
2508
24947
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
1.3e-02
7.8e-01
2.2e+00
—
1.2e+00
1.2e+00
8.7e-01
cases:4.74%
controls:4.68%
cases:4.92%
controls:2.32%
cases:2.90%
controls:0.34%
—
—
cases:1.28%
controls:0.39%
cases:7.69%
controls:2.37%
cases:16.28%
controls:7.53%
129
1272
2595
25923
134
630
2591
26571
79
93
2646
27108
—
35
105
2690
27089
209
642
2510
26416
412
1881
2119
23089
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
-3.5e-02
1.9e-01
2.6e+00
—
—
2.3e+00
1.3e+00
cases:0.55%
controls:0.57%
cases:0.33%
controls:0.27%
cases:0.40%
controls:0.03%
—
—
—
—
cases:1.73%
controls:0.18%
cases:2.45%
controls:0.65%
15
155
2709
27040
9
74
2716
27127
11
8
2714
27193
—
—
47
50
2672
27008
62
163
2469
24807
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
7.1e-01
1.5e+00
2.0e+00
—
2.0e+00
2.4e+00
2.2e+00
cases:0.62%
controls:0.31%
cases:0.55%
controls:0.12%
cases:0.18%
controls:0.03%
—
—
cases:0.18%
controls:0.03%
cases:1.47%
controls:0.13%
cases:3.63%
controls:0.42%
17
84
2707
27111
15
32
2710
27169
5
7
2720
27194
—
5
7
2720
27187
40
35
2679
27023
92
106
2439
24864
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.5e-01
8.1e-01
1.6e+00
1.0e+50
1.8e+00
1.1e+00
7.9e-01
cases:2.90%
controls:2.27%
cases:2.50%
controls:1.12%
cases:0.84%
controls:0.17%
cases:0.33%
controls:0.00%
cases:0.70%
controls:0.12%
cases:2.94%
controls:0.98%
cases:7.82%
controls:3.70%
79
616
2645
26579
68
306
2657
26895
23
46
2702
27155
9
0
2716
27201
19
32
2706
27162
80
265
2639
26793
198
924
2333
24046
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
1825-9 [3026285]
8.0e-01
1.9e+00
—
—
—
2.4e+00
1.9e+00
cases:0.29%
controls:0.13%
cases:0.26%
controls:0.04%
—
—
—
—
—
—
cases:0.37%
controls:0.03%
cases:1.30%
controls:0.20%
8
36
2716
27159
7
11
2718
27190
—
—
—
10
9
2709
27049
33
51
2498
24919
Gastritis, unspecified
K29.7 [45591583]
K29.7 [45591583]
9.0e-01
2.5e+00
—
1.0e+50
—
2.5e+00
1.1e+00
cases:0.44%
controls:0.18%
cases:0.62%
controls:0.05%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.77%
controls:0.06%
cases:0.67%
controls:0.23%
12
49
2712
27146
17
14
2708
27187
—
5
0
2720
27201
—
21
17
2698
27041
17
57
2514
24913
Acute abdomen
R10.0 [45563289]
R10.0 [45563289]
1.1e+00
2.4e+00
—
—
—
1.6e+00
1.0e+00
cases:0.62%
controls:0.22%
cases:0.55%
controls:0.05%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.67%
controls:0.24%
17
59
2707
27136
15
14
2710
27187
—
—
—
8
16
2711
27042
17
59
2514
24911
Neutrophils [#/volume] in Blood
26499-4 [3017732]
26499-4 [3017732]
5.9e-01
1.3e+00
1.9e+00
—
1.4e+00
1.6e+00
1.2e+00
cases:1.28%
controls:0.71%
cases:1.03%
controls:0.28%
cases:0.40%
controls:0.06%
—
—
cases:0.29%
controls:0.07%
cases:2.28%
controls:0.45%
cases:6.99%
controls:2.18%
35
194
2689
27001
28
77
2697
27124
11
16
2714
27185
—
8
20
2717
27174
62
121
2657
26937
177
545
2354
24425
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
3.1e-01
7.7e-01
2.2e+00
—
1.5e+00
1.1e+00
5.4e-01
cases:4.92%
controls:3.66%
cases:3.78%
controls:1.79%
cases:2.02%
controls:0.22%
—
—
cases:1.06%
controls:0.25%
cases:5.74%
controls:2.04%
cases:10.87%
controls:6.66%
134
995
2590
26200
103
488
2622
26713
55
59
2670
27142
—
29
68
2696
27126
156
551
2563
26507
275
1663
2256
23307
Other transluminal endoscopic local operation on intestine
JFA98 [2001304883]
JFA98 [2001304883]
—
—
—
—
—
3.2e+00
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.03%
cases:0.91%
controls:0.05%
—
—
—
—
—
17
7
2702
27051
23
13
2508
24957
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16182-8 [3021952]
16182-8 [3021952]
6.0e-01
1.5e+00
—
—
—
2.4e+00
2.2e+00
cases:0.22%
controls:0.12%
cases:0.33%
controls:0.07%
—
—
—
—
—
—
cases:0.59%
controls:0.06%
cases:1.42%
controls:0.16%
6
33
2718
27162
9
20
2716
27181
—
—
—
16
15
2703
27043
36
41
2495
24929
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
-2.6e-01
1.3e+00
—
—
—
2.5e+00
2.3e+00
cases:0.26%
controls:0.33%
cases:0.44%
controls:0.12%
—
—
—
—
—
—
cases:0.77%
controls:0.07%
cases:1.98%
controls:0.20%
7
91
2717
27104
12
34
2713
27167
—
—
—
21
18
2698
27040
50
50
2481
24920
pneumococcus, purified polysaccharides antigen conjugated
J07AL02 [21601313]
J07AL02 [21601313]
5.2e-01
6.7e-01
—
—
2.8e+00
2.4e+00
8.6e-01
cases:0.88%
controls:0.53%
cases:0.29%
controls:0.15%
—
—
—
—
cases:0.40%
controls:0.03%
cases:1.69%
controls:0.16%
cases:1.98%
controls:0.85%
24
143
2700
27052
8
41
2717
27160
—
—
11
7
2714
27187
46
42
2673
27016
50
211
2481
24759
hydroxocobalamin; parenteral
B03BA03 [21601123]
B03BA03 [21601123]
1.0e+00
1.3e+00
—
—
1.5e+00
1.7e+00
2.0e+00
cases:1.28%
controls:0.47%
cases:1.54%
controls:0.44%
—
—
—
—
cases:0.29%
controls:0.06%
cases:2.32%
controls:0.43%
cases:4.62%
controls:0.64%
35
128
2689
27067
42
120
2683
27081
—
—
8
17
2717
27177
63
115
2656
26943
117
160
2414
24810
hydroxocobalamin
V03AB33 [21605256]
V03AB33 [21605256]
1.0e+00
1.3e+00
—
—
1.5e+00
1.7e+00
2.0e+00
cases:1.28%
controls:0.47%
cases:1.54%
controls:0.44%
—
—
—
—
cases:0.29%
controls:0.06%
cases:2.32%
controls:0.43%
cases:4.62%
controls:0.64%
35
128
2689
27067
42
120
2683
27081
—
—
8
17
2717
27177
63
115
2656
26943
117
160
2414
24810
Hip joint ultrasound examination
NF1AE [2001307895]
NF1AE [2001307895]
7.8e-01
1.7e+00
—
—
—
2.4e+00
1.9e+00
cases:0.37%
controls:0.17%
cases:0.29%
controls:0.06%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.99%
controls:0.15%
10
46
2714
27149
8
15
2717
27186
—
—
—
14
13
2705
27045
25
37
2506
24933
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
-7.0e-02
9.2e-01
1.4e+00
—
1.8e+00
1.1e+00
6.6e-01
cases:0.84%
controls:0.90%
cases:1.21%
controls:0.49%
cases:0.37%
controls:0.09%
—
—
cases:0.44%
controls:0.07%
cases:1.62%
controls:0.54%
cases:3.48%
controls:1.83%
23
246
2701
26949
33
132
2692
27069
10
24
2715
27177
—
12
19
2713
27175
44
147
2675
26911
88
457
2443
24513
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
7.3e-01
1.8e+00
—
—
—
2.4e+00
1.8e+00
cases:0.40%
controls:0.19%
cases:0.48%
controls:0.08%
—
—
—
—
—
—
cases:0.74%
controls:0.07%
cases:1.62%
controls:0.27%
11
53
2713
27142
13
22
2712
27179
—
—
—
20
19
2699
27039
41
67
2490
24903
Melaena
K92.1 [45533624]
K92.1 [45533624]
1.5e+00
2.7e+00
—
—
—
1.7e+00
8.3e-01
cases:0.84%
controls:0.19%
cases:1.32%
controls:0.09%
—
—
—
—
—
—
cases:0.29%
controls:0.06%
cases:0.63%
controls:0.28%
23
51
2701
27144
36
24
2689
27177
—
—
—
8
15
2711
27043
16
69
2515
24901
Ulcerative (chronic) proctitis
K51.2 [45596329]
K51.2 [45596329]
4.8e-01
2.1e+00
—
—
—
2.2e+00
1.6e+00
cases:0.22%
controls:0.14%
cases:0.33%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.40%
controls:0.08%
6
37
2718
27158
9
11
2716
27190
—
—
—
9
10
2710
27048
10
20
2521
24950
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
1.1e+00
1.3e+00
1.4e+00
—
1.5e+00
1.6e+00
2.0e+00
cases:0.62%
controls:0.21%
cases:0.51%
controls:0.15%
cases:0.26%
controls:0.06%
—
—
cases:0.22%
controls:0.05%
cases:0.66%
controls:0.14%
cases:1.19%
controls:0.17%
17
58
2707
27137
14
40
2711
27161
7
17
2718
27184
—
6
13
2719
27181
18
37
2701
27021
30
42
2501
24928
Abdominal pain localized other
D06 [2002000305]
D06 [2002000305]
5.7e-01
1.4e+00
2.8e+00
—
—
1.1e+00
5.9e-01
cases:1.40%
controls:0.79%
cases:1.06%
controls:0.27%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.70%
controls:0.23%
cases:1.78%
controls:0.99%
38
216
2686
26979
29
73
2696
27128
8
5
2717
27196
—
—
19
62
2700
26996
45
248
2486
24722
Anal fissure, unspecified
K60.2 [45538540]
K60.2 [45538540]
1.5e+00
2.6e+00
—
—
—
1.7e+00
3.9e-01
cases:0.40%
controls:0.09%
cases:0.40%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.05%
cases:0.24%
controls:0.16%
11
25
2713
27170
11
8
2714
27193
—
—
—
8
14
2711
27044
6
40
2525
24930
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
4.0e-01
7.8e-01
2.0e+00
—
1.2e+00
9.4e-01
5.0e-01
cases:7.53%
controls:5.17%
cases:5.87%
controls:2.77%
cases:2.61%
controls:0.37%
—
—
cases:1.43%
controls:0.42%
cases:7.54%
controls:3.10%
cases:15.17%
controls:9.75%
205
1407
2519
25788
160
754
2565
26447
71
102
2654
27099
—
39
113
2686
27081
205
839
2514
26219
384
2435
2147
22535
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
1.0e-01
1.7e+00
—
—
—
2.3e+00
1.7e+00
cases:0.29%
controls:0.26%
cases:0.73%
controls:0.13%
—
—
—
—
—
—
cases:1.07%
controls:0.10%
cases:1.78%
controls:0.34%
8
72
2716
27123
20
36
2705
27165
—
—
—
29
28
2690
27030
45
84
2486
24886
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
7.9e-02
8.0e-01
1.8e+00
—
1.4e+00
1.0e+00
6.5e-01
cases:2.83%
controls:2.62%
cases:2.57%
controls:1.17%
cases:1.14%
controls:0.19%
—
—
cases:0.59%
controls:0.14%
cases:2.83%
controls:1.04%
cases:6.05%
controls:3.25%
77
712
2647
26483
70
318
2655
26883
31
51
2694
27150
—
16
38
2709
27156
77
282
2642
26776
153
812
2378
24158
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-2.1e-01
7.5e-01
1.7e+00
—
1.4e+00
1.0e+00
8.2e-01
cases:2.57%
controls:3.14%
cases:3.30%
controls:1.58%
cases:1.43%
controls:0.28%
—
—
cases:0.88%
controls:0.21%
cases:4.01%
controls:1.46%
cases:9.13%
controls:4.23%
70
855
2654
26340
90
431
2635
26770
39
75
2686
27126
—
24
57
2701
27137
109
395
2610
26663
231
1056
2300
23914
Endoscopic polypectomy in colon
JFA15 [2001304850]
JFA15 [2001304850]
2.0e-01
2.1e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.26%
controls:0.21%
cases:0.59%
controls:0.07%
—
—
cases:0.59%
controls:0.00%
—
—
cases:0.55%
controls:0.06%
cases:1.38%
controls:0.38%
7
57
2717
27138
16
20
2709
27181
—
16
0
2709
27201
—
15
15
2704
27043
35
95
2496
24875
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
26505-8 [3017354]
—
2.1e+00
—
—
—
3.1e+00
2.5e+00
—
—
cases:0.18%
controls:0.02%
—
—
—
—
—
—
cases:0.85%
controls:0.04%
cases:1.34%
controls:0.11%
—
5
6
2720
27195
—
—
—
23
10
2696
27048
34
28
2497
24942
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
1.6e-01
7.1e-01
2.0e+00
—
1.9e+00
2.2e+00
1.4e+00
cases:0.51%
controls:0.44%
cases:0.37%
controls:0.18%
cases:0.22%
controls:0.03%
—
—
cases:0.22%
controls:0.03%
cases:1.77%
controls:0.20%
cases:2.29%
controls:0.55%
14
119
2710
27076
10
49
2715
27152
6
8
2719
27193
—
6
9
2719
27185
48
55
2671
27003
58
138
2473
24832
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72872-5 [43534045]
72872-5 [43534045]
4.1e-01
2.6e+00
3.0e+00
—
—
4.4e-01
-6.6e-01
cases:1.47%
controls:0.98%
cases:3.08%
controls:0.23%
cases:0.51%
controls:0.03%
—
—
—
—
cases:0.44%
controls:0.28%
cases:0.55%
controls:1.06%
40
267
2684
26928
84
62
2641
27139
14
7
2711
27194
—
—
12
77
2707
26981
14
265
2517
24705
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.9e-01
7.6e-01
1.8e+00
—
1.3e+00
9.1e-01
4.7e-01
cases:8.41%
controls:5.86%
cases:7.01%
controls:3.42%
cases:2.79%
controls:0.49%
—
—
cases:1.91%
controls:0.51%
cases:9.12%
controls:3.89%
cases:18.93%
controls:12.77%
229
1594
2495
25601
191
930
2534
26271
76
133
2649
27068
—
52
138
2673
27056
248
1052
2471
26006
479
3188
2052
21782
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
1.3e-01
9.4e-01
1.9e+00
—
1.4e+00
8.5e-01
5.6e-01
cases:4.44%
controls:3.93%
cases:2.68%
controls:1.06%
cases:0.51%
controls:0.08%
—
—
cases:0.40%
controls:0.10%
cases:1.88%
controls:0.81%
cases:5.53%
controls:3.25%
121
1068
2603
26127
73
289
2652
26912
14
22
2711
27179
—
11
27
2714
27167
51
220
2668
26838
140
811
2391
24159
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
6.7e-01
9.4e-01
1.5e+00
—
1.3e+00
1.2e+00
1.3e+00
cases:1.80%
controls:0.93%
cases:1.39%
controls:0.55%
cases:0.44%
controls:0.10%
—
—
cases:0.29%
controls:0.08%
cases:1.88%
controls:0.58%
cases:4.70%
controls:1.31%
49
252
2675
26943
38
149
2687
27052
12
27
2713
27174
—
8
21
2717
27173
51
158
2668
26900
119
327
2412
24643
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
4.0e-01
9.6e-01
1.2e+00
—
1.1e+00
1.1e+00
8.2e-01
cases:4.07%
controls:2.78%
cases:2.64%
controls:1.03%
cases:0.48%
controls:0.15%
—
—
cases:0.48%
controls:0.15%
cases:2.72%
controls:0.92%
cases:6.80%
controls:3.12%
111
756
2613
26439
72
280
2653
26921
13
40
2712
27161
—
13
42
2712
27152
74
250
2645
26808
172
778
2359
24192
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.7e-01
7.4e-01
1.8e+00
—
1.3e+00
9.0e-01
4.6e-01
cases:8.08%
controls:5.74%
cases:6.75%
controls:3.35%
cases:2.79%
controls:0.47%
—
—
cases:1.80%
controls:0.51%
cases:8.97%
controls:3.86%
cases:18.61%
controls:12.60%
220
1562
2504
25633
184
912
2541
26289
76
128
2649
27073
—
49
140
2676
27054
244
1044
2475
26014
471
3147
2060
21823
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.7e-01
7.2e-01
1.8e+00
—
1.3e+00
9.1e-01
4.5e-01
cases:8.41%
controls:5.93%
cases:6.86%
controls:3.45%
cases:2.86%
controls:0.49%
—
—
cases:1.83%
controls:0.51%
cases:9.19%
controls:3.91%
cases:18.81%
controls:12.86%
229
1614
2495
25581
187
938
2538
26263
78
134
2647
27067
—
50
140
2675
27054
250
1059
2469
25999
476
3212
2055
21758
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
1.7e-01
6.8e-01
1.5e+00
—
1.5e+00
1.1e+00
7.0e-01
cases:4.41%
controls:3.73%
cases:3.34%
controls:1.72%
cases:1.10%
controls:0.24%
—
—
cases:0.92%
controls:0.20%
cases:4.01%
controls:1.38%
cases:9.64%
controls:5.04%
120
1015
2604
26180
91
467
2634
26734
30
65
2695
27136
—
25
55
2700
27139
109
374
2610
26684
244
1259
2287
23711
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
3.4e-01
9.0e-01
1.7e+00
—
1.6e+00
8.1e-01
4.6e-01
cases:2.86%
controls:2.06%
cases:3.23%
controls:1.33%
cases:1.03%
controls:0.18%
—
—
cases:0.77%
controls:0.16%
cases:3.64%
controls:1.66%
cases:9.52%
controls:6.22%
78
560
2646
26635
88
363
2637
26838
28
50
2697
27151
—
21
44
2704
27150
99
448
2620
26610
241
1552
2290
23418
Haemorrhage of anus and rectum
K62.5 [45596339]
K62.5 [45596339]
9.3e-01
2.3e+00
3.1e+00
1.0e+50
—
—
9.2e-02
cases:0.55%
controls:0.22%
cases:1.17%
controls:0.11%
cases:0.40%
controls:0.02%
cases:0.18%
controls:0.00%
—
—
—
—
cases:0.51%
controls:0.47%
15
59
2709
27136
32
31
2693
27170
11
5
2714
27196
5
0
2720
27201
—
—
13
117
2518
24853
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
32998-7 [3046870]
3.6e-01
2.2e+00
3.2e+00
—
—
4.9e-01
-5.3e-01
cases:0.37%
controls:0.26%
cases:1.14%
controls:0.12%
cases:0.44%
controls:0.02%
—
—
—
—
cases:0.29%
controls:0.18%
cases:0.71%
controls:1.20%
10
70
2714
27125
31
33
2694
27168
12
5
2713
27196
—
—
8
49
2711
27009
18
299
2513
24671
HLA-B27 [Presence]
4821-5 [3008898]
4821-5 [3008898]
8.7e-01
1.5e+00
—
—
—
2.1e+00
9.9e-01
cases:1.14%
controls:0.48%
cases:0.81%
controls:0.19%
—
—
—
—
—
—
cases:1.21%
controls:0.16%
cases:1.98%
controls:0.74%
31
131
2693
27064
22
51
2703
27150
—
—
—
33
42
2686
27016
50
186
2481
24784
dexrabeprazole
A02BC07 [45893509]
A02BC07 [45893509]
7.6e-01
1.1e+00
1.6e+00
—
9.9e-01
1.1e+00
6.7e-01
cases:1.36%
controls:0.64%
cases:0.95%
controls:0.31%
cases:0.37%
controls:0.07%
—
—
cases:0.26%
controls:0.10%
cases:1.10%
controls:0.37%
cases:1.70%
controls:0.88%
37
174
2687
27021
26
83
2699
27118
10
20
2715
27181
—
7
26
2718
27168
30
100
2689
26958
43
219
2488
24751
rabeprazole; oral
A02BC04 [21600099]
A02BC04 [21600099]
7.6e-01
1.1e+00
1.6e+00
—
9.9e-01
1.1e+00
6.7e-01
cases:1.36%
controls:0.64%
cases:0.95%
controls:0.31%
cases:0.37%
controls:0.07%
—
—
cases:0.26%
controls:0.10%
cases:1.10%
controls:0.37%
cases:1.70%
controls:0.88%
37
174
2687
27021
26
83
2699
27118
10
20
2715
27181
—
7
26
2718
27168
30
100
2689
26958
43
219
2488
24751
fluocortolone
C05AA08 [21601612]
C05AA08 [21601612]
1.1e+00
1.7e+00
—
—
—
1.3e+00
1.1e+00
cases:2.83%
controls:1.00%
cases:1.80%
controls:0.32%
—
—
—
—
—
—
cases:1.03%
controls:0.27%
cases:2.96%
controls:0.99%
77
273
2647
26922
49
87
2676
27114
—
—
—
28
73
2691
26985
75
248
2456
24722
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
-4.1e-02
6.9e-01
1.7e+00
—
1.3e+00
9.1e-01
6.7e-01
cases:2.61%
controls:2.71%
cases:2.31%
controls:1.18%
cases:0.99%
controls:0.19%
—
—
cases:0.59%
controls:0.16%
cases:2.50%
controls:1.02%
cases:5.65%
controls:2.98%
71
738
2653
26457
63
320
2662
26881
27
51
2698
27150
—
16
43
2709
27151
68
277
2651
26781
143
744
2388
24226
Varicella zoster virus IgG Ab [Units/volume] in Serum
8047-3 [3022575]
8047-3 [3022575]
—
—
—
—
1.0e+50
3.8e+00
1.4e+00
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.00%
cases:1.03%
controls:0.02%
cases:0.59%
controls:0.15%
—
—
—
—
7
0
2718
27194
28
6
2691
27052
15
37
2516
24933
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
NK6QA [2001308500]
3.7e-01
6.5e-01
—
—
—
2.9e+00
2.3e+00
cases:0.81%
controls:0.56%
cases:0.33%
controls:0.17%
—
—
—
—
—
—
cases:1.47%
controls:0.08%
cases:3.75%
controls:0.38%
22
152
2702
27043
9
47
2716
27154
—
—
—
40
22
2679
27036
95
95
2436
24875
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
JKE98 [2001305336]
JKE98 [2001305336]
1.5e+00
—
—
—
—
2.9e+00
2.2e+00
cases:0.22%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.03%
cases:1.03%
controls:0.11%
6
13
2718
27182
—
—
—
—
13
7
2706
27051
26
28
2505
24942
fluocortolone
D07AC05 [21602124]
D07AC05 [21602124]
1.1e+00
1.5e+00
—
—
—
1.2e+00
1.4e+00
cases:1.58%
controls:0.56%
cases:0.73%
controls:0.17%
—
—
—
—
—
—
cases:0.55%
controls:0.17%
cases:2.05%
controls:0.50%
43
151
2681
27044
20
46
2705
27155
—
—
—
15
47
2704
27011
52
126
2479
24844
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
D12.5 [45552326]
1.0e+00
2.2e+00
—
1.0e+50
—
1.7e+00
1.2e+00
cases:0.40%
controls:0.15%
cases:0.40%
controls:0.04%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.37%
controls:0.07%
cases:0.67%
controls:0.21%
11
40
2713
27155
11
12
2714
27189
—
11
0
2714
27201
—
10
18
2709
27040
17
52
2514
24918
scopolamine
S01FA02 [21605061]
S01FA02 [21605061]
1.4e+00
1.8e+00
—
—
—
—
1.9e+00
cases:0.48%
controls:0.12%
cases:0.33%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.32%
controls:0.05%
13
32
2711
27163
9
15
2716
27186
—
—
—
—
8
12
2523
24958
Inflammatory spondylopathy, unspecified
M46.9 [45533846]
M46.9 [45533846]
1.9e+00
1.7e+00
—
—
—
1.5e+00
1.5e+00
cases:0.70%
controls:0.11%
cases:0.40%
controls:0.08%
—
—
—
—
—
—
cases:0.29%
controls:0.07%
cases:0.63%
controls:0.14%
19
29
2705
27166
11
21
2714
27180
—
—
—
8
18
2711
27040
16
34
2515
24936
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.8e-02
7.3e-01
1.7e+00
—
1.4e+00
8.3e-01
4.7e-01
cases:3.63%
controls:3.54%
cases:3.74%
controls:1.84%
cases:1.54%
controls:0.30%
—
—
cases:0.95%
controls:0.24%
cases:4.27%
controls:1.91%
cases:9.17%
controls:5.92%
99
962
2625
26233
102
501
2623
26700
42
81
2683
27120
—
26
66
2699
27128
116
518
2603
26540
232
1477
2299
23493
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
7.0e-01
1.0e+00
7.3e-01
—
1.6e+00
9.0e-01
8.0e-01
cases:1.91%
controls:0.96%
cases:1.28%
controls:0.47%
cases:0.18%
controls:0.09%
—
—
cases:0.33%
controls:0.07%
cases:1.21%
controls:0.50%
cases:2.92%
controls:1.34%
52
260
2672
26935
35
127
2690
27074
5
24
2720
27177
—
9
18
2716
27176
33
135
2686
26923
74
334
2457
24636
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
6.7e-02
9.0e-02
1.3e+00
—
2.1e+00
1.8e+00
1.1e+00
cases:1.17%
controls:1.10%
cases:0.59%
controls:0.54%
cases:0.22%
controls:0.06%
—
—
cases:0.59%
controls:0.07%
cases:3.13%
controls:0.53%
cases:5.06%
controls:1.77%
32
299
2692
26896
16
146
2709
27055
6
16
2719
27185
—
16
19
2709
27175
85
143
2634
26915
128
441
2403
24529
Gastrointestinal haemorrhage, unspecified
K92.2 [45533625]
K92.2 [45533625]
2.0e+00
3.0e+00
—
—
—
—
1.1e+00
cases:0.40%
controls:0.06%
cases:0.59%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.12%
11
15
2713
27180
16
8
2709
27193
—
—
—
—
9
30
2522
24940
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
6.1e-02
7.3e-01
1.6e+00
—
1.3e+00
8.9e-01
5.0e-01
cases:3.16%
controls:2.97%
cases:3.23%
controls:1.58%
cases:1.28%
controls:0.26%
—
—
cases:0.73%
controls:0.21%
cases:3.75%
controls:1.58%
cases:7.66%
controls:4.78%
86
809
2638
26386
88
430
2637
26771
35
71
2690
27130
—
20
57
2705
27137
102
427
2617
26631
194
1194
2337
23776
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2608
12875
16.97
307.65
21.4
6.5
1.84
1.97
e9/l
6.38
2515
11494
2504
10742
14.11
307.65
5.4
2.5
73.27
74.21
nmol/l
1.08
2470
9987
1019
871
17.87
307.65
1.8
1.6
2.00
0.18
iu/ml
0.50
194
132
2376
11670
8.03
307.65
20.5
6.5
58.25
56.37
%
18.12
2348
11227
461
116
47.42
307.65
4.6
3.3
8.96
9.41
mg/l
0.25
399
96
2612
12936
17.23
307.65
21.5
6.8
0.17
0.19
e9/l
9.58
2510
11454
2379
11876
7.85
307.65
21.1
6.6
28.35
29.12
%
3.79
2354
11348
2629
13872
16.79
307.65
22.5
9.7
3.94
4.02
e9/l
1.43
2527
12140
927
1465
8.98
307.65
2.2
1.7
—
—
—
0
0
2602
12538
17.20
307.65
21.3
6.6
0.04
0.04
e9/l
0.02
2488
10918
1770
5830
6.58
307.65
5.1
2.2
2.56
2.66
mg/l
1.46
1693
5075
458
90
60.70
307.65
3.2
2.1
9.61
8.89
mg/l
0.65
407
73
206
18
123.50
307.65
2.9
2.1
2.98
3.58
mg/l
0.60
200
18
2601
12523
17.14
307.65
21.3
6.5
0.56
0.56
e9/l
0.01
2491
10915
404
96
49.05
307.65
3.3
3.0
151.82
86.44
au/ml
0.90
53
24
327
64
57.75
307.65
2.3
1.6
103.41
122.89
au/ml
0.12
43
11
2587
9526
24.91
307.65
12.6
5.0
37.11
36.67
g/l
5.16
2562
8995
2612
3614
100.18
307.65
10.1
2.4
197.46
110.82
ug/g
30.15
2562
2917
2366
11451
8.06
307.65
21.1
6.7
2.58
2.82
%
8.53
2336
10817
2727
17527
26.82
301.25
25.9
7.8
73.88
76.69
u/l
4.92
2707
16727
147
16
96.94
282.66
3.2
3.5
—
—
—
0
0
963
3086
4.24
265.81
3.0
2.6
21.61
24.08
%
6.54
940
2887
991
3384
3.99
247.78
3.0
2.5
2.44
2.39
g/l
2.06
961
3149
1032
3671
3.88
242.33
3.1
2.5
13.21
14.25
umol/l
4.13
1014
3432
1802
9307
3.65
234.04
2.8
2.0
89.37
97.13
pmol/l
12.73
1325
5132
2022
11712
3.65
208.65
8.3
6.4
10.29
11.11
umol/l
3.55
1966
11197
1938
10980
3.51
206.30
24.7
10.5
0.00
0.00
e9/l
0.64
1795
8991
2553
17443
6.52
205.54
10.0
4.1
11.76
9.85
mm/h
11.75
2496
16487
1469
7232
3.18
195.11
5.1
2.6
57.51
59.39
u/l
0.61
1405
6738
2090
12677
3.59
193.15
5.4
3.2
98.13
103.78
ug/l
0.61
2044
12043
357
647
6.18
191.90
1.5
1.4
—
—
—
0
0
363
691
5.89
185.17
1.2
1.3
273.62
242.03
u/ml
1.07
222
417
373
729
5.75
184.97
1.2
1.3
25.73
50.95
u/ml
—
8
15
629
2053
3.67
160.40
4.1
2.4
0.24
0.22
g/l
4.04
611
1931
352
749
5.23
157.99
1.6
1.3
82.56
90.95
titre
0.19
39
84
293
566
5.67
146.18
3.5
6.8
298.80
724.46
iu/ml
0.80
25
72
87
21
42.73
145.07
1.1
1.3
31.40
23.00
u/ml
—
24
5
87
21
42.73
145.07
1.1
1.3
40.59
17.88
u/ml
—
27
8
763
2977
3.15
144.34
2.1
1.7
1083.24
1178.51
nmol/l
2.10
577
2312
582
2009
3.40
134.07
2.3
2.9
11.05
10.55
g/l
2.40
543
1863
1493
8582
2.59
130.63
5.1
3.3
32.06
31.03
u/l
0.21
1406
8152
495
1569
3.62
130.01
1.8
1.9
1.19
1.29
g/l
1.01
471
1470
269
543
5.38
127.46
1.4
1.3
—
—
—
0
0
257
504
5.52
125.71
1.1
1.1
—
—
—
0
0
1692
10634
2.50
117.68
8.1
7.1
1.21
1.21
mmol/l
0.50
1495
9268
1561
9477
2.47
116.88
7.2
6.6
1.21
1.21
mmol/l
1.05
1479
8850
899
4257
2.64
114.61
2.7
1.6
408.00
28381016.85
pmol/l
3.52
828
3668
368
1043
3.91
113.17
1.6
1.8
—
—
—
0
0
75
29
26.55
108.70
1.0
1.0
—
—
—
0
0
170
256
7.01
108.41
1.7
1.5
—
—
—
0
0
170
261
6.87
106.45
1.7
1.5
—
—
—
0
0
169
259
6.88
106.00
1.7
1.5
—
—
—
0
0
1496
9236
2.34
103.24
10.4
11.1
1.11
1.16
inr
6.38
1275
7671
1071
5770
2.39
100.92
2.0
1.6
20.34
19.95
nmol/l
0.26
1005
5055
163
257
6.67
99.45
1.8
1.4
—
—
titre
—
0
0
180
324
5.87
96.14
1.3
1.3
—
—
—
0
0
157
249
6.62
95.22
1.7
1.6
—
—
—
0
0
1056
5772
2.34
95.00
1.7
1.5
2.46
2.28
g/l
3.00
793
3755
157
250
6.60
94.85
1.7
1.6
—
—
—
0
0
157
251
6.57
94.48
1.7
1.5
—
—
—
0
0
2753
24057
12.83
78.98
36.9
13.3
14.72
22.09
mg/l
53.91
2631
19408
2672
22810
5.15
78.34
27.6
12.3
92.01
89.77
ml/min/173m2
6.50
2585
20770
122
186
6.81
76.70
1.2
1.2
—
—
—
0
0
121
186
6.76
75.48
1.2
1.2
—
—
—
0
0
329
1120
3.20
75.06
1.3
1.4
—
—
—
0
0
125
208
6.24
72.18
1.6
1.3
128.00
196.25
titre
—
5
8
125
208
6.24
72.18
1.6
1.2
126.29
197.63
titre
0.56
35
38
122
201
6.30
71.14
2.9
3.7
58.05
54.39
%
1.01
103
186
123
208
6.14
69.88
1.2
1.2
60.03
59.95
u/l
0.00
106
189
151
322
4.90
66.54
2.7
4.0
1.04
1.44
%
0.87
134
302
285
980
3.13
63.57
1.8
1.6
4.61
10.94
iu/ml
1.06
12
34
1751
12830
1.98
63.38
4.5
3.5
0.00
0.13
estimate
0.55
499
2511
1090
6810
1.99
63.10
4.7
3.6
0.00
0.00
estimate
1.94
499
2503
1743
12767
1.98
62.96
4.4
3.5
0.00
5.41
estimate
2.54
509
2660
1730
12646
1.97
62.79
4.4
3.5
0.00
0.00
estimate
0.80
512
2642
561
2756
2.30
60.88
4.2
3.0
6.60
7.24
umol/l
0.43
494
2414
385
1640
2.56
57.10
2.6
3.1
71.67
72.75
e9/l
0.21
301
1172
1048
6634
1.93
56.94
1.4
1.4
0.86
1.60
u/ml
2.96
280
1895
208
636
3.45
56.05
1.7
1.3
5.87
6.04
iu/ml
—
9
12
172
465
3.88
55.65
2.0
1.7
0.62
0.77
g/l
0.95
138
367
950
5877
1.94
54.84
6.5
4.2
94.84
92.81
%
1.88
929
5757
102
183
5.75
54.47
1.1
1.1
1520.54
1568.65
miu/ml
0.14
102
183
81
119
6.98
52.64
1.3
1.2
74.15
81.09
u/l
0.21
66
102
80
118
6.95
51.80
1.3
1.2
19.55
17.39
u/l
0.19
65
100
496
2505
2.19
49.40
2.1
2.2
337.26
378.27
nmol/l
5.30
468
2338
467
2329
2.21
47.88
3.5
2.6
41.43
60.58
u/l
0.43
420
1983
142
374
3.95
47.61
1.1
1.1
1.49
1.47
g/l
0.28
136
343
1730
13342
1.78
45.53
5.8
5.1
6.38
6.52
mmol/l
2.20
1664
12499
788
4842
1.87
44.70
3.0
2.6
5.76
6.53
e6/l
0.88
730
4395
2753
25422
7.80
43.33
33.1
10.7
26.74
27.37
u/l
1.39
2745
24857
1344
9756
1.73
42.74
4.4
3.3
0.00
0.03
estimate
1.35
459
2206
65
97
6.84
41.63
1.5
1.4
—
—
—
0
0
940
6214
1.77
41.28
3.7
3.1
0.48
0.37
e6/l
0.49
749
4430
1884
15104
1.76
41.13
5.2
4.1
999.80
1345.02
e6/l
—
10
184
1127
7859
1.73
40.88
3.3
3.2
20.35
48.76
ng/l
2.13
651
4689
64
96
6.80
40.79
1.5
1.4
—
—
—
0
0
222
861
2.72
39.30
1.6
2.0
1.46
1.44
g/l
0.11
196
765
2621
23661
2.81
38.67
23.0
14.6
139.40
139.66
mmol/l
8.13
2587
23202
1040
7182
1.71
38.46
3.8
3.2
41.36
70.65
e6/l
0.70
852
5358
2621
23722
2.76
37.31
23.3
14.7
3.89
3.94
mmol/l
20.20
2583
23211
1453
11070
1.65
36.19
3.4
2.7
—
—
estimate
—
0
0
52
72
7.34
35.63
1.5
1.5
—
—
—
0
0
52
72
7.34
35.63
1.5
1.5
—
—
—
0
0
181
666
2.84
35.37
1.5
1.4
299.02
292.50
ug/g
0.14
92
373
501
2864
1.91
34.41
7.2
6.5
1.04
1.05
mmol/l
0.25
476
2678
183
691
2.76
34.05
1.3
1.1
—
—
—
0
0
433
2371
1.98
33.72
3.7
4.9
217.47
240.12
u/l
2.74
419
2272
67
128
5.34
33.44
1.7
1.5
4.76
5.85
u/l
0.30
55
105
181
686
2.75
33.43
1.3
1.1
—
—
—
0
0
245
1075
2.40
33.43
1.8
2.0
4.52
7.78
iu/ml
1.98
63
262
156
552
2.93
32.73
3.2
3.0
2.52
1.92
index
0.34
79
314
171
636
2.80
32.73
1.3
1.5
31.10
15.70
u/ml
—
5
9
839
5673
1.69
32.31
3.1
2.3
—
—
—
0
0
1160
8556
1.61
31.38
4.4
3.8
48.80
78.31
e6/l
1.47
897
5768
116
355
3.37
31.10
4.1
3.2
535.17
50.52
u/ml
0.46
116
349
1019
7308
1.62
30.79
3.8
2.9
0.01
0.05
estimate
1.07
455
2150
134
459
3.02
29.78
2.3
3.6
1047.14
1649.32
u/ml
—
7
28
56
101
5.64
29.75
1.3
1.2
—
—
—
0
0
546
3360
1.78
29.11
1.9
1.9
—
—
—
0
0
157
596
2.73
28.89
1.3
1.5
150.19
150.70
au/ml
0.01
37
167
196
831
2.46
28.77
1.8
1.9
1.19
1.20
g/l
0.21
190
785
191
804
2.48
28.47
1.8
1.9
0.23
0.23
g/l
0.06
185
759
580
3676
1.73
27.74
5.0
3.9
0.80
0.82
mmol/l
2.47
550
3509
1020
7458
1.58
27.66
3.3
3.3
2.33
2.35
mmol/l
5.40
934
6896
71
175
4.14
26.08
2.5
1.5
—
—
—
0
0
223
1050
2.22
25.68
1.3
1.3
0.32
1.00
u/ml
1.23
20
79
341
1879
1.93
25.67
8.5
8.6
8.15
8.45
mmol/l
0.40
333
1825
46
80
5.83
25.40
1.3
1.2
—
—
—
0
0
54
109
5.03
25.37
1.6
1.6
3778.46
2522.35
titre
0.65
26
17
658
4417
1.64
24.99
1.3
1.3
7.90
10.02
u/ml
0.44
280
1819
354
2051
1.83
22.66
4.6
4.3
1.19
1.81
mmol/l
2.47
319
1779
163
710
2.38
22.51
4.8
3.8
41.13
2175.89
u/ml
0.89
137
611
169
752
2.33
22.23
2.0
2.0
1.85
1.69
ug/l
0.08
155
675
2049
18086
1.50
19.14
5.2
3.3
43.60
42.55
u/l
0.28
1972
17340
676
4819
1.53
19.10
1.4
1.3
17.54
25.80
iu/ml
2.61
192
1377
39
78
5.06
18.56
3.7
3.1
0.58
0.62
mmol/l
2.35
39
78
139
620
2.31
18.20
2.4
2.8
—
—
—
0
0
242
1336
1.89
17.92
5.1
4.5
23.72
24.23
mmol/l
1.75
242
1326
557
3854
1.56
17.87
3.3
2.8
0.97
1.10
e6/l
0.30
326
1943
147
686
2.21
17.28
1.9
1.8
—
—
—
0
0
208
1115
1.94
16.83
2.1
2.1
0.02
0.67
estimate
0.49
51
381
106
434
2.50
16.79
1.7
1.7
—
—
—
0
0
301
1816
1.74
16.60
4.0
4.4
12.05
20.04
ug/l
0.50
230
1435
26
39
6.72
16.58
1.6
1.2
—
—
—
0
0
91
356
2.61
15.85
4.3
3.9
47.12
956.42
u/ml
0.73
84
333
381
2487
1.62
15.52
1.8
1.8
—
—
—
0
0
2756
26665
4.02
15.50
49.2
20.2
275.41
256.05
e9/l
44.51
2749
26239
255
1502
1.77
15.26
1.4
1.4
—
—
—
0
0
38
88
4.36
15.22
1.6
2.3
3886.50
30260.07
u/ml
—
6
15
152
756
2.07
15.19
2.2
2.0
—
—
—
0
0
2756
26682
3.96
15.13
49.0
20.2
4.48
4.59
e12/l
25.03
2748
26203
750
5683
1.44
15.03
4.5
3.5
1.02
1.56
kg/l
0.80
529
3698
2756
26688
3.94
15.00
49.1
20.3
6.83
6.69
e9/l
2.46
2748
26198
158
802
2.03
14.94
3.6
5.2
1.46
1.36
mg/l
0.73
151
747
326
2076
1.65
14.63
3.5
3.0
—
—
—
0
0
94
400
2.40
13.75
1.2
1.2
874.29
480.77
titre
0.59
14
26
307
1955
1.64
13.75
7.4
8.7
1.24
1.33
mmol/l
1.20
295
1914
271
1671
1.69
13.74
2.3
2.4
0.28
0.34
e6/l
0.33
260
1585
500
3573
1.49
13.41
3.3
2.9
3.93
2.70
e6/l
0.79
270
1662
249
1514
1.71
13.29
4.5
4.3
87.70
81.20
ng/l
0.50
223
1361
80
332
2.45
12.39
1.5
1.2
—
—
—
0
0
229
1388
1.71
12.36
3.8
3.7
4.98
5.14
kpa
3.02
223
1342
714
5538
1.39
12.08
1.8
1.9
1.01
1.01
mg/l
0.01
499
4125
818
6487
1.37
12.07
2.1
2.2
131.45
227.96
u/l
3.66
796
6211
119
592
2.06
11.93
1.3
1.3
8.70
3.71
u/ml
—
9
35
245
1544
1.64
11.40
2.0
2.7
65.87
67.12
g/l
1.79
229
1447
819
6557
1.35
11.21
1.9
1.7
—
—
—
0
0
181
1058
1.76
11.12
3.1
3.3
0.67
0.61
%
0.76
181
1051
194
1161
1.72
10.97
1.6
1.6
—
—
—
0
0
120
623
1.97
10.72
1.9
1.7
—
—
—
0
0
344
2387
1.50
10.51
1.8
1.8
—
—
—
0
0
253
1640
1.60
10.49
3.8
3.7
1.23
1.23
mmol/l
0.18
222
1421
272
1794
1.57
10.48
3.2
2.6
73.26
74.37
ml/min/173m2
0.17
119
728
223
1405
1.64
10.39
1.7
1.8
0.28
0.31
mg/l
0.31
102
670
184
1109
1.71
10.15
1.5
1.5
—
—
—
0
0
58
228
2.58
10.12
1.1
1.3
88.00
79.38
—
7
8
2080
19136
1.34
10.06
4.4
4.4
14.74
14.55
pmol/l
3.16
1944
17891
136
752
1.85
10.06
1.1
1.1
10.73
4.09
eliau/ml
0.36
16
114
30
80
3.78
10.03
2.0
4.0
1.85
1.84
ratio
0.00
30
73
141
791
1.82
9.96
3.8
3.9
24.62
24.69
mmol/l
0.10
135
744
737
5894
1.34
9.95
2.7
2.6
328.02
334.51
umol/l
1.04
680
5336
194
1198
1.67
9.78
3.6
3.6
1.27
1.50
mmol/l
0.35
140
885
178
1076
1.70
9.72
3.1
3.4
1.33
1.35
%
0.08
178
1068
26
64
4.09
9.69
1.0
1.3
99.62
94.23
%
0.35
26
64
325
2282
1.48
9.34
6.9
5.7
—
—
—
0
0
51
198
2.61
9.16
2.0
3.2
130.24
220.61
e6/l
5.13
46
169
2015
18583
1.30
8.72
3.6
3.5
—
—
—
0
0
109
592
1.88
8.57
1.5
1.7
—
—
—
0
0
514
3977
1.36
8.47
2.8
2.8
2.43
2.43
mmol/l
0.06
454
3585
26
71
3.69
8.44
1.2
1.2
—
—
—
0
0
94
489
1.95
8.42
3.7
3.3
33.18
34.25
umol/l
0.21
87
454
48
191
2.54
8.23
1.8
3.1
398.74
566.17
e6/l
1.35
42
156
36
123
2.95
8.23
2.4
3.3
0.86
0.86
index
0.00
36
123
30
92
3.29
8.20
1.5
1.2
103.00
105.76
%
0.21
24
79
111
616
1.84
8.17
1.5
1.7
—
—
—
0
0
103
560
1.87
8.09
1.4
1.4
—
—
—
0
0
20
47
4.28
7.93
1.2
1.1
—
—
—
0
0
127
745
1.74
7.78
1.4
1.3
5.25
9.03
u/ml
0.53
23
107
46
185
2.51
7.74
1.4
1.3
175877.57
97082.29
e6/l
0.21
30
124
126
741
1.73
7.66
1.3
1.3
2.19
3.07
u/ml
0.56
11
62
98
535
1.86
7.62
2.9
2.4
9.98
5.58
umol/l
1.89
73
394
276
1954
1.46
7.59
1.4
1.3
144.62
266.25
u/ml
1.49
257
1829
314
2281
1.42
7.51
9.5
8.9
4.92
5.11
kpa
3.56
302
2200
98
538
1.85
7.50
1.9
1.6
7844.43
13459.91
e6/l
1.18
82
377
313
2281
1.42
7.36
9.5
8.9
12.66
12.86
kpa
0.32
301
2204
131
788
1.70
7.35
1.3
1.2
31.19
32.19
u/ml
—
7
38
2349
22285
1.34
7.30
5.3
5.2
1.73
1.82
mu/l
3.31
2223
21093
630
5122
1.30
7.23
2.6
3.1
1021.64
985.47
ng/l
0.08
525
4268
30
100
3.02
7.19
1.6
1.2
0.30
0.29
g/l
0.22
25
81
422
3253
1.35
7.05
2.3
2.3
29.64
29.47
s
0.25
415
3158
70
351
2.02
7.01
1.2
1.2
—
—
—
0
0
48
208
2.33
6.91
2.6
2.1
34.67
21.23
mg/l
1.00
21
79
308
2266
1.40
6.85
9.6
8.9
0.14
0.87
mmol/l
2.34
252
1862
32
115
2.80
6.74
1.1
1.1
193.39
214.07
iu/ml
0.18
32
115
37
144
2.59
6.70
1.2
1.2
—
—
—
0
0
74
388
1.93
6.55
1.5
1.9
—
—
—
0
0
42
176
2.41
6.53
2.8
3.1
14.25
13.56
index
0.16
36
123
498
3984
1.30
6.39
3.7
3.5
361.35
484.51
ng/l
0.19
297
2685
265
1934
1.41
6.18
10.7
9.7
121.29
123.77
g/l
1.05
259
1891
239
1718
1.43
6.07
2.6
2.4
11376.11
6259.90
u/l
0.70
76
675
25
83
3.03
6.07
1.3
1.4
10.61
8.35
ug/l
1.43
25
83
52
247
2.13
6.05
1.1
1.1
—
—
—
0
0
17
33
5.18
6.00
5.6
8.2
32.82
44.45
ug/min
0.38
11
26
119
739
1.64
5.97
1.8
2.3
203.67
345.84
ug/l
0.80
104
693
48
223
2.17
5.91
1.3
1.6
48.65
56.52
%
0.65
31
146
238
1720
1.42
5.87
1.4
1.5
—
—
—
0
0
210
1490
1.44
5.74
2.3
2.2
6.06
7.44
ug/l
0.43
180
1352
16
31
5.18
5.69
1.7
1.8
—
—
—
0
0
274
2043
1.38
5.64
10.4
9.4
96.63
95.91
%
2.17
266
1977
58
297
1.97
5.55
1.2
1.7
—
—
—
0
0
39
171
2.30
5.53
1.5
1.6
35.40
33.62
%
0.09
25
111
28
105
2.68
5.50
1.3
1.4
—
1308.33
—
0
6
72
398
1.83
5.48
1.4
1.6
—
—
—
0
0
84
492
1.73
5.28
1.9
3.3
1.51
3.07
ratio
1.15
41
267
13
22
5.93
5.21
1.1
1.1
—
—
—
0
0
91
552
1.67
5.05
2.1
3.4
37.35
42.30
mg/l
0.31
75
469
91
553
1.67
5.02
2.2
3.4
45.36
64.32
mg/l
0.76
76
469
168
1176
1.46
4.96
8.9
7.3
24.06
24.46
mmol/l
0.77
161
1123
100
628
1.61
4.86
1.9
2.4
0.34
0.90
g/l
1.34
86
558
55
291
1.91
4.83
1.3
1.6
—
—
—
0
0
89
547
1.65
4.72
1.3
1.5
—
—
—
0
0
110
714
1.56
4.67
1.9
2.2
4.08
4.27
g/l
1.76
102
665
110
714
1.56
4.67
1.9
2.2
3.72
3.71
g/l
0.01
102
666
110
715
1.56
4.64
1.9
2.2
7.04
7.27
g/l
0.79
102
666
188
1362
1.41
4.62
10.7
11.1
94.59
93.92
%
1.28
188
1356
157
1101
1.45
4.61
1.6
2.1
36.84
40.11
u/l
1.43
143
1014
227
1698
1.37
4.61
1.3
1.3
40.60
50.12
au/ml
—
10
106
36
166
2.18
4.59
1.1
1.7
—
—
—
0
0
148
1028
1.46
4.57
1.5
1.7
7.02
12.68
u/ml
1.72
28
269
240
1814
1.35
4.56
2.5
2.4
21.08
21.02
au/ml
0.00
23
224
217
1617
1.37
4.52
1.1
1.1
—
—
—
0
0
104
680
1.55
4.30
1.9
2.2
2.94
2.92
g/l
0.11
96
631
76
462
1.66
4.24
1.3
1.4
—
—
—
0
0
126
862
1.48
4.22
8.1
5.3
1.60
1.64
%
0.19
121
810
47
248
1.91
4.21
1.6
1.8
—
—
—
0
0
72
1159
0.61
4.18
1.4
1.8
3.66
4.58
mg/l
0.61
53
829
73
442
1.67
4.14
1.0
1.1
2.00
2.13
eliau/ml
0.08
21
215
116
787
1.49
4.06
8.6
5.6
0.79
0.88
%
1.89
110
737
73
448
1.65
3.95
1.3
1.5
—
—
—
0
0
160
1163
1.40
3.90
13.0
11.6
15.91
16.25
%
0.74
154
1119
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
87
564
1.56
3.78
3.5
3.7
0.34
0.36
iu/ml
0.22
36
301
14
44
3.19
3.77
2.2
2.1
1.16
1.34
umol/l
1.05
14
29
30
140
2.16
3.77
1.1
1.2
—
—
—
0
0
71
444
1.61
3.60
3.8
3.4
6.98
7.85
pmol/l
0.41
71
444
563
4857
1.20
3.55
2.3
2.2
—
—
—
0
0
18
69
2.62
3.47
1.2
1.1
—
—
—
0
0
59
357
1.67
3.42
1.2
1.5
—
—
—
0
0
83
550
1.52
3.31
1.9
2.3
0.01
0.01
g/l
0.11
74
504
17
65
2.63
3.30
2.8
1.7
38.85
41.50
g/l
1.16
17
65
19
77
2.48
3.29
2.1
2.4
77.16
75.31
ug/l
0.02
19
77
6
7
8.59
3.26
1.2
1.0
273.00
325.14
u/ml
—
6
7
40
220
1.83
3.23
1.7
1.9
—
—
—
0
0
76
497
1.54
3.23
1.9
2.3
0.00
0.00
g/l
-0.00
71
472
91
619
1.49
3.22
1.8
2.3
9.85
10.33
g/l
0.61
83
567
304
2491
1.25
3.19
3.8
4.2
33.09
31.35
%
1.80
226
1779
603
5282
1.18
3.18
2.4
2.3
—
—
—
0
0
27
130
2.09
3.18
1.3
1.3
38.60
68.53
%
—
5
17
11
30
3.68
3.08
1.0
1.2
—
—
—
0
0
80
536
1.51
3.06
1.9
2.3
0.00
0.00
g/l
-0.00
71
473
22
99
2.23
3.06
1.1
1.1
31.00
314.63
ng/l
—
8
22
44
254
1.74
3.05
1.9
1.6
—
—
—
0
0
226
2812
0.79
3.02
1.4
1.6
3.34
3.49
mmol/l
1.08
144
1894
35
189
1.86
3.01
1.5
2.3
—
—
—
0
0
54
334
1.63
2.92
1.4
1.4
0.63
5.86
nmol/l
0.49
54
323
91
633
1.45
2.91
1.8
1.6
1303.79
1290.35
e6/l
0.01
70
487
63
406
1.56
2.88
2.4
2.5
40.73
42.66
iu/ml
—
6
31
34
186
1.84
2.83
2.3
1.8
—
—
—
0
0
34
186
1.84
2.83
2.3
1.8
—
—
—
0
0
34
186
1.84
2.83
2.3
1.8
—
—
—
0
0
98
696
1.42
2.81
1.5
2.3
11.67
11.06
mg/l
0.32
90
658
29
151
1.93
2.80
2.1
3.1
1020.83
936.76
u/ml
0.13
29
151
55
346
1.60
2.80
1.4
1.4
0.16
0.35
nmol/l
—
7
21
32
173
1.86
2.77
1.1
1.8
—
—
—
0
0
89
625
1.44
2.72
1.7
1.5
17.34
33.02
e6/l
0.54
62
455
27
139
1.95
2.70
1.2
1.1
—
—
—
0
0
9
230
0.39
2.67
12.3
16.8
544.78
812.59
nmol/l
—
9
225
16
67
2.40
2.63
1.1
1.1
—
—
—
0
0
12
41
2.93
2.61
1.0
1.6
11.31
782359.32
nmol/l
—
7
34
32
177
1.82
2.59
2.7
2.5
—
—
—
0
0
108
797
1.37
2.51
2.6
2.9
203.44
177.66
%
1.74
102
766
31
172
1.81
2.50
1.5
2.0
0.78
1.90
u/ml
—
8
58
50
317
1.59
2.49
1.1
1.1
—
—
—
0
0
208
1682
1.26
2.49
3.1
3.6
4.64
4.61
pmol/l
0.12
189
1522
12
45
2.67
2.45
1.0
1.1
—
—
—
0
0
316
3707
0.83
2.42
1.6
1.9
3.62
3.57
ratio
0.27
240
2769
15
64
2.35
2.38
1.2
1.1
—
—
—
0
0
57
380
1.51
2.31
1.2
1.3
60.31
31.41
u/l
0.35
52
327
81
579
1.41
2.30
3.6
3.5
8.95
8.63
kpa
0.94
81
567
46
293
1.58
2.28
1.5
1.4
0.19
0.24
nmol/l
0.28
39
229
10
34
2.95
2.28
1.9
1.9
—
—
—
0
0
66
455
1.46
2.28
1.7
1.6
—
—
—
0
0
15
66
2.28
2.24
1.1
1.1
—
—
—
0
0
64
441
1.46
2.22
3.2
2.8
1.35
1.49
mmol/l
0.90
64
422
15
67
2.25
2.17
1.2
1.1
—
—
—
0
0
10
237
0.42
2.10
15.8
21.9
1291.80
1412.38
nmol/l
—
10
232
20
102
1.97
2.10
1.6
5.6
7413.00
69.40
mg/l
0.47
14
77
123
956
1.30
2.07
3.4
2.9
1.02
1.02
ratio
0.67
117
866
9
31
2.91
2.07
1.0
1.2
—
—
—
0
0
5
10
5.01
2.07
1.0
1.1
—
—
—
0
0
7
20
3.51
2.05
1.1
1.4
—
—
—
0
0
52
353
1.48
1.97
3.2
2.9
7.08
7.28
mmol/l
0.24
52
339
22
119
1.86
1.97
2.4
1.7
—
—
—
0
0
16
78
2.06
1.90
2.9
2.3
—
—
—
0
0
25
143
1.76
1.89
1.3
1.1
—
—
—
0
0
15
72
2.09
1.86
1.1
1.7
—
—
—
0
0
84
630
1.34
1.84
1.3
1.2
20.80
45.02
u/ml
1.15
12
60
65
469
1.40
1.81
1.4
1.4
20.68
20.59
u/l
0.01
56
398
40
263
1.53
1.79
1.6
1.2
—
—
—
0
0
17
88
1.94
1.74
2.5
3.8
1.24
1.23
%
0.00
17
88
6
18
3.34
1.74
1.7
1.4
363.67
349.06
umol/24h
—
6
18
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
36
234
1.55
1.70
1.1
1.1
—
—
—
0
0
32
203
1.58
1.68
1.2
1.1
104.66
112.57
pmol/l
0.41
32
203
73
546
1.35
1.66
1.2
1.2
—
—
—
0
0
6
19
3.16
1.66
1.7
4.7
—
—
—
0
0
155
1282
1.22
1.60
2.3
2.9
143.74
152.42
ng/l
0.11
136
1144
23
137
1.68
1.55
1.3
1.4
138.32
138.16
nmol/l
0.01
23
137
21
122
1.73
1.54
1.8
1.4
126.33
165.54
mmol/24h
2.46
21
122
7
27
2.60
1.51
2.9
2.2
—
—
—
0
0
141
1165
1.22
1.49
1.5
1.5
6.96
8.27
u/l
0.97
116
939
188
2203
0.84
1.49
1.5
1.6
951.21
994.79
mu/l
0.28
159
1852
42
292
1.45
1.48
1.0
1.1
—
—
—
0
0
61
453
1.35
1.48
1.5
1.6
590.24
347.03
mu/l
0.71
49
368
7
28
2.50
1.45
1.0
1.2
—
—
—
0
0
6
22
2.73
1.43
1.5
1.7
2.36
4.74
mg/l
—
6
12
6
22
2.73
1.43
1.5
1.7
0.99
2.50
mg/l
—
6
15
6
22
2.73
1.43
1.5
1.7
0.66
0.41
mg/l
—
6
12
6
22
2.73
1.43
1.5
1.7
0.64
1.25
mg/l
—
6
11
37
254
1.46
1.40
1.1
1.2
38.62
40.70
mg/l
0.12
30
208
7
29
2.42
1.39
1.1
1.0
—
—
—
0
0
11
53
2.08
1.38
1.3
1.2
—
—
—
0
0
24
150
1.61
1.37
1.0
1.5
—
—
—
0
0
66
503
1.32
1.37
2.7
2.3
131.89
131.72
g/l
0.02
45
401
6
23
2.61
1.36
1.2
1.1
—
—
—
0
0
20
323
0.62
1.36
2.6
4.2
55.95
28.64
u/ml
0.66
20
317
37
256
1.45
1.36
4.1
5.1
45.09
73.49
u/ml
0.38
15
79
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
135
1.63
1.35
1.2
1.1
—
—
—
0
0
22
135
1.63
1.35
1.1
1.6
—
—
—
0
0
43
594
0.72
1.35
1.2
1.3
—
—
—
0
0
11
54
2.04
1.32
1.2
1.1
—
—
—
0
0
12
61
1.97
1.32
1.0
1.1
—
—
—
0
0
12
61
1.97
1.32
1.3
1.1
—
—
—
0
0
6
24
2.50
1.30
1.5
1.7
3.12
1.75
mg/l
—
6
14
2196
22392
0.91
1.27
3.9
3.9
1.40
1.29
mmol/l
7.48
2073
21172
30
202
1.49
1.27
1.4
1.8
—
—
—
0
0
38
269
1.42
1.25
1.2
1.1
—
—
—
0
0
16
92
1.74
1.25
1.1
1.4
91.60
92.41
%
—
5
49
22
139
1.59
1.23
1.1
1.6
—
—
—
0
0
499
4600
1.10
1.21
1.8
1.5
—
—
—
0
0
7
141
0.50
1.20
3.0
2.4
147.86
151.59
nmol/l
—
7
126
13
226
0.57
1.20
1.2
1.7
—
—
—
0
0
151
1287
1.18
1.20
1.4
1.3
184.93
225.65
miu/ml
0.60
53
616
84
1038
0.80
1.19
1.6
1.6
—
—
—
0
0
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
16
94
1.71
1.17
1.1
1.1
96.80
91.88
%
—
5
49
23
149
1.55
1.17
2.8
2.6
753.50
626.11
ml
0.80
18
101
6
128
0.47
1.16
2.0
2.6
46.17
49.44
umol/l
—
6
116
34
240
1.42
1.16
1.3
1.1
—
—
—
0
0
691
6481
1.09
1.15
4.3
4.3
11.39
8.97
mg/mmol
0.51
465
4162
2355
23905
0.90
1.14
4.7
5.0
2.63
2.80
mmol/l
21.70
2241
22753
19
118
1.61
1.14
1.6
3.3
85.55
120.24
umol/l
0.48
11
63
145
1240
1.18
1.12
2.0
2.9
56.70
59.76
u/ml
0.05
138
1198
110
1307
0.84
1.08
1.0
1.1
0.56
0.65
ratio
—
10
125
7
32
2.19
1.08
2.9
2.1
—
—
—
0
0
52
400
1.31
1.06
2.1
2.0
4.58
5.19
mmol/24h
0.67
47
357
97
805
1.21
1.05
1.2
1.2
4.56
4.22
0.13
13
129
123
1044
1.19
1.05
1.6
1.5
—
—
—
0
0
7
33
2.12
1.05
1.9
1.7
—
—
—
0
0
116
1366
0.84
1.04
1.0
1.1
1.44
1.51
g/l
2.09
116
1366
20
130
1.54
1.02
1.6
2.8
23.75
263.16
ug/l
0.68
20
116
804
7623
1.08
1.02
3.5
3.6
8.19
8.21
mmol/l
0.06
706
6660
117
997
1.18
0.97
1.5
1.5
—
—
—
0
0
52
406
1.29
0.97
1.4
1.3
—
—
—
0
0
52
406
1.29
0.97
1.4
1.3
—
—
—
0
0
28
198
1.42
0.97
1.4
1.3
0.68
0.63
ratio
0.19
15
111
122
1417
0.85
0.95
1.6
1.5
—
—
—
0
0
16
101
1.59
0.93
2.1
1.9
—
—
—
0
0
6
27
2.22
0.93
9.2
6.3
3.30
6.26
mmol/l
—
6
27
17
109
1.56
0.93
2.8
2.1
—
—
—
0
0
17
109
1.56
0.93
2.8
2.1
—
—
—
0
0
17
109
1.56
0.93
2.8
2.1
—
—
—
0
0
17
109
1.56
0.93
2.8
2.1
—
—
—
0
0
90
753
1.20
0.93
1.1
1.1
3.12
1.11
u/ml
0.41
37
337
96
1135
0.84
0.92
1.4
1.5
—
—
—
0
0
13
78
1.67
0.91
3.7
4.4
—
—
—
0
0
20
290
0.69
0.90
1.9
2.5
21.27
21.62
nmol/l
0.06
20
277
21
143
1.47
0.89
1.1
1.2
—
—
—
0
0
56
448
1.26
0.88
1.1
1.1
2.91
3.50
—
10
84
8
42
1.91
0.88
1.0
1.0
9.44
6.47
u/ml
—
8
42
16
241
0.66
0.87
1.4
1.3
148.12
177.43
pmol/l
0.71
16
241
8
43
1.86
0.87
1.3
1.3
1.22
1.18
mmol/l
—
8
43
8
43
1.86
0.87
1.9
3.4
3.62
4.74
ug/l
—
8
43
6
30
2.00
0.87
1.5
2.2
—
—
—
0
0
98
1146
0.85
0.85
1.4
1.5
1.25
1.13
ratio
0.60
66
675
2333
23626
0.92
0.84
4.3
4.5
1.40
1.44
mmol/l
4.18
2219
22461
12
73
1.65
0.81
1.2
1.2
—
—
—
0
0
107
1235
0.86
0.80
1.4
1.5
66.52
59.19
ug/l
0.72
92
1034
201
1813
1.12
0.79
1.5
1.4
20.19
22.02
iu/l
0.43
177
1527
99
1148
0.86
0.79
1.4
1.5
1.17
1.17
ratio
0.02
67
681
99
1148
0.86
0.79
1.4
1.5
0.98
0.94
ratio
0.46
67
677
108
935
1.16
0.78
1.3
1.3
—
—
—
0
0
22
302
0.73
0.75
1.6
1.5
—
—
—
0
0
30
227
1.33
0.74
1.2
1.1
—
—
—
0
0
91
784
1.17
0.72
1.1
1.1
6.77
6.13
u/ml
0.11
43
443
48
588
0.81
0.71
1.3
1.4
2.89
3.92
ug/l
0.91
48
541
23
169
1.36
0.69
1.7
2.8
43.38
44.05
%
0.07
14
81
39
310
1.26
0.69
1.1
1.1
—
—
—
0
0
2256
22282
1.07
0.66
4.4
4.4
5.72
5.79
mmol/l
1.80
2117
20910
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
30
232
1.30
0.66
1.2
1.1
—
—
—
0
0
229
2106
1.10
0.65
1.2
1.2
125.71
143.53
u/ml
0.17
60
795
10
62
1.62
0.65
1.0
1.1
—
—
—
0
0
43
526
0.81
0.65
2.1
1.7
—
—
—
0
0
29
224
1.30
0.64
1.2
1.1
—
—
—
0
0
30
233
1.29
0.64
1.2
1.1
—
—
—
0
0
54
450
1.20
0.64
1.4
1.3
3.66
4.52
u/ml
0.41
29
206
5
29
1.73
0.64
1.2
1.3
—
14.80
—
0
6
98
862
1.14
0.61
1.1
1.1
0.63
2.34
u/ml
2.99
44
459
29
226
1.29
0.61
1.2
1.3
0.02
2.48
u/ml
2.32
14
118
2348
23714
0.94
0.61
4.4
4.6
4.51
4.70
mmol/l
18.95
2241
22655
34
271
1.26
0.61
1.3
1.6
275.42
282.54
mosm/kgh2o
1.14
26
206
13
88
1.48
0.60
1.1
1.0
—
—
—
0
0
2215
21886
1.06
0.59
5.2
5.4
37.01
38.08
mmol/mol
9.23
2110
20887
85
743
1.15
0.59
1.5
2.2
4.74
3.92
iu/l
0.26
28
332
23
175
1.32
0.58
1.3
1.3
76.30
75.71
umol/l
0.07
23
175
10
65
1.54
0.55
1.2
1.2
—
—
—
0
0
24
188
1.28
0.51
3.3
4.1
—
—
—
0
0
9
65
1.39
0.50
1.3
1.6
—
0.78
—
0
6
73
828
0.88
0.49
1.5
1.5
58.16
59.83
ug/l
0.14
73
828
38
454
0.83
0.49
4.3
3.3
21.79
24.08
mg/l
0.20
25
303
21
163
1.29
0.48
1.3
1.2
—
—
—
0
0
53
457
1.16
0.47
1.5
1.3
2.35
4.31
u/ml
0.82
26
166
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
10.2
—
155.91
—
0
11
23
186
1.24
0.40
1.2
1.1
1.36
1.07
u/l
0.31
11
81
7
101
0.69
0.39
1.1
1.1
61.37
57.25
u/ml
—
7
101
5
35
1.43
0.39
5.8
7.6
10.38
11.01
%
—
5
35
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
52
458
1.14
0.37
1.3
1.3
—
—
—
0
0
5
76
0.66
0.35
2.2
1.3
73.40
64.51
ug/l
—
5
76
5
77
0.65
0.35
1.0
1.0
7.74
41.60
iu/ml
—
5
77
982
10022
0.97
0.34
2.0
1.9
1.54
1.40
mmol/l
3.55
862
8761
14
109
1.29
0.33
3.4
2.4
7.64
8.07
mmol/l
0.20
14
109
6
46
1.30
0.33
1.3
1.4
—
—
—
0
0
606
5894
1.04
0.32
4.5
4.6
1.81
1.96
ug/l
0.54
567
5404
13
101
1.29
0.31
1.0
1.1
—
—
—
0
0
410
3960
1.04
0.31
1.8
1.9
1.41
1.44
%
0.47
350
3538
62
562
1.11
0.30
1.1
1.1
8.71
16.61
au/ml
1.12
14
160
62
565
1.10
0.28
1.0
1.1
0.48
0.28
u/ml
0.18
18
180
81
748
1.09
0.28
1.0
1.1
1.90
1.87
u/ml
0.01
39
380
239
2493
0.95
0.27
2.4
2.4
12.61
13.32
nmol/l
0.83
223
2314
65
595
1.09
0.27
1.0
1.1
6.46
5.11
u/ml
0.22
27
266
89
955
0.93
0.26
1.8
1.8
—
—
—
0
0
69
638
1.08
0.24
1.0
1.1
3.14
3.59
u/ml
0.14
30
320
51
465
1.10
0.24
1.1
1.1
—
—
—
0
0
16
134
1.20
0.22
1.3
2.1
1.00
1.94
u/field
—
9
84
26
229
1.14
0.21
1.4
1.4
1.61
1.46
nmol/l
0.39
26
210
13
107
1.22
0.21
1.2
1.6
73.46
101.59
nmol/24h
0.97
13
107
0
11
0.00
0.21
0.0
6.5
—
—
—
0
0
0
12
0.00
0.21
0.0
5.2
—
444.50
—
0
12
0
12
0.00
0.21
0.0
1.3
—
2.04
—
0
12
0
12
0.00
0.21
0.0
1.1
—
8.07
—
0
12
20
173
1.16
0.21
1.5
1.4
2934.25
1953.05
e6/l
0.32
12
115
47
431
1.09
0.20
1.1
1.1
125.22
116.01
%
0.87
41
401
28
249
1.13
0.20
2.0
1.5
1.03
1.30
promille
0.39
20
201
142
1485
0.95
0.20
1.6
1.7
311.09
286.52
mu/l
0.40
129
1349
6
48
1.25
0.20
14.3
6.5
7.40
5.22
kpa
—
6
48
26
292
0.89
0.20
1.9
3.0
—
—
—
0
0
11
133
0.83
0.19
2.1
1.6
1.24
1.29
nmol/l
0.06
11
103
21
184
1.14
0.19
1.4
1.4
—
—
—
0
0
17
148
1.15
0.17
6.7
7.4
7.17
133.59
ug/l
0.61
11
100
351
3589
0.97
0.16
2.7
2.9
0.59
0.69
ug/l
2.74
208
2012
17
149
1.14
0.15
1.6
1.4
18127.50
25699.88
e6/l
—
8
80
22
245
0.90
0.15
3.5
3.4
0.67
0.79
nmol/l
1.44
12
203
7
87
0.80
0.14
3.1
2.0
19.33
15.51
umol/l
—
7
87
10
85
1.18
0.12
3.0
2.3
—
—
—
0
0
10
85
1.18
0.12
3.0
2.3
—
—
—
0
0
10
85
1.18
0.12
3.0
2.3
—
—
—
0
0
12
137
0.88
0.12
6.5
6.4
9.33
7.99
%
0.45
12
137
12
137
0.88
0.12
3.3
3.2
45.42
45.66
%
0.02
12
137
11
125
0.88
0.10
1.4
1.4
70.73
73.69
%
0.24
11
119
48
457
1.05
0.09
1.1
1.1
21.44
1201.93
iu/ml
—
8
115
13
145
0.90
0.09
2.3
1.7
—
—
—
0
0
13
116
1.12
0.09
1.8
1.8
—
—
—
0
0
13
116
1.12
0.09
1.8
1.8
—
—
—
0
0
5
65
0.77
0.08
2.6
3.6
4.76
4.90
kpa
—
5
65
5
65
0.77
0.08
2.6
3.6
10.60
10.62
kpa
—
5
65
44
460
0.96
0.08
3.0
2.6
51.84
114.89
ug/min
1.37
28
285
9
84
1.07
0.07
1.7
1.8
—
—
—
0
0
54
521
1.04
0.07
1.5
2.7
1.03
0.86
nmol/l
0.80
49
455
11
122
0.90
0.07
1.4
1.4
644.09
380.31
mu/l
0.82
11
116
17
183
0.93
0.06
1.8
1.6
0.52
0.48
e9/l
0.32
17
183
18
168
1.07
0.06
1.4
1.2
11.56
8.43
mm/h
1.02
18
168
24
228
1.05
0.05
1.0
1.1
—
—
—
0
0
261
2633
0.99
0.04
2.2
2.2
—
—
—
0
0
11
101
1.09
0.04
1.3
2.1
60.56
107.28
ng/l
2.85
11
101
10
92
1.09
0.03
1.4
1.1
—
—
—
0
0
316
3141
1.01
0.03
2.4
2.3
—
—
—
0
0
84
852
0.99
0.02
1.9
1.9
200.80
209.41
pmol/l
0.44
79
810
25
259
0.96
0.02
1.1
1.1
22.23
16.16
u/ml
—
7
113
61
620
0.98
0.02
1.6
1.5
0.47
0.42
nmol/l
0.25
48
494
31
304
1.02
0.00
1.6
1.6
7.69
7.57
mmol/l
0.12
31
294
19
194
0.98
0.00
1.9
2.5
25.23
30.19
mg/l
0.29
13
133
52
516
1.01
0.00
1.5
1.6
—
—
—
0
0
466
4663
1.00
0.00
3.9
3.8
21.49
21.06
%
0.21
206
1886
0
5
0.00
-0.00
0.0
6.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
59
0.85
-0.00
1.0
2.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.28
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
2.75
—
0
8
0
9
0.00
-0.00
0.0
1.2
—
7.47
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
99.60
—
0
5
0
6
0.00
-0.00
0.0
5.3
—
0.34
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint K11_CD_STRICT2 and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CD_STRICT2 | 1.165 [1.01, 1.34] | 0.033 |
| Birth year | 0.998 [0.99, 1.01] | 0.711 |
During the follow-up period (1.1.1998 — 31.12.2019), 291 out of 5295 females with K11_CD_STRICT2 died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CD_STRICT2 | 1.13 [0.99, 1.29] | 0.074 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 374 out of 5115 males with K11_CD_STRICT2 died.
Mortality risk
Mortality risk for people of age
years, who have K11_CD_STRICT2.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.11% | 0.199% |
| 5 | 0.842% | 1.372% |
| 10 | 1.983% | 3.277% |
| 15 | 3.736% | 6.183% |
| 20 | 6.677% | 10.509% |
Relationships between endpoints
↥Index endpoint: K11_CD_STRICT2 – Crohn disease (strict definition, require KELA, min 2 HDR)
GWS hits: 16
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data